,drug_name,section_name,gpt_output
0,XEOMIN,adverse reactions,"hypersensitivity, dysphagia, breathing difficulties, spread of effects from toxin, neck pain, muscle weakness, injection site pain, musculoskeletal pain, eyelid ptosis, dry eye, dry mouth, diarrhea, headache, visual impairment, dyspnea, nasopharyngitis, respiratory tract infection, facial paresis, injection site hematoma, eyelid edema, sensation of pressure, blepharospasm, eye disorder, immunogenicity, eye swelling, nausea, flu-like symptoms, injection site reaction, allergic dermatitis, localized allergic reactions, swelling, edema, erythema, pruritus, rash, herpes zoster, muscle spasm, dysarthria, myalgia, hypersensitivity"
1,XEOMIN,boxed warnings,"Peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity in the presence of severe renal impairment, increased toxicity in the presence of moderate or severe hepatic impairment, hepatotoxicity, asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death"
2,XEOMIN,warnings and precautions,"respiratory difficulties, speech difficulties, swallowing difficulties, compromised respiratory function, dysphagia, neuromuscular disorders, exacerbate clinical effects, corneal exposure, corneal ulceration, reduced blinking, ectropion, ptosis, asthenia, generalized muscle weakness, diplopia, blurred vision, dysphonia, dysarthria, urinary incontinence, breathing difficulties, anaphylaxis, serum sickness, urticaria, soft tissue edema, dyspnea, severe dysphagia, respiratory failure, peripheral motor neuropathic diseases, amyotrophic lateral sclerosis, neuromuscular junctional disorders, myasthenia gravis, Lambert-Eaton syndrome, severe dysphagia, respiratory compromise, persistent epithelial defect, VII nerve disorders, narrow angle glaucoma, ecchymosis"
3,QUTENZA,adverse reactions,"application-associated pain, increase in blood pressure, application site erythema, application site pain, application site pruritus, application site papules, application site edema, application site swelling, application site dryness, nasopharyngitis, bronchitis, sinusitis, nausea, vomiting, pruritus, hypertension, application site urticaria, application site paresthesia, application site dermatitis, application site hyperesthesia, application site excoriation, application site warmth, application site anesthesia, application site bruising, application site inflammation, application site exfoliation, peripheral edema, headache, burning sensation, peripheral sensory neuropathy, dizziness, dysgeusia, hyperesthesia, hypoesthesia, cough, throat irritation, abnormal skin odor"
4,QUTENZA,warnings and precautions,"coughing, sneezing, irritation of eyes, irritation of airway, transient increases in blood pressure, procedural pain, increases in blood pressure"
5,ZYTIGA,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity in the presence of severe renal impairment, increased toxicity in the presence of moderate or severe hepatic impairment, hepatotoxicity, hypertension, hypokalemia, fluid retention, adrenocortical insufficiency, fatigue, joint swelling or discomfort, edema, hot flush, diarrhea, vomiting, cough, dyspnea, urinary tract infection, contusion, anemia, elevated alkaline phosphatase, hypertriglyceridemia, lymphopenia, hypercholesterolemia, hyperglycemia, elevated AST, hypophosphatemia, elevated ALT, muscle discomfort, dyspepsia, upper respiratory tract infection, urinary frequency, nocturia, fractures, arrhythmia, chest pain or chest discomfort, cardiac failure, pyrexia, groin pain, constipation, insomnia, falls, nasopharyngitis, hematuria, rash, hypernatremia, non-infectious pneumonitis, myopathy, rhabdomyolysis"
6,ZYTIGA,warnings and precautions,"mineralocorticoid excess, cardiovascular disease, LVEF < 50%, NYHA Class III or IV heart failure, hypertension, hypokalemia, fluid retention, adrenocortical insufficiency, hepatotoxicity, grade 3 to 4 hypertension, grade 3 to 4 hypokalemia, grade 3 to 4 edema, heart failure, myocardial infarction, ventricular arrhythmia, adrenal insufficiency, liver enzyme increases, ALT or AST increases, treatment discontinuation due to liver enzyme increases, serum transaminases increases, bilirubin levels increases"
7,TOVIAZ,adverse reactions,"dry mouth, constipation, dyspepsia, nausea, abdominal pain upper, urinary tract infection, upper respiratory tract infection, dry eyes, dysuria, urinary retention, cough, dry throat, edema peripheral, back pain, insomnia, ALT increased, GGT increased, rash, angina, chest pain, gastroenteritis, QT prolongation on ECG, blurred vision, palpitations, hypersensitivity reactions, angioedema with airway obstruction, face edema, dizziness, headache, somnolence, urticaria, pruritus, urinary retention, diverticulitis, irritable bowel syndrome, electrocardiogram QT corrected interval prolongation"
8,TOVIAZ,warnings and precautions,"angioedema, urinary retention, severe constipation, narrow-angle glaucoma, somnolence, headache, dizziness, anticholinergic CNS effects"
9,STRIBILD,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity in the presence of severe renal impairment, increased toxicity in the presence of moderate or severe hepatic impairment, hepatotoxicity, lactic acidosis, severe hepatomegaly with steatosis, severe acute exacerbations of hepatitis B, new onset or worsening renal impairment, bone effects of tenofovir DF, immune reconstitution syndrome, nausea, diarrhea, ocular icterus, flatulence, fatigue, jaundice, somnolence, headache, dizziness, insomnia, abnormal dreams, rash, suicidal ideation, suicide attempt, depression, abdominal pain, dyspepsia, vomiting, fever, pain, nasopharyngitis, pneumonia, sinusitis, upper respiratory tract infection, arthralgia, back pain, myalgia, paresthesia, peripheral neuropathy, anxiety, increased cough, rhinitis, skin discoloration, hyperpigmentation, AST elevation, ALT elevation, amylase elevation, creatine kinase elevation, urine RBC, hematuria, bone mineral density decrease, bone fractures, proteinuria, serum creatinine increase, estimated creatinine clearance decrease, ALT abnormalities, alkaline phosphatase abnormalities, bilirubin abnormalities, serum glucose abnormalities, glycosuria, neutrophils abnormalities, fasting cholesterol abnormalities, fasting triglycerides abnormalities, total cholesterol increase, HDL-cholesterol increase, LDL-cholesterol increase, triglycerides increase, allergic reaction, angioedema, hypokalemia, hypophosphatemia, dyspnea, pancreatitis, hepatic steatosis, hepatitis, increased liver enzymes, rhabdomyolysis, osteomalacia, muscular weakness, myopathy, acute renal failure, renal failure, acute tubular necrosis, Fanconi syndrome, proximal renal tubulopathy, interstitial nephritis, nephrogenic diabetes insipidus, renal insufficiency, polyuria, asthenia"
10,STRIBILD,boxed warnings,"lactic acidosis, severe hepatomegaly with steatosis, fatal cases, severe acute exacerbations of hepatitis B"
11,STRIBILD,warnings and precautions,"renal impairment, acute renal failure, Fanconi syndrome, lactic acidosis, severe hepatomegaly with steatosis, fatal cases, exacerbations of hepatitis B, liver decompensation, liver failure, renal adverse reaction, proximal renal tubulopathy, renal replacement therapy, acute renal failure, nephrotoxic drugs, bone pain, pain in extremities, fractures, muscular pain, weakness, proximal renal tubulopathy, renal function, bone mineral density (BMD), osteoporosis, bone loss, bone abnormalities, osteomalacia, bone pain, pain in extremities, fractures, arthralgias, muscle pain, weakness, hypophosphatemia, osteomalacia, redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, cushingoid appearance, immune reconstitution syndrome, inflammatory response, opportunistic infections, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jirovecii pneumonia (PCP), tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome"
12,FARXIGA,adverse reactions,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, increases in LDL-C, bladder cancer, nasopharyngitis, urinary tract infections, back pain, increased urination, male genital mycotic infections, nausea, influenza, dyslipidemia, constipation, discomfort with urination, pain in extremity, volume depletion, dehydration, hypovolemia, orthostatic hypotension, renal failure, blood creatinine increase, bone fractures, hypersensitivity reactions, angioedema, urticaria, anaphylactic reactions, severe cutaneous adverse reactions, increase in hematocrit, increase in serum inorganic phosphorus, increase in low-density lipoprotein cholesterol"
13,FARXIGA,warnings and precautions,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, increased LDL-C, bladder cancer"
14,VICTRELIS,adverse reactions,"'anemia, neutropenia, pancytopenia, hypersensitivity, fatigue, nausea, headache, dysgeusia, anemia, nausea, headache, dysgeusia, anemia, neutropenia, gastrointestinal disorders, nausea, dysgeusia, diarrhea, vomiting, dry mouth, fatigue, chills, asthenia, decreased appetite, arthralgia, dizziness, insomnia, irritability, dyspnea exertional, alopecia, dry skin, rash, agranulocytosis, thrombocytopenia, mouth ulceration, stomatitis, pneumonia, sepsis, angioedema, urticaria, drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, exfoliative rash, exfoliative dermatitis, Stevens-Johnson syndrome, toxic skin eruption, toxicoderma'"
15,VICTRELIS,warnings and precautions,"'embryofetal toxicity, birth defects, fetal death, anemia, decrease in hemoglobin concentrations, neutropenia, worsening of neutropenia, hypersensitivity, serious acute hypersensitivity reactions, urticaria, angioedema, pancytopenia, thromboembolic events, pulmonary embolism, acute myocardial infarction, cerebrovascular accident, deep vein thrombosis, infections, life-threatening neutropenia'"
16,VIMIZIM,adverse reactions,"'anaphylaxis, hypersensitivity reactions, pyrexia, vomiting, headache, nausea, abdominal pain, chills, fatigue, immunogenicity, anti-drug antibodies, neutralizing antibodies'"
17,VIMIZIM,boxed warnings,"anaphylactic reactions, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, hypersensitivity reactions"
18,VIMIZIM,warnings and precautions,"anaphylaxis, hypersensitivity reactions, acute respiratory complications, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, peripheral edema, acute febrile, respiratory illness, sleep apnea, spinal or cervical cord compression, back pain, paralysis, urinary incontinence, fecal incontinence"
19,BEPREVE,adverse reactions,"mild taste following instillation, eye irritation, headache, nasopharyngitis, hypersensitivity reactions, itching, body rash, swelling of lips, tongue and/or throat"
20,BEPREVE,warnings and precautions,contamination
21,PRISTIQ,adverse reactions,"hypersensitivity, suicidal thoughts and behaviors, serotonin syndrome, elevated blood pressure, abnormal bleeding, angle closure glaucoma, activation of mania/hypomania, discontinuation syndrome, seizure, hyponatremia, interstitial lung disease, eosinophilic pneumonia, nausea, dizziness, insomnia, hyperhidrosis, constipation, somnolence, decreased appetite, anxiety, specific male sexual function disorders, blood pressure increased, dry mouth, vomiting, fatigue, chills, feeling jittery, decreased appetite, tremor, disturbance in attention, nervousness, abnormal dreams, urinary hesitation, yawning, vision blurred, mydriasis, vertigo, tinnitus, dysgeusia, hot flush, anorgasmia, libido decreased, orgasm abnormal, ejaculation delayed, erectile dysfunction, ejaculation disorder, ejaculation failure, sexual dysfunction, tachycardia, asthenia, weight increased, liver function test abnormal, blood prolactin increased, musculoskeletal stiffness, syncope, convulsion, dystonia, depersonalization, bruxism, urinary retention, rash, alopecia, photosensitivity reaction, angioedema, myocardial ischemia, myocardial infarction, coronary occlusion requiring revascularization, total cholesterol increase, LDL cholesterol increase, triglycerides increase, proteinuria, supine systolic blood pressure increase, supine diastolic blood pressure increase, pulse rate increase, weight decrease, sustained hypertension, orthostatic hypotension, Stevens-Johnson syndrome"
22,PRISTIQ,boxed warnings,"suicidal thoughts, behaviors"
23,PRISTIQ,warnings and precautions,"clinical worsening, suicide risk, serotonin syndrome, elevated blood pressure, abnormal bleeding, angle closure glaucoma, activation of mania/hypomania, discontinuation syndrome, seizure, hyponatremia, interstitial lung disease, eosinophilic pneumonia"
24,TAFINLAR,adverse reactions,"new primary malignancies, tumor promotion in BRAF wild-type melanoma, hemorrhage, venous thromboembolism, cardiomyopathy, ocular toxicities, serious febrile reactions, serious skin toxicity, hyperglycemia, glucose-6-phosphate dehydrogenase deficiency, hyperkeratosis, headache, pyrexia, arthralgia, papilloma, alopecia, palmar-plantar erythrodysesthesia syndrome, chills, fatigue, rash, nausea, vomiting, diarrhea, abdominal pain, peripheral edema, cough, night sweats, decreased appetite, constipation, myalgia, back pain, myalgia, cough, constipation, nasopharyngitis, pancreatitis, hypersensitivity manifesting as bullous rash, interstitial nephritis, vision blurred, transient blindness, stomatitis, asthenia, cellulitis, folliculitis, paronychia, rash pustular, skin papilloma, palmar-plantar erythrodysesthesia syndrome, hyperkeratosis, hyperhidrosis, hypertension, leukopenia, lymphopenia, neutropenia, anemia, thrombocytopenia, increased AST, increased alkaline phosphatase, increased ALT, hyperbilirubinemia, hyperglycemia, increased GGT, hyponatremia, hypoalbuminemia, hypophosphatemia, hypokalemia, increased creatinine, hypomagnesemia, hyperkalemia, hypercalcemia, hypocalcemia, QT prolongation"
25,TAFINLAR,warnings and precautions,"retinal vein occlusion, interstitial lung disease, new primary malignancies, cutaneous, non-cutaneous, tumor promotion in BRAF wild-type melanoma, hemorrhage, venous thromboembolism, deep vein thrombosis, pulmonary embolism, cardiomyopathy, ocular toxicities, serious febrile reactions, serious skin toxicity, hyperglycemia, glucose-6-phosphate dehydrogenase deficiency, embryofetal toxicity, cutaneous squamous cell carcinoma, keratoacanthoma, melanoma, basal cell carcinoma, non-cutaneous malignancies, pancreatic adenocarcinoma, colorectal carcinoma, head and neck carcinoma, glioblastoma, major hemorrhagic events, intracranial hemorrhage, gastric hemorrhage, retinal pigment epithelial detachment, uveitis, iritis, fever, hypotension, rigors, chills, dehydration, renal failure, skin toxicity, secondary infections of the skin, hemolytic anemia"
26,MULTAQ,adverse reactions,"'heart failure, liver injury, pulmonary toxicity, hypokalemia, hypomagnesemia, QT prolongation, diarrhea, nausea, abdominal pain, vomiting, asthenia, gastrointestinal disorders, QT prolongation, bradycardia, rashes, pruritus, eczema, dermatitis, dermatitis allergic, photosensitivity reaction, dysgeusia, increases in creatinine, QTc prolonged, worsening heart failure, atrial flutter with 1:1 atrioventricular conduction, liver injury, interstitial lung disease, pneumonitis, pulmonary fibrosis, anaphylactic reactions, angioedema, vasculitis, leukocytoclastic vasculitis'"
27,MULTAQ,boxed warnings,"death, stroke, heart failure"
28,MULTAQ,warnings and precautions,"'cardiovascular death, heart failure, liver injury, pulmonary toxicity, hypokalemia, hypomagnesemia, QT interval prolongation, renal impairment, renal failure, hepatocellular liver injury, acute liver failure, interstitial lung disease, pneumonitis, pulmonary fibrosis, dyspnea, non-productive cough, pre-renal azotemia, fetal harm'"
29,TANZEUM,adverse reactions,"thyroid C-cell tumors, acute pancreatitis, hypoglycemia, hypersensitivity reactions, renal impairment, upper respiratory tract infection, diarrhea, nausea, injection site reaction, cough, back pain, arthralgia, sinusitis, influenza, vomiting, gastroesophageal reflux disease, dyspepsia, constipation, injection site hematoma, injection site erythema, injection site rash, injection site hypersensitivity, injection site hemorrhage, injection site pruritus, pneumonia, atrial fibrillation, atrial flutter, appendicitis, liver enzyme abnormalities, gamma glutamyltransferase (GGT) increase, heart rate increase"
30,TANZEUM,boxed warnings,"thyroid C-cell tumors, medullary thyroid carcinoma"
31,TANZEUM,warnings and precautions,"thyroid C-cell tumors, pancreatitis, hypoglycemia, hypersensitivity reactions, renal impairment, acute renal failure, worsening of chronic renal failure"
32,BELEODAQ,adverse reactions,"hematologic toxicity, infection, hepatotoxicity, tumor lysis syndrome, gastrointestinal toxicity, nausea, fatigue, pyrexia, anemia, vomiting, constipation, diarrhea, dyspnea, rash, peripheral edema, cough, thrombocytopenia, pruritus, chills, increased blood lactate dehydrogenase, decreased appetite, headache, infusion site pain, hypokalemia, prolonged QT, abdominal pain, hypotension, phlebitis, dizziness, pneumonia, increased creatinine, multi-organ failure, hepatic failure, ventricular fibrillation"
33,BELEODAQ,warnings and precautions,"thrombocytopenia, leukopenia, neutropenia, lymphopenia, anemia, infection, serious infections, fatal infections, pneumonia, sepsis, hepatotoxicity, liver function test abnormalities, tumor lysis syndrome, gastrointestinal toxicity, nausea, vomiting, diarrhea, embryo-fetal toxicity, fetal harm, teratogenicity, embryo-fetal lethality"
34,HALAVEN,adverse reactions,"neutropenia, anemia, asthenia/fatigue, alopecia, peripheral neuropathy, nausea, constipation, febrile neutropenia, mucosal inflammation, pyrexia, diarrhea, vomiting, arthralgia/myalgia, back pain, bone pain, pain in extremity, weight decreased, anorexia, cough, dyspnea, urinary tract infection, thrombocytopenia, peripheral motor neuropathy, liver function test abnormalities, increased lacrimation, dyspepsia, abdominal pain, stomatitis, dry mouth, peripheral edema, upper respiratory tract infection, hypokalemia, muscle spasms, muscular weakness, dysgeusia, dizziness, insomnia, depression, rash, lymphopenia, pancreatitis, hepatotoxicity, drug hypersensitivity, pneumonia, sepsis/neutropenic sepsis, hypomagnesemia, dehydration, interstitial lung disease, pruritus"
35,HALAVEN,warnings and precautions,"'neutropenia, peripheral neuropathy, embryo-fetal toxicity, QT prolongation, severe neutropenia, Grade 4 neutropenia, febrile neutropenia, Grade 3 peripheral neuropathy, Grade 4 peripheral neuropathy, neuropathy lasting more than one year, new or worsening neuropathy'"
36,XIAFLEX,adverse reactions,"tendon ruptures, injury to the injected extremity, corporal rupture (penile fracture), severe penile hematoma, penile ecchymoses, hematoma, sudden penile detumescence, penile ""popping"" sound or sensation, edema peripheral, contusion, injection site hemorrhage, injection site reaction, pain in the injected extremity, pruritus, lymphadenopathy, skin laceration, lymph node pain, erythema, axillary pain, vasovagal syncope, blood blister, injection site hematoma, injection site swelling, ecchymosis, penile pain, penile ecchymoses, penile blister, pruritus genital, painful erection, erectile dysfunction, skin discoloration, procedural pain, injection site vesicles, localized edema, dyspareunia, injection site pruritus, nodule, suprapubic pain"
37,XIAFLEX,boxed warnings,"corporal rupture, penile fracture, serious penile injury, penile ecchymoses, hematoma, sudden penile detumescence, penile ""popping"" sound, severe penile hematoma"
38,XIAFLEX,warnings and precautions,"tendon rupture, serious injury, injected finger/hand, permanent injury, tendon rupture, ligament damage, skin laceration, corporal rupture (penile fracture), serious injury to the penis, hypersensitivity reactions, anaphylaxis, abnormal coagulation, flexor tendon ruptures, pulley rupture, ligament injury, complex regional pain syndrome (CRPS), sensory abnormality of the hand, skin laceration (tear), skin laceration requiring skin graft, corporal rupture, penile ecchymoses, hematoma, sudden penile detumescence, penile ""popping"" sound or sensation, severe penile hematoma, allergic reactions (pruritus), IgE-anti-drug antibodies, ecchymosis/contusion, injection site hemorrhage, penile hematoma, penile ecchymosis"
39,CIMZIA,adverse reactions,"upper respiratory tract infection, rash, urinary tract infection, serious infections, malignancies, heart failure, abdominal pain, diarrhea, intestinal obstruction, tuberculosis infections, pyrexia, urticaria, pneumonia, nasopharyngitis, laryngitis, viral infection, bladder infection, bacteriuria, cystitis, arthralgia, anemia, leukopenia, lymphadenopathy, pancytopenia, thrombophilia, angina pectoris, arrhythmias, atrial fibrillation, cardiac failure, hypertensive heart disease, myocardial infarction, myocardial ischemia, pericardial effusion, pericarditis, stroke, transient ischemic attack, optic neuritis, retinal hemorrhage, uveitis, bleeding, injection site reactions, elevated liver enzymes, hepatitis, alopecia totalis, anxiety, bipolar disorder, suicide attempt, nephrotic syndrome, renal failure, menstrual disorder, dermatitis, erythema nodosum, thrombophlebitis, vasculitis, upper respiratory tract infection, headache, hypertension, back pain, pharyngitis, acute bronchitis, fatigue, herpes infections, lower respiratory tract infections, cellulitis, pyelonephritis, lupus-like syndrome, systemic vasculitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, new or worsening psoriasis, sarcoidosis"
40,CIMZIA,boxed warnings,"serious infections, hospitalization, death, active tuberculosis, reactivation of latent tuberculosis, invasive fungal infections, histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, bacterial infections, viral infections, infections due to opportunistic pathogens, Legionella, Listeria, sepsis, lymphoma, malignancies"
41,CIMZIA,warnings and precautions,"serious infections, invasive fungal infections, lymphoma, other malignancies, heart failure, anaphylaxis, serious allergic reactions, hepatitis B virus reactivation, demyelinating disease, cytopenias, pancytopenia, lupus-like syndrome, worsening congestive heart failure, new onset congestive heart failure, hypersensitivity reactions, angioedema, dyspnea, hypotension, rash, serum sickness, urticaria, hepatitis B virus reactivation, neurologic reactions, new onset or exacerbation of central nervous system demyelinating disease, multiple sclerosis, peripheral demyelinating disease, Guillain-Barre syndrome, seizure disorder, optic neuritis, peripheral neuropathy, hematological reactions, pancytopenia, aplastic anemia, leukopenia, thrombocytopenia, blood dyscrasias, infection, fever, bruising, bleeding, pallor, autoantibodies, lupus-like syndrome, immunosuppression"
42,GRANIX,adverse reactions,"splenic rupture, acute respiratory distress syndrome, serious allergic reactions, capillary leak syndrome, tumor growth stimulatory effects on malignant cells, bone pain, leukocytosis, myalgia, headache, vomiting, Sweet's syndrome, cutaneous vasculitis, thrombocytopenia"
43,GRANIX,warnings and precautions,"'splenic rupture, acute respiratory distress syndrome (ARDS), allergic reactions, angioneurotic edema, dermatitis allergic, drug hypersensitivity, hypersensitivity, rash, pruritic rash, urticaria, sickle cell crisis, capillary leak syndrome (CLS), tumor growth stimulatory effects on malignant cells'"
44,TUDORZA,adverse reactions,"paradoxical bronchospasm, worsening of narrow-angle glaucoma, worsening of urinary retention, immediate hypersensitivity reactions, headache, nasopharyngitis, cough, diarrhea, sinusitis, rhinitis, toothache, fall, vomiting, diabetes mellitus, dry mouth, 1st degree AV block, osteoarthritis, cardiac failure, cardio-respiratory arrest, anaphylaxis, angioedema, urticaria, rash, bronchospasm, itching"
45,TUDORZA,warnings and precautions,"paradoxical bronchospasm, worsening of narrow-angle glaucoma, worsening of urinary retention, immediate hypersensitivity reactions, angioedema, bronchospasm, anaphylaxis, urticaria, rash, itching"
46,JEVTANA,adverse reactions,"Bone Marrow Suppression, Hypersensitivity Reactions, Gastrointestinal Adverse Reactions, Renal Failure, Embryo-Fetal Toxicity, neutropenia, anemia, leukopenia, thrombocytopenia, diarrhea, fatigue, nausea, vomiting, constipation, asthenia, abdominal pain, hematuria, back pain, anorexia, peripheral neuropathy, pyrexia, dyspnea, dysgeusia, cough, arthralgia, alopecia, infections, renal failure, ventricular fibrillation, cerebral hemorrhage, dyspnea, febrile neutropenia, peripheral edema, mucosal inflammation, pain, urinary tract infection, weight decreased, dehydration, muscle spasms, dizziness, headache, dysuria, hypotension, sepsis, septic shock, gastritis, intestinal obstruction"
47,JEVTANA,boxed warnings,"neutropenic deaths, neutropenia, severe hypersensitivity, generalized rash/erythema, hypotension, bronchospasm"
48,JEVTANA,warnings and precautions,"bone marrow suppression, neutropenia, febrile neutropenia, neutropenic infections, hypersensitivity, hypersensitivity reactions, gastrointestinal disorders, nausea, vomiting, diarrhea, gastrointestinal hemorrhage, gastrointestinal perforation, neutropenic enterocolitis, renal failure, fetal harm"
49,ILARIS,adverse reactions,"'peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, infections, serious infections, nasopharyngitis, diarrhea, influenza, headache, nausea, abdominal pain, injection site reactions, vertigo, bronchitis, gastroenteritis, pharyngitis, weight increased, musculoskeletal pain, pneumonia, varicella, gastroenteritis, measles, sepsis, otitis media, sinusitis, adenovirus, lymph node abscess, pharyngitis, hypersensitivity, decreased white blood cells, neutrophils, platelets, elevated transaminases, asymptomatic and mild elevations of serum bilirubin'"
50,ILARIS,warnings and precautions,"serious infections, infections, recurring infections, opportunistic infections, aspergillosis, atypical mycobacterial infections, cytomegalovirus, herpes zoster, tuberculosis, reactivation of latent tuberculosis, immunosuppression, malignancies, hypersensitivity reactions, anaphylactic reactions, immunizations, live vaccines, Macrophage Activation Syndrome (MAS)"
51,AMPYRA,adverse reactions,"seizures, anaphylaxis, urinary tract infections, urinary tract infection, insomnia, dizziness, headache, nausea, asthenia, back pain, balance disorder, multiple sclerosis relapse, paresthesia, nasopharyngitis, constipation, dyspepsia, pharyngolaryngeal pain"
52,AMPYRA,warnings and precautions,"seizures, anaphylaxis, severe allergic reactions, respiratory compromise, urticaria, angioedema, urinary tract infections"
53,SIRTURO,adverse reactions,"increased mortality, QT prolongation, hepatotoxicity, nausea, arthralgia, headache, hemoptysis, chest pain, anorexia, transaminases increased, rash, blood amylase increased"
54,SIRTURO,boxed warnings,"increased mortality, QT prolongation, death, ventricular arrhythmia"
55,SIRTURO,warnings and precautions,"QT prolongation, ventricular arrhythmia, QTcF interval > 500 ms, hepatotoxicity, increased mortality, death, ventricular arrhythmias, myocardial infarction, Torsade de Pointes, congenital long QT syndrome, hypothyroidism, bradyarrhythmias, uncompensated heart failure, serum calcium below normal, serum magnesium below normal, serum potassium below normal, clinically significant ventricular arrhythmia, syncope, hepatic-related adverse reactions, fatigue, anorexia, nausea, jaundice, dark urine, liver tenderness, hepatomegaly, aminotransferase elevations, total bilirubin elevation, increased risk of adverse reactions"
56,ADREVIEW,adverse reactions,"hypersensitivity reactions, dizziness, rash, pruritis, flushing, headache, injection site hemorrhage, hematoma, bruising"
57,ADREVIEW,warnings and precautions,"hypersensitivity reactions, anaphylactic and hypersensitivity treatment measures, serious reactions, increased radiation exposure, decreased quality of AdreView images, iodine 123 accumulation in the thyroid, benzyl alcohol toxicity, hypotension, metabolic acidosis, kernicterus, deaths, increased long term risk for thyroid neoplasia, transient episode of hypertension"
58,ARCAPTA,adverse reactions,"asthma-related death, cough, oropharyngeal pain, nasopharyngitis, headache, nausea, COPD, dyspnea, COPD exacerbation, pneumonia, angina pectoris, atrial fibrillation, muscle spasm, musculoskeletal pain, edema peripheral, diabetes mellitus, hyperglycemia, sinusitis, upper respiratory tract infection, respiratory-related deaths, asthma exacerbation, hypersensitivity reactions, paradoxical bronchospasm, tachycardia, heart rate increase, palpitations, pruritus, rash, dizziness"
59,ARCAPTA,boxed warnings,asthma-related death
60,ARCAPTA,warnings and precautions,"asthma-related death, serious asthma-related events, deterioration of disease, acute episodes of bronchospasm, excessive use, cardiovascular effects, fatalities, immediate hypersensitivity reactions, paradoxical bronchospasm, life-threatening, cardiovascular effects, pulse rate increase, systolic blood pressure increase, diastolic blood pressure increase, ECG changes, flattening of the T wave, prolongation of the QTc interval, ST segment depression, convulsive disorders, thyrotoxicosis, diabetes mellitus aggravation, ketoacidosis, hypokalemia, hyperglycemia"
61,INTELENCE,adverse reactions,"severe skin reactions, hypersensitivity reactions, rash, peripheral neuropathy, diarrhea, Stevens-Johnson syndrome, drug hypersensitivity reaction, erythema multiforme, myocardial infarction, angina pectoris, atrial fibrillation, vertigo, blurred vision, gastroesophageal reflux disease, flatulence, gastritis, abdominal distension, pancreatitis, constipation, dry mouth, hematemesis, retching, stomatitis, sluggishness, hemolytic anemia, hepatic failure, hepatomegaly, cytolytic hepatitis, hepatic steatosis, hepatitis, immune reconstitution syndrome, diabetes mellitus, anorexia, dyslipidemia, paraesthesia, somnolence, convulsion, hypoesthesia, amnesia, syncope, disturbance in attention, hypersomnia, tremor, anxiety, sleep disorders, abnormal dreams, confusional state, disorientation, nervousness, nightmares, acute renal failure, gynecomastia, exertional dyspnea, bronchospasm, night sweats, lipohypertrophy, prurigo, hyperhidrosis, dry skin, swelling face, acquired lipodystrophy, angioneurotic edema, haemorrhagic stroke, pancreatic amylase increase, lipase increase, creatinine increase, decreased hemoglobin, white blood cell count decrease, neutrophils decrease, platelet count decrease, total cholesterol increase, low density lipoprotein increase, triglycerides increase, elevated glucose levels, alanine amino transferase increase, aspartate amino transferase increase, severe hypersensitivity reactions, DRESS, hepatic failure, rhabdomyolysis, toxic epidermal necrolysis"
62,INTELENCE,warnings and precautions,"severe skin reactions, fatal skin reactions, Stevens-Johnson syndrome, hypersensitivity reaction, toxic epidermal necrolysis, erythema multiforme, severe hypersensitivity, severe rash, rash with systemic symptoms, liver transaminase elevations, hypersensitivity reactions, Drug Rash with Eosinophilia and Systemic Symptoms (DRESS), rash, constitutional findings, organ dysfunction, hepatic failure, Grade 3 and 4 rashes, severe rash, rash accompanied by fever, general malaise, fatigue, muscle or joint aches, blisters, oral lesions, conjunctivitis, facial edema, hepatitis, eosinophilia, angioedema, redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, cushingoid appearance, immune reconstitution syndrome, inflammatory response, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jiroveci pneumonia (PCP), tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome"
63,PICATO,adverse reactions,"ophthalmic adverse reaction, hypersensitivity reactions, local skin reactions, application site pain, application site pruritus, application site irritation, application site infection, periorbital edema, nasopharyngitis, headache, erythema, flaking/scaling, crusting, swelling, vesiculation/pustulation, erosion/ulceration, eyelid edema, eye pain, conjunctivitis, hypersensitivity, allergic contact dermatitis, herpes zoster, chemical conjunctivitis, corneal burn"
64,PICATO,warnings and precautions,"eye disorders, severe eye pain, chemical conjunctivitis, corneal burn, eyelid edema, eyelid ptosis, periorbital edema, local skin reactions, vesiculation/pustulation, erosion/ulceration, hypersensitivity reactions, anaphylaxis, allergic contact dermatitis, erythema, crusting, swelling"
65,VIZAMYL,adverse reactions,"flushing, headache, increased blood pressure, nausea, dizziness, hypersensitivity reaction, dyspnea, chest pressure"
66,VIZAMYL,warnings and precautions,"hypersensitivity reactions, flushing, dyspnea, image interpretation errors, radiation risk"
67,POTIGA,adverse reactions,"retinal abnormalities, potential vision loss, urinary retention, skin discoloration, neuropsychiatric symptoms, dizziness, somnolence, QT interval effect, suicidal behavior, ideation, withdrawal seizures, fatigue, confusional state, vertigo, tremor, abnormal coordination, diplopia, disturbance in attention, memory impairment, asthenia, blurred vision, gait disturbance, aphasia, dysarthria, balance disorder, nausea, constipation, dyspepsia, influenza, weight increased, paresthesia, amnesia, dysphasia, anxiety, disorientation, psychotic disorder, dysuria, urinary hesitation, hematuria, chromaturia, increased appetite, hallucinations, myoclonus, peripheral edema, hypokinesia, dry mouth, dysphagia, hyperhydrosis, malaise, increased liver enzymes, rash, nystagmus, dyspnea, leukopenia, muscle spasms, alopecia, nephrolithiasis, syncope, neutropenia, thrombocytopenia, euphoric mood, renal colic, coma, encephalopathy"
68,POTIGA,boxed warnings,"retinal abnormalities, vision loss, abnormal visual acuity, decreased visual acuity, retinal pigmentary abnormalities, vision changes"
69,POTIGA,warnings and precautions,"urinary retention, skin discoloration, confusional state, psychotic symptoms, hallucinations, dizziness, somnolence, QT prolongation, suicidal thoughts or behaviors, retinal abnormalities, potential vision loss, hydronephrosis, renal function impairment, neuropsychiatric symptoms, withdrawal seizures"
70,BREO,adverse reactions,"asthma-related death, asthma-related hospitalization, pneumonia, immunosuppression, hypercorticism, adrenal suppression, reduction in bone mineral density, nasopharyngitis, upper respiratory tract infection, headache, oral candidiasis, oropharyngeal candidiasis, candidiasis, fungal oropharyngitis, back pain, bronchitis, sinusitis, cough, arthralgia, influenza, pharyngitis, pyrexia, dysphonia, oropharyngeal pain, viral respiratory tract infection, extrasystoles, upper abdominal pain, respiratory tract infection, allergic rhinitis, rhinitis, supraventricular extrasystoles, ventricular extrasystoles, acute sinusitis, palpitations, tachycardia, hypersensitivity reactions, anaphylaxis, angioedema, rash, urticaria, muscle spasms, tremor, nervousness"
71,BREO,boxed warnings,"asthma-related death, increase in asthma-related deaths, increased risk of asthma-related hospitalization"
72,BREO,warnings and precautions,"'asthma-related death, asthma-related hospitalizations, Candida albicans infection, pneumonia, worsening of infections, tuberculosis, fungal infections, bacterial infections, viral infections, parasitic infections, ocular herpes simplex, chickenpox, measles, adrenal insufficiency, hypercorticism, adrenal suppression, paradoxical bronchospasm, anaphylaxis, angioedema, rash, urticaria, cardiovascular effects, arrhythmias, supraventricular tachycardia, extrasystoles, electrocardiographic changes, flattening of the T wave, prolongation of the QTc interval, ST segment depression, ventricular arrhythmias, coronary insufficiency, cardiac arrhythmias, hypertension, reduction in bone mineral density, glaucoma, increased intraocular pressure, cataracts, convulsive disorders, thyrotoxicosis, diabetes mellitus, ketoacidosis, hypokalemia, hyperglycemia, reduction in growth velocity'"
73,DOTAREM,adverse reactions,"'NSF, hypersensitivity reactions, acute kidney injury, nausea, headache, injection site pain, injection site coldness, burning sensation, feeling cold, rash, somnolence, fatigue, dizziness, vomiting, pruritus, paresthesia, dysgeusia, pain in extremity, anxiety, hypertension, palpitations, oropharyngeal discomfort, serum creatinine increased, injection site reactions, site inflammation, extravasation, warmth, bradycardia, tachycardia, arrhythmia, anaphylactoid reactions, cardiac arrest, respiratory arrest, cyanosis, pharyngeal edema, laryngospasm, bronchospasm, angioedema, conjunctivitis, ocular hyperemia, eyelid edema, lacrimation increased, hyperhidrosis, urticaria, coma, convulsion, syncope, presyncope, parosmia, tremor, muscle contracture, muscle weakness, diarrhea, salivary hypersecretion, malaise, fever, superficial phlebitis'"
74,DOTAREM,boxed warnings,"nephrogenic systemic fibrosis, fatal fibrosis, debilitating fibrosis, chronic severe kidney disease, acute kidney injury"
75,DOTAREM,warnings and precautions,"nephrogenic systemic fibrosis, anaphylactoid reactions, anaphylactic reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, death, acute kidney injury, drug-induced kidney toxicity, NSF, fibrosis affecting the skin, fibrosis affecting the muscle, fibrosis affecting internal organs, circulatory collapse, hypersensitivity reactions, extravasation, tissue irritation"
76,NESINA,adverse reactions,"'nasopharyngitis, headache, upper respiratory tract infection, pancreatitis, hypersensitivity reactions, serum sickness, hypoglycemia, anaphylaxis, angioedema, rash, urticaria, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic enzyme elevations, fulminant hepatic failure, severe and disabling arthralgia, acute pancreatitis'"
77,NESINA,warnings and precautions,"acute pancreatitis, hypersensitivity reactions, anaphylaxis, angioedema, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic failure, hypoglycemia, arthralgia, liver injury, liver enzyme elevations, fatigue, anorexia, right upper abdominal discomfort, dark urine, jaundice"
78,EYLEA,adverse reactions,"endophthalmitis, retinal detachments, increased intraocular pressure, thromboembolic events, conjunctival hemorrhage, eye pain, cataract, vitreous floaters, vitreous detachment, ocular hyperemia, corneal epithelium defect, detachment of the retinal pigment epithelium, injection site pain, foreign body sensation in eyes, lacrimation increased, vision blurred, intraocular inflammation, retinal pigment epithelium tear, injection site hemorrhage, eyelid edema, corneal edema, hypersensitivity, retinal detachment, retinal tear, immunogenicity"
79,EYLEA,warnings and precautions,"endophthalmitis, retinal detachments, increases in intraocular pressure, arterial thromboembolic events, nonfatal stroke, nonfatal myocardial infarction, vascular death"
80,TECFIDERA,adverse reactions,"anaphylaxis, angioedema, progressive multifocal leukoencephalopathy, lymphopenia, flushing, abdominal pain, diarrhea, nausea, vomiting, pruritus, rash, albumin urine present, erythema, dyspepsia, aspartate aminotransferase increased, gastrointestinal events, elevations of hepatic transaminases, eosinophilia"
81,TECFIDERA,warnings and precautions,"anaphylaxis, angioedema, progressive multifocal leukoencephalopathy (PML), lymphopenia, infections, serious infections, flushing"
82,TREANDA,adverse reactions,"myelosuppression, infections, anaphylaxis, infusion reactions, tumor lysis syndrome, skin reactions, other malignancies, extravasation injury, pyrexia, nausea, vomiting, fatigue, diarrhea, constipation, anorexia, cough, headache, weight decreased, dyspnea, rash, stomatitis, lymphopenia, anemia, leukopenia, thrombocytopenia, neutropenia, asthenia, malaise, weakness, dry mouth, somnolence, mucosal inflammation, hypertension, hypertensive crisis, hypersensitivity, gastrointestinal disorders, general disorders and administration site conditions, immune system disorders, infections and infestations, investigations, metabolism and nutrition disorders, respiratory, thoracic and mediastinal disorders, skin and subcutaneous tissue disorders, hematology laboratory abnormalities, bilirubin elevations, increased AST, increased ALT, creatinine levels changes, cardiac disorders, tachycardia, abdominal pain, dyspepsia, gastroesophageal reflux disease, edema peripheral, chest pain, infusion site pain, pain, catheter site pain, herpes zoster, upper respiratory tract infection, urinary tract infection, sinusitis, pneumonia, febrile neutropenia, oral candidiasis, nasopharyngitis, dehydration, decreased appetite, hypokalemia, back pain, arthralgia, pain in extremity, bone pain, dizziness, dysgeusia, insomnia, anxiety, depression, pharyngolaryngeal pain, wheezing, nasal congestion, night sweats, hyperhidrosis, hypotension, hyperglycemia, hyponatremia, hypocalcemia, acute renal failure, cardiac failure, pulmonary fibrosis, myelodysplastic syndrome, hemolysis, taste disorder, atypical pneumonia, sepsis, erythema, dermatitis, skin necrosis, anaphylaxis, phlebitis, pruritus, irritation, pain, swelling, pneumocystis jiroveci pneumonia, pneumonitis, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN)"
83,TREANDA,warnings and precautions,"myelosuppression, death, infections, fever, anaphylaxis, infusion reactions, tumor lysis syndrome, acute renal failure, skin reactions, severe skin reactions, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), other malignancies, extravasation injury, erythema, swelling, pain, embryo-fetal toxicity, resorptions, skeletal malformations, visceral malformations, decreased fetal body weights"
84,ELIQUIS,adverse reactions,"thrombotic events, bleeding, spinal/epidural anesthesia or puncture, intracranial bleed, hemorrhagic stroke, gastrointestinal bleed, fatal bleeding, hypersensitivity reactions, anaphylactic reactions, syncope, nausea, anemia, contusion, hemorrhage, postprocedural hemorrhage, transaminases increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, thrombocytopenia, hypotension, epistaxis, gastrointestinal hemorrhage, hematochezia, liver function test abnormal, blood alkaline phosphatase increased, blood bilirubin increased, hematuria, wound secretion, incision-site hemorrhage, operative hemorrhage, gingival bleeding, hemoptysis, hypersensitivity, muscle hemorrhage, ocular hemorrhage, rectal hemorrhage, hemorrhagic anemia, hemorrhoidal hemorrhage, hematemesis, melena, anal hemorrhage, wound hemorrhage, postprocedural hemorrhage, traumatic hematoma, periorbital hematoma, muscle hemorrhage, vaginal hemorrhage, metrorrhagia, menometrorrhagia, genital hemorrhage, hemorrhage, ecchymosis, skin hemorrhage, petechiae, conjunctival hemorrhage, retinal hemorrhage, eye hemorrhage, blood urine present, occult blood positive, occult blood, red blood cells urine positive, injection-site hematoma, vessel puncture-site hematoma"
85,ELIQUIS,boxed warnings,"thrombotic events, spinal/epidural hematoma, paralysis"
86,ELIQUIS,warnings and precautions,"serious, potentially fatal bleeding, thrombotic events, stroke, bleeding, blood loss, active pathological hemorrhage, epidural or spinal hematoma, long-term or permanent paralysis, neurological impairment, numbness, weakness of the legs, bowel dysfunction, bladder dysfunction"
87,BOSULIF,adverse reactions,"'gastrointestinal toxicity, myelosuppression, hepatic toxicity, fluid retention, renal toxicity, diarrhea, nausea, thrombocytopenia, vomiting, abdominal pain, rash, anemia, pyrexia, fatigue, anaphylactic shock, increased alanine aminotransferase, headache, cough, increased aspartate aminotransferase, neutropenia, edema, arthralgia, decreased appetite, respiratory tract infection, nasopharyngitis, back pain, asthenia, pruritus, dizziness, dyspnea, QTcF interval prolongation, platelet count low, absolute neutrophil count low, hemoglobin low, SGPT/ALT greater than 5.0*ULN, SGOT/AST greater than 5.0*ULN, lipase greater than 2*ULN, phosphorus low, total bilirubin greater than 3.0*ULN, febrile neutropenia, pericardial effusion, pericarditis, tinnitus, gastritis, acute pancreatitis, gastrointestinal hemorrhage, chest pain, pain, hepatotoxicity, toxic hepatitis, cytolytic hepatitis, abnormal hepatic function, liver disorder, liver injury, drug hypersensitivity, anaphylactic shock, pneumonia, bronchopneumonia, lobar pneumonia, primary atypical pneumonia, influenza, bronchitis, electrocardiogram QT prolonged, increased blood creatine phosphokinase, increased blood creatinine, hyperkalemia, dehydration, myalgia, dysgeusia, acute renal failure, renal failure, pleural effusion, acute pulmonary edema, respiratory failure, pulmonary hypertension, urticaria, acne, erythema multiforme, exfoliative rash, drug eruption'"
88,BOSULIF,warnings and precautions,"gastrointestinal toxicity, diarrhea, nausea, vomiting, abdominal pain, myelosuppression, thrombocytopenia, anemia, neutropenia, hepatic toxicity, drug induced liver injury, ALT elevation, AST elevation, fluid retention, pericardial effusion, pleural effusion, pulmonary edema, peripheral edema, renal toxicity, decline in estimated glomerular filtration rate (eGFR), embryofetal toxicity"
89,GILENYA,adverse reactions,"'bradyarrhythmia, atrioventricular blocks, infections, progressive multifocal leukoencephalopathy, macular edema, posterior reversible encephalopathy syndrome, respiratory effects, liver injury, headache, liver transaminase elevation, diarrhea, cough, influenza, sinusitis, back pain, abdominal pain, pain in extremity, serum transaminase elevations, basal cell carcinoma, influenza, sinusitis, bronchitis, herpes zoster, tinea versicolor, bradycardia, headache, migraine, nausea, diarrhea, abdominal pain, asthenia, back pain, pain in extremity, alopecia, actinic keratosis, liver transaminase elevations, blood triglycerides increased, cough, dyspnea, vision blurred, hypertension, lymphopenia, leukopenia, skin papilloma, basal cell carcinoma, dizziness, pneumonia, eczema, pruritus, ischemic strokes, hemorrhagic strokes, peripheral arterial occlusive disease, lymphoma'"
90,GILENYA,warnings and precautions,"bradycardia, atrioventricular conduction, infections, progressive multifocal leukoencephalopathy (PML), macular edema, posterior reversible encephalopathy syndrome (PRES), decrease in pulmonary function tests (PFT), liver injury, blood pressure (BP) effects, symptomatic bradycardia, hypotension, dizziness, fatigue, palpitations, chest pain, atrioventricular blocks, third-degree AV block, AV block with junctional escape, transient asystole, unexplained death, syncope, bronchitis, herpes zoster, influenza, sinusitis, pneumonia, serious infections, herpetic infections, disseminated primary herpes zoster, herpes simplex encephalitis, disseminated varicella zoster, herpes simplex infections, encephalitis, multiorgan failure, cryptococcal infections, cryptococcal meningitis, varicella zoster virus, respiratory effects, dyspnea, liver transaminases elevations, nausea, vomiting, abdominal pain, fatigue, anorexia, jaundice, dark urine, fetal harm, hypertension, immune system effects"
91,BENLYSTA,adverse reactions,"mortality, serious infections, malignancy, hypersensitivity reactions, anaphylaxis, infusion reactions, depression, nausea, diarrhea, pyrexia, nasopharyngitis, bronchitis, insomnia, pain in extremity, migraine, pharyngitis, cystitis, leukopenia, gastroenteritis viral, fatal anaphylaxis"
92,BENLYSTA,warnings and precautions,"mortality, serious infections, fatal infections, progressive multifocal leukoencephalopathy (PML), hypersensitivity reactions, anaphylaxis, death, depression, suicidality, malignancies, non-melanoma skin cancers, infusion reactions, bradycardia, myalgia, headache, rash, urticaria, hypotension, psychiatric events, insomnia, anxiety, serious psychiatric events, serious depression, suicides"
93,XALKORI,adverse reactions,"hepatotoxicity, interstitial lung disease, pneumonitis, QT interval prolongation, bradycardia, severe visual loss, vision disorders, diarrhea, nausea, vomiting, constipation, edema, elevated transaminases, upper respiratory infection, decreased appetite, dysgeusia, dyspnea, pulmonary embolism, septic shock, acute respiratory failure, diabetic ketoacidosis, nausea, hepatotoxicity, ILD, neutropenia, lymphopenia, hypophosphatemia, pneumonia, respiratory failure, sepsis, alanine aminotransferase elevation, QTc prolongation, neuropathy, rash, renal cyst, hepatic failure, hypokalemia, visual impairment, photopsia, blurred vision, vitreous floaters, sensory neuropathy, dysesthesia, gait disturbance, hypoesthesia, muscular weakness, neuralgia, peripheral neuropathy, parasthesia, peripheral sensory neuropathy, polyneuropathy, burning sensation in skin, acute respiratory distress syndrome, pneumonitis"
94,XALKORI,warnings and precautions,"'fatal hepatotoxicity, hepatotoxicity, Interstitial Lung Disease, ILD, Pneumonitis, QT Interval Prolongation, Bradycardia, Severe Visual Loss, Embryofetal Toxicity, elevated transaminases, fatal interstitial lung disease, drug-related ILD, pneumonitis, QTc prolongation, Torsade de pointes, polymorphic ventricular tachycardia, symptomatic bradycardia, Grade 3 syncope, vision loss, optic atrophy, optic nerve disorder, embryotoxicity, fetotoxicity'"
95,CLEVIPREX,adverse reactions,"hypotension, reflex tachycardia, headache, nausea, vomiting, acute renal failure, atrial fibrillation, myocardial infarction, cardiac arrest, syncope, dyspnea, increased blood triglycerides, ileus, hypersensitivity, decreased oxygen saturation"
96,CLEVIPREX,warnings and precautions,"hypotension, reflex tachycardia, negative inotropic effects, exacerbate heart failure, rebound hypertension"
97,LUMIZYME,adverse reactions,"hypersensitivity reactions, anaphylaxis, rash, pyrexia, flushing/feeling hot, urticaria, headache, hyperhidrosis, nausea, cough, decreased oxygen saturation, tachycardia, tachypnea, chest discomfort, dizziness, muscle twitching, agitation, cyanosis, erythema, hypertension/increased blood pressure, pallor, rigors, tremor, vomiting, fatigue, myalgia, acute cardiorespiratory failure, livedo reticularis, irritability, retching, increased lacrimation, ventricular extrasystoles, nodal rhythm, rales, respiratory tract irritation, cold sweat, angioedema, throat tightness, supraventricular tachycardia, local swelling, diarrhea, pruritus, delayed-onset reactions, hyperhidrosis, paresthesia, edema, peripheral, rash papular, flu-like illness, arthralgia, pain, anaphylactic shock, respiratory failure, respiratory arrest, cardiac arrest, hypoxia, dyspnea, wheezing, convulsions, peripheral coldness, restlessness, nervousness, back pain, stridor, pharyngeal edema, abdominal pain, apnea, muscle spasm, conjunctivitis, hyperparathyroidism, proteinuria, nephrotic syndrome, membranous glomerulonephritis, necrotizing skin lesions"
98,LUMIZYME,boxed warnings,"anaphylactic reactions, hypersensitivity reactions, respiratory distress, hypoxia, apnea, dyspnea, bradycardia, tachycardia, bronchospasm, throat tightness, hypotension, angioedema, tongue swelling, lip swelling, periorbital edema, face edema, urticaria, proteinuria, nephrotic syndrome, necrotizing skin lesions, fluid overload, exacerbation of cardiac compromise, exacerbation of respiratory compromise"
99,LUMIZYME,warnings and precautions,"anaphylaxis, hypersensitivity reactions, life-threatening anaphylaxis, immune-mediated reactions, acute cardiorespiratory failure, cardiac arrhythmia, sudden cardiac death, anaphylactic shock, cardiac arrest, respiratory arrest, respiratory distress, hypoxia, apnea, dyspnea, bradycardia, tachycardia, bronchospasm, throat tightness, hypotension, angioedema, urticaria, chest discomfort/pain, wheezing, tachypnea, cyanosis, decreased oxygen saturation, convulsions, pruritus, rash, hyperhidrosis, nausea, dizziness, hypertension/increased blood pressure, flushing/feeling hot, erythema, pyrexia, pallor, peripheral coldness, restlessness, nervousness, headache, back pain, paresthesia, necrotizing skin lesions, inflammatory arthropathy, pyrexia, elevated erythrocyte sedimentation rate, nephrotic syndrome, membranous glomerulonephritis, immune complex deposition, ventricular arrhythmias, bradycardia, cardiac resuscitation, defibrillation, immunogenicity, reduced clinical efficacy, loss of motor function, ventilator dependence, inhibitory antibody activity, IgE antibodies"
100,CERDELGA,adverse reactions,"fatigue, headache, nausea, diarrhea, back pain, pain in extremities, upper abdominal pain, arthralgia, migraine, flatulence, oropharyngeal pain, dizziness, asthenia, cough, dyspepsia, gastroesophageal reflux disease, constipation, palpitations, rash"
101,CERDELGA,warnings and precautions,"ECG changes, cardiac arrhythmias, prolongation of the PR interval, prolongation of the QTc interval, prolongation of the QRS interval"
102,NEURACEQ,adverse reactions,"erythema, irritation, pain"
103,NEURACEQ,warnings and precautions,"'image interpretation errors, false positives, unintentional radiation exposure, increased risk of cancer'"
104,PROLIA,adverse reactions,"hypocalcemia, serious infections, dermatologic adverse reactions, osteonecrosis of the jaw, atypical subtrochanteric and diaphyseal femoral fractures, pancreatitis, new malignancies, back pain, pain in extremity, musculoskeletal pain, hypercholesterolemia, cystitis, arthralgia, nasopharyngitis, anemia, angina pectoris, atrial fibrillation, vertigo, abdominal pain upper, flatulence, gastroesophageal reflux disease, edema peripheral, asthenia, upper respiratory tract infection, pneumonia, pharyngitis, herpes zoster, bone pain, myalgia, spinal osteoarthritis, sciatica, insomnia, rash, pruritus, cataracts, drug-related hypersensitivity reactions, anaphylaxis, rash, urticaria, facial swelling, erythema, severe symptomatic hypocalcemia, severe musculoskeletal pain, marked elevation in serum PTH"
105,PROLIA,warnings and precautions,"hypersensitivity, anaphylactic reactions, hypocalcemia, osteonecrosis of the jaw, atypical femoral fractures, serious infections, skin infections, dermatologic reactions, dermatitis, rashes, eczema, severe bone pain, joint pain, muscle pain, suppression of bone turnover"
106,FANAPT,adverse reactions,"dizziness, dry mouth, fatigue, nasal congestion, orthostatic hypotension, somnolence, tachycardia, weight increased, arthralgia, musculoskeletal stiffness, vision blurred, nausea, diarrhea, abdominal discomfort, nasopharyngitis, upper respiratory tract infection, extrapyramidal disorder, tremor, lethargy, ejaculation failure, dyspnea, rash, hypotension, akathisia, bradykinesia, dyskinesia, dystonia, parkinsonism, palpitations, arrhythmia, atrioventricular block first degree, cardiac failure, vertigo, tinnitus, hypothyroidism, conjunctivitis, dry eye, blepharitis, eyelid edema, eye swelling, lenticular opacities, cataract, hyperemia, gastritis, salivary hypersecretion, fecal incontinence, mouth ulceration, aphthous stomatitis, duodenal ulcer, hiatus hernia, hyperchlorhydria, lip ulceration, reflux esophagitis, stomatitis, edema, difficulty in walking, thirst, hyperthermia, cholelithiasis, weight decreased, hemoglobin decreased, neutrophil count increased, hematocrit decreased, increased appetite, dehydration, hypokalemia, fluid retention, myalgia, muscle spasms, torticollis, paresthesia, psychomotor hyperactivity, restlessness, amnesia, nystagmus, restless legs syndrome, aggression, delusion, hostility, libido decreased, paranoia, anorgasmia, confusional state, mania, catatonia, mood swings, panic attack, obsessive-compulsive disorder, bulimia nervosa, delirium, polydipsia psychogenic, impulse-control disorder, major depression, urinary incontinence, dysuria, pollakiuria, enuresis, nephrolithiasis, urinary retention, renal failure acute, erectile dysfunction, testicular pain, amenorrhea, breast pain, menstruation irregular, gynecomastia, menorrhagia, metrorrhagia, postmenopausal hemorrhage, prostatitis, epistaxis, asthma, rhinorrhea, sinus congestion, nasal dryness, dry throat, sleep apnea syndrome, dyspnea exertional, retrograde ejaculation"
107,FANAPT,boxed warnings,"increased mortality, death, cardiovascular events, heart failure, sudden death, infections, pneumonia"
108,FANAPT,warnings and precautions,"'increased risk of death, cerebrovascular-related adverse events, stroke, QT prolongation, arrhythmia, sudden death, Neuroleptic Malignant Syndrome, Tardive dyskinesia, Hyperglycemia, diabetes mellitus, Dyslipidemia, Weight Gain, Seizures, Orthostatic hypotension, dizziness, tachycardia, syncope, Leukopenia, Neutropenia, Agranulocytosis, Suicide, Priapism, cognitive and motor impairment, somnolence, sedation'"
109,FULYZAQ,adverse reactions,"'upper respiratory tract infection, bronchitis, cough, flatulence, increased bilirubin, nausea, back pain, arthralgia, urinary tract infection, nasopharyngitis, musculoskeletal pain, hemorrhoids, giardiasis, anxiety, increased alanine aminotransferase, abdominal distension, abdominal pain, acne, increased aspartate aminotransferase, increased conjugated bilirubin, increased unconjugated blood bilirubin, constipation, depression, dermatitis, dizziness, dry mouth, dyspepsia, gastroenteritis, herpes zoster, nephrolithiasis, pain in extremity, pollakiuria, procedural pain, seasonal allergy, sinusitis, decreased white blood cell count'"
110,FULYZAQ,warnings and precautions,disease may worsen
111,EOVIST,adverse reactions,"nephrogenic systemic fibrosis, hypersensitivity reactions, nausea, headache, feeling hot, dizziness, back pain, vomiting, blood pressure increased, injection site reactions, dysgeusia, paresthesia, flushing, parosmia, pruritus, rash, respiratory disorders, fatigue, chest pain, vertigo, dry mouth, chills, feeling abnormal, tremor, akathisia, bundle branch block, palpitation, oral discomfort, salivary hypersecretion, maculopapular rash, hyperhidrosis, discomfort, malaise, elevation of serum iron values, elevation of serum bilirubin, anaphylactic shock, hypotension, pharyngolaryngeal edema, urticaria, face edema, rhinitis, conjunctivitis, abdominal pain, hypoesthesia, sneezing, cough, pallor, tachycardia, restlessness"
112,EOVIST,boxed warnings,"nephrogenic systemic fibrosis, fatal fibrosis, debilitating fibrosis"
113,EOVIST,warnings and precautions,"nephrogenic systemic fibrosis, hypersensitivity reactions, anaphylactoid reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, severe reactions, shock, acute kidney injury, dialysis, extravasation, injection site reactions, myocyte necrosis, inflammation, falsely high or low serum iron values, impaired visualization of liver lesions"
114,ONFI,adverse reactions,"somnolence or sedation, potentiation of sedation, withdrawal symptoms, serious dermatological reactions, physical and psychological dependence, suicidal behavior and ideation, constipation, pyrexia, lethargy, drooling, vomiting, dysphagia, irritability, fatigue, upper respiratory tract infection, pneumonia, urinary tract infection, bronchitis, decreased appetite, increased appetite, sedation, ataxia, psychomotor hyperactivity, dysarthria, aggression, insomnia, cough, anemia, eosinophilia, leukopenia, thrombocytopenia, diplopia, vision blurred, abdominal distention, hypothermia, hepatic enzyme increased, muscle spasms, agitation, anxiety, apathy, confusional state, depression, delirium, delusion, hallucination, urinary retention, aspiration, respiratory depression, rash, urticaria, angioedema, facial and lip edema"
115,ONFI,warnings and precautions,"somnolence, sedation, CNS depression, withdrawal symptoms, serious dermatological reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis, physical dependence, psychological dependence, suicidal behavior, suicidal ideation, convulsions, psychosis, hallucinations, behavioral disorder, tremor, anxiety, dysphoria, insomnia, depression, mood changes, thoughts about self-harm"
116,COMETRIQ,adverse reactions,"perforations, fistula, hemorrhage, thromboembolic events, wound complications, hypertension, osteonecrosis of the jaw, palmar-plantar erythrodysesthesia syndrome, proteinuria, reversible posterior leukoencephalopathy syndrome, diarrhea, stomatitis, decreased weight, decreased appetite, nausea, fatigue, oral pain, hair color changes, dysgeusia, abdominal pain, constipation, increased AST, increased ALT, lymphopenia, increased alkaline phosphatase, hypocalcemia, neutropenia, thrombocytopenia, hypophosphatemia, hyperbilirubinemia, pneumonia, septicemia, cardiac arrest, respiratory failure, unspecified death, hypocalcemia, increased lipase, pancreatitis, tracheal fistula formation, vomiting, increased levels of thyroid stimulating hormone (TSH), dehydration, arthralgia, muscle spasms, musculoskeletal chest pain, headache, dizziness, paresthesia, peripheral sensory neuropathy, peripheral neuropathy, anxiety, dysphonia, rash, dry skin, alopecia, erythema, hyperkeratosis, hypotension, hypomagnesemia, hypokalemia, hyponatremia"
117,COMETRIQ,boxed warnings,"perforations, fistulas, gastrointestinal perforations, fistula formation, hemorrhage, fatal hemorrhage, hemoptysis, gastrointestinal hemorrhage"
118,COMETRIQ,warnings and precautions,"thrombotic events, myocardial infarction, cerebral infarction, arterial thromboembolic events, wound complications, dehiscence, hypertension, hypertensive crisis, osteonecrosis of the jaw, palmar-plantar erythrodysesthesia syndrome, proteinuria, nephrotic syndrome, reversible posterior leukoencephalopathy syndrome, embryofetal toxicity, gastrointestinal perforations, fistulas, non-GI fistulas, tracheal/esophageal fistulas, hemorrhage, hemoptysis, venous thromboembolism, arterial thromboembolism, wound healing complications, treatment-emergent hypertension, jaw pain, osteomyelitis, osteitis, bone erosion, tooth or periodontal infection, toothache, gingival ulceration or erosion, slow healing of the mouth or jaw, seizures, headache, visual disturbances, confusion, altered mental function, skeletal variations, visceral variations, malformations"
119,NULOJIX,adverse reactions,"PTLD, CNS PTLD, malignancies, serious infections, JC virus-associated PML, polyoma virus nephropathy, anemia, diarrhea, urinary tract infection, peripheral edema, constipation, hypertension, pyrexia, graft dysfunction, cough, nausea, vomiting, headache, hypokalemia, hyperkalemia, leukopenia, cytomegalovirus infection, complications of transplanted kidney, non-melanoma skin cancer, progressive multifocal leukoencephalopathy, bacterial infections, mycobacterial infections, viral infections, fungal infections, tuberculosis, herpes infections, cryptococcal meningitis, Chagas encephalitis, cerebral aspergillosis, West Nile encephalitis, infusion reactions, hypotension, proteinuria, immunogenicity, new-onset diabetes after transplantation, dyslipidemia, infections and infestations, upper respiratory infection, nasopharyngitis, influenza, bronchitis, abdominal pain, hypophosphatemia, dyslipidemia, hyperglycemia, hypocalcemia, hypercholesterolemia, hypomagnesemia, hyperuricemia, hematuria, dysuria, renal tubular necrosis, hypotension, dyspnea, blood creatinine increased, arthralgia, back pain, dizziness, tremor, acne, insomnia, anxiety, Guillain-Barre syndrome, stomatitis, aphthous stomatitis, chronic allograft nephropathy, wound dehiscence, arteriovenous fistula thrombosis, neutropenia, renal impairment, acute renal failure, renal artery stenosis, urinary incontinence, hydronephrosis, hematoma, lymphocele, musculoskeletal pain, alopecia, hyperhidrosis, atrial fibrillation"
120,NULOJIX,boxed warnings,"'post-transplant lymphoproliferative disorder, malignancies, serious infections, increased susceptibility to infection, graft loss, death'"
121,NULOJIX,warnings and precautions,"'post-transplant lymphoproliferative disorder, other malignancies, progressive multifocal leukoencephalopathy, serious infections, bacterial infections, viral infections, fungal infections, protozoal infections, opportunistic infections, tuberculosis, polyoma virus-associated nephropathy, graft loss, death, acute rejection, grade III rejection, liver allograft involvement, cytomegalovirus disease, herpes, pneumocystis jiroveci infections, JC virus-associated progressive multifocal leukoencephalopathy, BK virus infection, deteriorating renal function, kidney graft loss, increased rate of graft loss, increased rate of death, increased risk of developing malignancies, skin malignancies, increased risk of bacterial infections, increased risk of viral infections, increased risk of fungal infections, increased risk of protozoal infections, increased risk of tuberculosis, increased risk of polyoma virus-associated nephropathy, increased rate and grade of acute rejection, increased risk of grade III rejection'"
122,GILOTRIF,adverse reactions,"Peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity in the presence of severe renal impairment, increased toxicity in the presence of moderate or severe hepatic impairment, hepatotoxicity, diarrhea, bullous skin disorders, exfoliative skin disorders, interstitial lung disease, hepatic toxicity, keratitis, rash/dermatitis acneiform, stomatitis, paronychia, dry skin, decreased appetite, nausea, vomiting, pruritus, pulmonary toxicity/ILD-like adverse reactions, sepsis, pneumonia, dyspnea, fatigue, hypokalemia, ventricular dysfunction, gastrointestinal disorders, skin and subcutaneous tissue disorders, infections and infestations, metabolism and nutrition disorders, respiratory, thoracic and mediastinal disorders, investigations, general disorders and administration site conditions, eye disorders, laboratory abnormalities, pancreatitis"
123,GILOTRIF,warnings and precautions,"diarrhea, dehydration, renal failure, bullous skin disorders, exfoliative skin disorders, interstitial lung disease (ILD), hepatic toxicity, keratitis, embryofetal toxicity"
124,DATSCAN,adverse reactions,"hypersensitivity, injection site reactions, headache, nausea, vertigo, dry mouth, dizziness, rash, pruritis, injection site pain"
125,DATSCAN,warnings and precautions,"hypersensitivity reactions, skin erythema, pruritis, anaphylactic, hypersensitivity treatment measures, thyroid accumulation, thyroid neoplasia"
126,KALBITOR,adverse reactions,"hypersensitivity reactions, anaphylaxis, headache, nausea, diarrhea, pyrexia, injection site reactions, nasopharyngitis, fatigue, upper respiratory tract infection, vomiting, pruritus, upper abdominal pain, seroconversion, anti-ecallantide antibodies, neutralizing antibodies, anti-ecallantide IgE antibodies, anti-P. pastoris IgE antibodies"
127,KALBITOR,boxed warnings,"Anaphylaxis, hypersensitivity reactions"
128,KALBITOR,warnings and precautions,"anaphylaxis, hypersensitivity reactions, chest discomfort, flushing, pharyngeal edema, pruritus, rhinorrhea, sneezing, nasal congestion, throat irritation, urticaria, wheezing, hypotension, rash"
129,APTIOM,adverse reactions,"suicidal behavior and ideation, serious dermatologic reactions, drug reaction with eosinophilia and systemic symptoms (DRESS)/multiorgan hypersensitivity, anaphylactic reactions, angioedema, hyponatremia, neurological adverse reactions, drug induced liver injury, abnormal thyroid function tests, dizziness, somnolence, nausea, headache, diplopia, vomiting, fatigue, vertigo, ataxia, blurred vision, tremor, ear and labyrinth disorders, vertigo, eye disorders, diplopia, blurred vision, visual impairment, gastrointestinal disorders, nausea, vomiting, diarrhea, constipation, abdominal pain, gastritis, general disorders and administration site conditions, fatigue, asthenia, gait disturbance, peripheral edema, infections and infestations, urinary tract infections, injury, poisoning and procedural complications, fall, metabolism and nutrition disorders, hyponatremia, nervous system disorders, dizziness, somnolence, headache, ataxia, balance disorder, tremor, dysarthria, memory impairment, nystagmus, psychiatric disorders, depression, insomnia, respiratory, thoracic and mediastinal disorders, cough, skin and subcutaneous tissue disorders, rash, vascular disorders, hypertension"
130,APTIOM,warnings and precautions,"'suicidal behavior and ideation, serious dermatologic reactions, drug reaction with eosinophilia and systemic symptoms (DRESS), anaphylactic reactions, angioedema, hyponatremia, dizziness, disturbance in gait and coordination, somnolence, fatigue, cognitive dysfunction, visual changes, drug induced liver injury, abnormal thyroid function tests'"
131,DUAVEE,adverse reactions,"cardiovascular disorders, malignant neoplasms, gallbladder disease, hypertriglyceridemia, muscle spasms, nausea, diarrhea, dyspepsia, abdominal pain upper, oropharyngeal pain, dizziness, neck pain, venous thromboembolism"
132,DUAVEE,boxed warnings,"endometrial cancer, cardiovascular disorders, probable dementia, stroke, deep vein thrombosis (DVT), blood clots, cancer of the uterus, cancer of the breast, cancer of the ovary, gallbladder problems, loss of vision, high blood pressure, increased fats in your blood, liver problems, thyroid problems, fluid retention, low calcium, swelling of your mouth or tongue, worsening of medical problems, new breast lumps, changes in vision or speech, sudden new severe headaches, severe pains in chest or legs with or without shortness of breath, weakness and fatigue, muscle spasms, nausea, diarrhea, upset stomach, abdominal pain, throat pain, dizziness, neck pain"
133,DUAVEE,warnings and precautions,"'cardiovascular disorders, venous thromboembolism, pulmonary embolism, stroke, retinal vascular thrombosis, malignant neoplasms, endometrial cancer, breast cancer, ovarian cancer, gallbladder disease, loss of vision, severe hypertriglyceridemia, cholestatic jaundice, thyroid function, dementia, visual abnormalities, elevated blood pressure, hypertriglyceridemia, hepatic impairment, past history of cholestatic jaundice, hypothyroidism, fluid retention, hypocalcemia, hereditary angioedema, exacerbation of asthma, diabetes mellitus, epilepsy, migraine, porphyria, systemic lupus erythematosus, hepatic hemangiomas, laboratory tests, drug-laboratory test interactions, impaired glucose tolerance'"
134,KALYDECO,adverse reactions,"transaminase elevations, headache, oropharyngeal pain, upper respiratory tract infection, nasal congestion, abdominal pain, nasopharyngitis, diarrhea, rash, nausea, dizziness, serious adverse reactions, abdominal pain, increased hepatic enzymes, hypoglycemia, rhinitis, arthralgia, bacteria in sputum, infections and infestations, aspartate aminotransferase increased, blood glucose increased, hepatic enzyme increased, musculoskeletal chest pain, myalgia, sinus headache, pharyngeal erythema, pleuritic pain, sinus congestion, wheezing, acne"
135,KALYDECO,warnings and precautions,"elevated transaminases, increased transaminase levels, lens opacities, cataracts"
136,AMYVID,adverse reactions,"headache, musculoskeletal pain, blood pressure increased, fatigue, nausea, injection site reaction, anxiety, back pain, claustrophobia, dizziness, feeling cold, insomnia, neck pain, infusion site rash, dysgeusia, pruritis, urticaria, flushing"
137,AMYVID,warnings and precautions,"image interpretation errors, false negatives, radiation risk, increased risk of cancer"
138,TIVICAY,adverse reactions,"hypersensitivity reactions, effects on serum liver biochemistries, fat redistribution, immune reconstitution syndrome, insomnia, fatigue, headache, abdominal pain, abdominal discomfort, flatulence, upper abdominal pain, vomiting, hepatitis, myositis, suicidal ideation, suicidal attempt, suicidal behavior, suicidal completion, renal impairment, pruritus, rash, depression, abnormal dreams, dizziness, nausea, diarrhea, vertigo, elevated ALT, elevated AST, elevated creatine kinase, hyperglycemia, elevated lipase, elevated total neutrophils, elevated cholesterol, elevated HDL cholesterol, elevated LDL cholesterol, elevated triglycerides"
139,TIVICAY,warnings and precautions,"hypersensitivity reactions, rash, constitutional findings, organ dysfunction, liver injury, transaminase elevations, hepatotoxicity, redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement, peripheral wasting, facial wasting, breast enlargement, cushingoid appearance, immune reconstitution syndrome, inflammatory response, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jirovecii pneumonia, tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome"
140,ULESFIA,adverse reactions,"ocular irritation, application site irritation, application site anesthesia, hypoesthesia, skin irritation, scalp irritation, application site pain, pruritus, erythema, pyoderma, application site dryness, application site excoriation, paraesthesia, application site dermatitis, excoriation, thermal burn, dandruff, rash, skin exfoliation"
141,ULESFIA,warnings and precautions,"neonatal toxicity, gasping syndrome, metabolic acidosis, gasping respirations, progressive hypotension, seizures, central nervous system depression, intraventricular hemorrhage, death, eye irritation, contact dermatitis"
142,JUBLIA,adverse reactions,"Ingrown toenails, application site dermatitis, application site vesicles, application site pain"
143,TRULICITY,adverse reactions,"thyroid C-cell tumors, pancreatitis, hypoglycemia, hypersensitivity reactions, renal impairment, severe gastrointestinal disease, nausea, diarrhea, vomiting, abdominal pain, decreased appetite, dyspepsia, fatigue, gastrointestinal adverse reactions, constipation, flatulence, abdominal distension, gastroesophageal reflux disease, eructation, documented symptomatic hypoglycemia, severe hypoglycemia, heart rate increase, tachycardia, sinus tachycardia, immunogenicity, anti-drug antibodies, dulaglutide-neutralizing antibodies, antibodies against native GLP-1, systemic hypersensitivity, severe urticaria, systemic rash, facial edema, lip swelling, injection-site reactions, injection-site rash, erythema, PR interval prolongation, first degree atrioventricular block, amylase increase, lipase increase"
144,TRULICITY,boxed warnings,"thyroid C-cell tumors, adenomas, carcinomas, medullary thyroid carcinoma"
145,TRULICITY,warnings and precautions,"thyroid C-cell tumors, pancreatitis, hypoglycemia, hypersensitivity reactions, renal impairment, gastrointestinal reactions"
146,TEFLARO,adverse reactions,"hypersensitivity reactions, Clostridium difficile-associated diarrhea, Direct Coombs' Test Seroconversion, diarrhea, nausea, rash, serious adverse reactions, treatment discontinuation, hypersensitivity, increased transaminases, hypokalemia, phlebitis, anemia, eosinophilia, neutropenia, thrombocytopenia, bradycardia, palpitations, abdominal pain, pyrexia, hepatitis, anaphylaxis, Clostridium difficile colitis, hyperglycemia, hyperkalemia, dizziness, convulsion, renal failure, urticaria, agranulocytosis"
147,TEFLARO,warnings and precautions,"hypersensitivity reactions, anaphylactic reactions, skin reactions, Clostridium difficile-associated diarrhea, CDAD, fatal colitis, Coombs' test seroconversion, hemolytic anemia, drug-induced hemolytic anemia, development of drug-resistant bacteria"
148,JARDIANCE,adverse reactions,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, urinary tract infections, increased LDL-C, urinary tract infection, female genital mycotic infections, upper respiratory tract infection, increased urination, dyslipidemia, arthralgia, male genital mycotic infections, nausea, thirst, volume depletion, increased urination, impairment in renal function, hypoglycemia, genital mycotic infections, phimosis, urinary tract infections, increase in LDL-C, increase in hematocrit"
149,JARDIANCE,warnings and precautions,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, urinary tract infections, increased LDL-C"
150,ULORIC,adverse reactions,"'liver function abnormalities, nausea, arthralgia, rash, dizziness, anemia, idiopathic thrombocytopenic purpura, leukocytosis/leukopenia, neutropenia, pancytopenia, splenomegaly, thrombocytopenia, angina pectoris, atrial fibrillation/flutter, cardiac murmur, ECG abnormal, palpitations, sinus bradycardia, tachycardia, deafness, tinnitus, vertigo, vision blurred, abdominal distention, abdominal pain, constipation, dry mouth, dyspepsia, flatulence, frequent stools, gastritis, gastroesophageal reflux disease, gastrointestinal discomfort, gingival pain, haematemesis, hyperchlorhydria, hematochezia, mouth ulceration, pancreatitis, peptic ulcer, vomiting, asthenia, chest pain/discomfort, edema, fatigue, feeling abnormal, gait disturbance, influenza-like symptoms, mass, pain, thirst, cholelithiasis/cholecystitis, hepatic steatosis, hepatitis, hepatomegaly, hypersensitivity, herpes zoster, contusion, anorexia, appetite decreased/increased, dehydration, diabetes mellitus, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypokalemia, weight decreased/increased, arthritis, joint stiffness, joint swelling, muscle spasms/twitching/tightness/weakness, musculoskeletal pain/stiffness, myalgia, altered taste, balance disorder, cerebrovascular accident, Guillain-Barre syndrome, headache, hemiparesis, hypoesthesia, hyposmia, lacunar infarction, lethargy, mental impairment, migraine, paresthesia, somnolence, transient ischemic attack, tremor, agitation, anxiety, depression, insomnia, irritability, libido decreased, nervousness, panic attack, personality change, hematuria, nephrolithiasis, pollakiuria, proteinuria, renal failure, renal insufficiency, urgency, incontinence, breast pain, erectile dysfunction, gynecomastia, bronchitis, cough, dyspnea, epistaxis, nasal dryness, paranasal sinus hypersecretion, pharyngeal edema, respiratory tract congestion, sneezing, throat irritation, upper respiratory tract infection, alopecia, angio-edema, dermatitis, dermographism, ecchymosis, eczema, hair color changes, hair growth abnormal, hyperhidrosis, peeling skin, petechiae, photosensitivity, pruritus, purpura, skin discoloration/altered pigmentation, skin lesion, skin odor abnormal, urticaria, flushing, hot flush, hypertension, hypotension, activated partial thromboplastin time prolonged, creatine increased, bicarbonate decreased, sodium increased, EEG abnormal, glucose increased, cholesterol increased, triglycerides increased, amylase increased, potassium increased, TSH increased, platelet count decreased, hematocrit decreased, hemoglobin decreased, MCV increased, RBC decreased, creatinine increased, blood urea increased, BUN/creatinine ratio increased, creatine phosphokinase (CPK) increased, alkaline phosphatase increased, LDH increased, PSA increased, urine output increased/decreased, lymphocyte count decreased, neutrophil count decreased, WBC increased/decreased, coagulation test abnormal, low density lipoprotein (LDL) increased, prothrombin time prolonged, urinary casts, urine positive for white blood cells and protein, hepatic failure, jaundice, abnormal liver function test results, liver disorder, anaphylaxis, anaphylactic reaction, rhabdomyolysis, psychotic behavior including aggressive thoughts, tubulointerstitial nephritis, generalized rash, Stevens Johnson Syndrome, hypersensitivity skin reactions'"
151,ULORIC,warnings and precautions,"gout flare, cardiovascular thromboembolic events, myocardial infarctions, strokes, hepatic failure, liver injury, transaminase elevations, fatigue, anorexia, right upper abdominal discomfort, dark urine, jaundice, severe drug-induced liver injury"
152,KYPROLIS,adverse reactions,"cardiac toxicities, acute renal failure, tumor lysis syndrome, pulmonary toxicity, pulmonary hypertension, dyspnea, hypertension, venous thrombosis, infusion reactions, thrombocytopenia, hepatic toxicity, hepatic failure, thrombotic thrombocytopenic purpura/hemolytic uremic syndrome, posterior reversible encephalopathy syndrome (PRES), anemia, fatigue, nausea, pyrexia, decreased platelets, decreased lymphocyte, headache, decreased hemoglobin, cough, edema peripheral, decreased absolute neutrophil count, decreased phosphorus, neutropenia, decreased total white blood cell count, diarrhea, muscle spasm, upper respiratory tract infection, hypokalemia, pneumonia, respiratory tract infection, pulmonary embolism, myocardial infarction, upper respiratory tract infection, constipation, infections, nasopharyngitis, bronchitis, hypocalcemia, hyperglycemia, muscle spasms, peripheral neuropathies NEC, insomnia, embolic and thrombotic events, venous, febrile neutropenia, lymphopenia, cardiac arrest, cardiac failure, cardiac failure congestive, cataract, vision blurred, abdominal pain, abdominal pain upper, dyspepsia, toothache, chills, infusion site reaction, multi-organ failure, pain, influenza, sepsis, urinary tract infection, viral infection, dehydration, hyperkalemia, hyperuricemia, hypoalbuminemia, hyponatremia, muscular weakness, myalgia, hypoesthesia, paresthesia, deafness, anxiety, delirium, renal failure, renal failure acute, renal impairment, dysphonia, epistaxis, oropharyngeal pain, pulmonary edema, erythema, hyperhidrosis, pruritus, deep vein thrombosis, hypotension, decreased appetite, hypercalcemia, back pain, arthralgia, pain in extremity, musculoskeletal pain, dizziness, renal failure, hepatic failure, bronchitis, nasopharyngitis, respiratory tract infection, hyperglycemia, hyperuricemia, hypoalbuminemia, hypocalcemia, hypomagnesemia, hypophosphatemia, musculoskeletal chest pain, dysphonia, oropharyngeal pain, rash, embolic and thrombotic events, venous (including deep vein thrombosis and pulmonary embolism), dehydration, thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS), posterior reversible encephalopathy syndrome (PRES)"
153,KYPROLIS,warnings and precautions,"'cardiac failure, myocardial infarction, myocardial ischemia, acute renal failure, tumor lysis syndrome, acute respiratory distress syndrome, acute respiratory failure, acute diffuse infiltrative pulmonary disease, pulmonary hypertension, dyspnea, hypertension, hypertensive crisis, venous thrombosis, infusion reactions, thrombocytopenia, hepatic toxicity, hepatic failure, thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, posterior reversible encephalopathy syndrome, embryo-fetal toxicity'"
154,YERVOY,adverse reactions,"immune-mediated enterocolitis, immune-mediated hepatitis, immune-mediated dermatitis, immune-mediated neuropathies, immune-mediated endocrinopathies, ocular manifestations, fatigue, diarrhea, pruritus, rash, colitis, enterocolitis, hepatotoxicity, dermatitis, neuropathy, endocrinopathy, hypopituitarism, adrenal insufficiency, pneumonitis, meningitis, nephritis, eosinophilia, pericarditis, urticaria, large intestinal ulcer, esophagitis, acute respiratory distress syndrome, renal failure, infusion reaction, Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome)"
155,YERVOY,boxed warnings,"immune-mediated adverse reactions, enterocolitis, hepatitis, dermatitis, toxic epidermal necrolysis, neuropathy, endocrinopathy"
156,YERVOY,warnings and precautions,"immune-mediated reactions, severe reactions, moderate immune-mediated adverse reactions, immune-mediated hepatitis, immune-mediated endocrinopathies, severe immune-mediated enterocolitis, moderate enterocolitis, intestinal perforation, complications, severe enterocolitis, moderate enterocolitis, severe hepatotoxicity, fatal hepatic failure, moderate hepatotoxicity, immune-mediated hepatitis, severe immune-mediated dermatitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, rash complicated by full thickness dermal ulceration, necrotic, bullous, or hemorrhagic manifestations, moderate dermatitis, severe dermatitis, moderate dermatitis, immune-mediated neuropathies, fatal Guillain-Barre syndrome, severe peripheral motor neuropathy, Guillain-Barre-like syndromes, severe neuropathy, moderate neuropathy, severe to life-threatening immune-mediated endocrinopathies, hypopituitarism, adrenal insufficiency, hypogonadism, hypothyroidism, moderate endocrinopathy, hyperthyroidism, Cushing's syndrome, immune-mediated adverse reactions, nephritis, pneumonitis, meningitis, pericarditis, uveitis, iritis, hemolytic anemia, myocarditis, angiopathy, temporal arteritis, vasculitis, polymyalgia rheumatica, conjunctivitis, blepharitis, episcleritis, scleritis, leukocytoclastic vasculitis, erythema multiforme, psoriasis, pancreatitis, arthritis, autoimmune thyroiditis, sarcoidosis, neurosensory hypoacusis, autoimmune central neuropathy (encephalitis), myositis, polymyositis, ocular myositis, severe immune-mediated adverse reactions, uveitis, iritis, episcleritis, immune-mediated ocular disease"
157,GADAVIST,adverse reactions,"Nephrogenic Systemic Fibrosis (NSF), hypersensitivity reactions, headache, nausea, dizziness, dysgeusia, feeling hot, injection site reactions, vomiting, rash, pruritus, erythema, hypersensitivity/anaphylactoid, dyspnea, paresthesia, loss of consciousness, convulsion, parosmia, tachycardia, palpitation, dry mouth, malaise, feeling cold, cardiac arrest, anaphylactic shock, circulatory collapse, respiratory arrest, pulmonary edema, bronchospasm, cyanosis, oropharyngeal swelling, laryngeal edema, blood pressure increased, chest pain, angioedema, conjunctivitis, hyperhidrosis, cough, sneezing, burning sensation, pallor"
158,GADAVIST,boxed warnings,"nephrogenic systemic fibrosis, fatal or debilitating fibrosis affecting the skin, muscle and internal organs, chronic severe kidney disease, acute kidney injury"
159,GADAVIST,warnings and precautions,"nephrogenic systemic fibrosis, anaphylactic reactions, hypersensitivity reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, death, acute kidney injury, dialysis, extravasation, injection site reactions, overestimation of malignant disease"
160,OTEZLA,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, increased toxicity, hepatotoxicity, diarrhea, nausea, headache, upper respiratory tract infection, tension headache, vomiting, nasopharyngitis, abdominal pain upper, hypersensitivity, weight decrease, frequent bowel movement, gastroesophageal reflux disease, dyspepsia, decreased appetite, migraine, cough, rash, abdominal pain, fatigue, insomnia, back pain, frequent bowel movements, depression, bronchitis, tooth abscess, folliculitis, sinus headache, severe worsening of psoriasis"
161,OTEZLA,warnings and precautions,"depression, suicidal thoughts, mood changes, weight decrease, drug interactions"
162,DYSPORT,adverse reactions,"distant spread of toxin effect, lack of interchangeability between botulinum toxin products, spread of effects from toxin, dysphagia, breathing difficulties, facial anatomy in the treatment of glabellar lines, pre-existing neuromuscular disorders, human albumin, intradermal immune reaction, muscular weakness, dry mouth, injection site discomfort, fatigue, headache, neck pain, musculoskeletal pain, dysphonia, injection site pain, eye disorders, blurred vision, diplopia, reduced visual acuity and accommodation, disturbance in attention, eyelid disorder, feeling abnormal, dysphagia, injection site discomfort, fatigue, injection site pain, muscular weakness, musculoskeletal pain, gastrointestinal disorders, dysphagia, dry mouth, nervous system disorders, headache, infections and infestations, respiratory, thoracic and mediastinal disorders, dysphonia, eye disorders, dysphagia, dry mouth, muscular weakness, injection site discomfort, dysphonia, facial paresis, eye disorders, injection site discomfort, injection site pain, breathing difficulties, dyspnea, dizziness, muscle atrophy, blood glucose increase, electrocardiographic findings, heart rate reduction, nasopharyngitis, headache, injection site pain, injection site reaction, upper respiratory tract infection, eyelid edema, eyelid ptosis, sinusitis, nausea, blood present in urine, bronchitis, influenza, pharyngolaryngeal pain, cough, contact dermatitis, injection site swelling, injection site discomfort, eyelid ptosis, nasopharyngitis, urinary tract infection, muscular weakness, pain in extremity, musculoskeletal pain, back pain, headache, dizziness, convulsion, syncope, hypoaesthesia, partial seizures, fatigue, asthenia, fall, injury, contusion, diarrhea, nausea, constipation, blood triglycerides increased, cough, hypertension, depression, injection site reactions, pain, bruising, haemorrhage, injection site erythema/haematoma, dysphagia, gait disturbance, hypertonia, sensation of heaviness, vertigo, photophobia, influenza-like illness, amyotrophy, burning sensation, facial paresis, hypoesthesia, erythema, excessive granulation tissue"
163,DYSPORT,boxed warnings,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death"
164,DYSPORT,warnings and precautions,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death, severe dysphagia, aspiration, respiratory failure, eyelid ptosis, severe dysphagia, respiratory compromise"
165,FIRAZYR,adverse reactions,"'injection site reactions, pyrexia, transaminase increase, dizziness, rash, nausea, headache, anti-icatibant antibodies'"
166,FIRAZYR,warnings and precautions,laryngeal attacks
167,INVOKANA,adverse reactions,"hypotension, impairment in renal function, hyperkalemia, hypoglycemia, genital mycotic infections, hypersensitivity reactions, bone fracture, increased urination, male genital mycotic infections, vulvovaginal pruritus, thirst, constipation, nausea, abdominal pain, fatigue, loss of strength or energy, asthenia, pancreatitis, erythema, rash, pruritus, urticaria, angioedema, photosensitivity reaction, polymorphic light eruption, sunburn, volume depletion-related adverse reactions, postural dizziness, orthostatic hypotension, syncope, dehydration, falls, increased blood creatinine, decreased glomerular filtration rate, renal impairment, acute renal failure, significant renal function decline, increased serum potassium, severe elevations of serum potassium, increases in serum magnesium, increases in serum phosphate, increases in low-density lipoprotein cholesterol (LDL-C), increases in non-high-density lipoprotein cholesterol (non-HDL-C), increases in hemoglobin, decreases in bone mineral density"
168,INVOKANA,warnings and precautions,"hypotension, impairment in renal function, hyperkalemia, hypoglycemia, genital mycotic infections, hypersensitivity reactions, bone fracture, increased LDL-C"
169,XTANDI,adverse reactions,"seizure, asthenia/fatigue, back pain, decreased appetite, constipation, arthralgia, diarrhea, hot flush, upper respiratory tract infection, peripheral edema, dyspnea, musculoskeletal pain, weight decreased, headache, hypertension, dizziness/vertigo, asthenic conditions, peripheral edema, musculoskeletal pain, muscular weakness, musculoskeletal stiffness, diarrhea, hot flush, hypertension, headache, dizziness, spinal cord compression and cauda equina syndrome, paresthesia, mental impairment disorders, hypoesthesia, upper respiratory tract infection, lower respiratory tract and lung infection, insomnia, anxiety, hematuria, pollakiuria, fall, non-pathologic fractures, pruritus, dry skin, epistaxis, constipation, diarrhea, hot flush, hypertension, dizziness, headache, dysgeusia, mental impairment disorders, restless legs syndrome, dyspnea, upper respiratory tract infection, lower respiratory tract and lung infection, insomnia, hematuria, fall, non-pathological fracture, decreased appetite, weight decreased, gynecomastia, neutropenia, thrombocytopenia, elevations in ALT, elevations in bilirubin, infections, falls and fall-related injuries, hypertension"
170,XTANDI,warnings and precautions,seizure
171,AFINITOR,adverse reactions,"non-infectious pneumonitis, infections, angioedema, oral ulceration, renal failure, impaired wound healing, stomatitis, rash, fatigue, diarrhea, edema, abdominal pain, nausea, fever, asthenia, cough, headache, decreased appetite, hyperglycemia, dyspnea, pneumonitis, hypercholesterolemia, leukopenia, thrombocytopenia, lymphopenia, anemia, increased aspartate transaminase (AST), increased alanine transaminase (ALT), hypertriglyceridemia, arthralgia, back pain, pain in extremity, dysgeusia, insomnia, epistaxis, pruritus, alopecia, hot flush, hemoglobin decreased, WBC decreased, platelets decreased, lymphocytes decreased, neutrophils decreased, glucose increased, cholesterol increased, creatinine increased, potassium decreased, acute renal failure, acute respiratory distress, cardiac arrest, death (cause unknown), hepatic failure, pneumonia, sepsis, pulmonary embolism, hypoglycemia, myocardial infarction with congestive heart failure, sudden death, renal angiomyolipoma, thrombotic events, pulmonary embolus, thrombosis, abdominal pain, vomiting, constipation, dry mouth, peripheral edema, upper respiratory tract infection, muscle spasms, headache/migraine, dizziness, cough/productive cough, dyspnea/dyspnea exertional, oropharyngeal pain, nail disorders, dry skin/xeroderma, hypertension, irregular menstruation, hemoglobin decreased, lymphocytes decreased, platelets decreased, WBC decreased, neutrophils decreased, alkaline phosphatase increased, glucose (fasting) increased, cholesterol increased, bicarbonate decreased, aspartate transaminase (AST) increased, alanine transaminase (ALT) increased, phosphate decreased, triglycerides increased, calcium decreased, potassium decreased, sodium decreased, albumin decreased, bilirubin increased, stomatitis, infections, asthenia, fatigue, cough, diarrhea, anorexia, pain in extremity, abdominal pain, dehydration, mucosal inflammation, rash, dry skin, anemia, hypercholesterolemia, hypertriglyceridemia, hyperglycemia, lymphopenia, increased creatinine, hypophosphatemia, acute respiratory failure, infection, renal failure, pleural effusion, pharyngolaryngeal pain, rhinorrhea, hand-foot syndrome, erythema, onychoclasis, skin lesion, acneiform dermatitis, angioedema, exacerbation of pre-existing diabetes mellitus, new onset of diabetes mellitus, insomnia, paresthesia, eyelid edema, conjunctivitis, hypertension, deep vein thrombosis, tachycardia, congestive cardiac failure, jaw pain, hemorrhage, hemoglobin decreased, platelets decreased, neutrophils decreased, cholesterol increased, triglycerides increased, glucose increased, phosphate decreased, aspartate transaminase (AST) increased, alanine transaminase (ALT) increased, bilirubin increased, amenorrhea, menorrhagia, menstrual irregularities, vaginal hemorrhage, epistaxis, decreased appetite, otitis media, depression, abnormal taste, increased blood luteinizing hormone (LH) levels, increased blood follicle stimulating hormone (FSH) levels, hypersensitivity, ovarian cyst, pneumonitis, angioedema, elevated partial thromboplastin time, neutropenia, elevated aspartate transaminase (AST), hypertriglyceridemia, elevated alanine transaminase (ALT), hypophosphatemia, cellulitis, hyperglycemia, elevated creatinine, acute pancreatitis, cholecystitis, cholelithiasis, arterial thrombotic events, reflex sympathetic dystrophy"
172,AFINITOR,warnings and precautions,"'non-infectious pneumonitis, fatal cases, infections, fatal infections, angioedema, oral ulceration, mouth ulcers, stomatitis, oral mucositis, renal failure, acute renal failure, fatal outcome, impaired wound healing, wound-related complications, wound dehiscence, wound infection, incisional hernia, lymphocele, seroma, surgical intervention, laboratory test alterations, serum creatinine elevations, urinary protein elevations, blood glucose elevations, lipid elevations, hemoglobin decreases, neutrophils decreases, platelets decreases, vaccinations, live vaccines, embryo-fetal toxicity, fetal harm'"
173,ENTEREG,adverse reactions,dyspepsia
174,ENTEREG,boxed warnings,myocardial infarction
175,ENTEREG,warnings and precautions,"myocardial infarctions, abdominal pain, nausea and vomiting, diarrhea, serious adverse reactions"
176,COARTEM,adverse reactions,"'headache, anorexia, dizziness, asthenia, arthralgia, myalgia, pyrexia, cough, vomiting, hypersensitivity reactions, headache, dizziness, anorexia, asthenia, pyrexia, chills, fatigue, malaise, arthralgia, myalgia, nausea, vomiting, abdominal pain, diarrhea, sleep disorder, insomnia, palpitations, hepatomegaly, splenomegaly, anemia, cough, pruritus, rash, vertigo, malaria, nasopharyngitis, chills, asthenia, fatigue, cough, vomiting, abdominal pain, diarrhea, nausea, Plasmodium falciparum infection, rhinitis, anorexia, headache, dizziness, splenomegaly, anemia, hepatomegaly, aspartate aminotransferase increased, arthralgia, myalgia, rash, eosinophilia, tinnitus, conjunctivitis, constipation, dyspepsia, dysphagia, peptic ulcer, gait disturbance, abscess, acrodermatitis, bronchitis, ear infection, gastroenteritis, helminthic infection, hookworm infection, impetigo, influenza, lower respiratory tract infection, malaria, nasopharyngitis, oral herpes, pneumonia, respiratory tract infection, subcutaneous abscess, upper respiratory tract infection, urinary tract infection, alanine aminotransferase increased, hematocrit decreased, lymphocyte morphology abnormal, platelet count decreased, platelet count increased, white blood cell count decreased, white blood cell count increased, hypokalemia, back pain, ataxia, clonus, fine motor delay, hyperreflexia, hypoesthesia, nystagmus, tremor, agitation, mood swings, hematuria, proteinuria, asthma, pharyngo-laryngeal pain, urticaria, anaphylaxis, angioedema, serious skin reactions, bullous eruption'"
177,COARTEM,warnings and precautions,"QT prolongation, hypokalemia, hypomagnesemia, symptomatic cardiac arrhythmias, clinically relevant bradycardia, severe cardiac disease, sudden death, electrolyte balance disturbances, decreased exposure to lumefantrine, decreased efficacy, decreased concentrations of substrate, potential loss of substrate efficacy, increased concentrations of artemether and/or lumefantrine, potentiate QT prolongation, loss of antimalarial efficacy, reduced effectiveness of hormonal contraceptives, increased plasma concentrations of coadministered drug, increased risk of adverse effects, recrudescence, severe hepatic impairment, severe renal impairment, relapsing malaria"
178,DALVANCE,adverse reactions,"nausea, headache, diarrhea, vomiting, rash, pruritus, anemia, hemorrhagic anemia, leucopenia, neutropenia, thrombocytopenia, petechiae, eosinophilia, thrombocytosis, gastrointestinal hemorrhage, melena, hematochezia, abdominal pain, infusion-related reactions, hepatotoxicity, anaphylactoid reaction, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, hepatic transaminases increased, blood alkaline phosphatase increased, international normalized ratio increased, hypoglycemia, dizziness, bronchospasm, urticaria, flushing, phlebitis, wound hemorrhage, spontaneous hematoma, ALT elevations"
179,DALVANCE,warnings and precautions,"hypersensitivity reactions, anaphylactic reactions, skin reactions, infusion reactions, ALT elevations, Clostridium difficile-associated diarrhea, flushing of the upper body, urticaria, pruritus, rash, liver test abnormalities, increased morbidity, mortality, fluid and electrolyte management, protein supplementation, antibacterial treatment, surgical evaluation, development of drug-resistant bacteria"
180,FERRIPROX,adverse reactions,"chromaturia, nausea, vomiting, abdominal pain, alanine aminotransferase increased, arthralgia, neutropenia, agranulocytosis, elevated ALT, decreased plasma zinc concentrations, diarrhea, dyspepsia, neutrophil count decreased, weight increased, aspartate aminotransferase increased, increased appetite, decreased appetite, back pain, pain in extremity, arthropathy, headache, thrombocytosis, pancytopenia, atrial fibrillation, cardiac failure, hypospadias, diplopia, papilledema, retinal toxicity, enterocolitis, rectal hemorrhage, gastric ulcer, pancreatitis, parotid gland enlargement, chills, pyrexia, edema peripheral, multi-organ failure, jaundice, hepatomegaly, anaphylactic shock, hypersensitivity, cryptococcal cutaneous infection, enteroviral encephalitis, pharyngitis, pneumonia, sepsis, furuncle, infectious hepatitis, rash pustular, subcutaneous abscess, blood bilirubin increased, blood creatinine phosphokinase increased, metabolic acidosis, dehydration, myositis, chondropathy, trismus, cerebellar syndrome, cerebral hemorrhage, convulsion, gait disturbance, intracranial pressure increased, psychomotor skills impaired, pyramidal tract syndrome, somnolence, bruxism, depression, obsessive-compulsive disorder, glycosuria, hemoglobinuria, acute respiratory distress syndrome, epistaxis, hemoptysis, pulmonary embolism, hyperhidrosis, periorbital edema, photosensitivity reaction, pruritis, urticaria, rash, Henoch-Schonlein purpura, hypotension, hypertension"
181,FERRIPROX,boxed warnings,"agranulocytosis, neutropenia, serious infections, death, infection"
182,FERRIPROX,warnings and precautions,"agranulocytosis, neutropenia, infection, fetal harm, embryofetal death, malformations, increased ALT values, increased AST levels, decreased plasma zinc concentrations"
183,PRADAXA,adverse reactions,"bleeding, gastritis-like symptoms, gastrointestinal hemorrhage, diarrhea, dyspepsia, nausea, upper abdominal pain, gastrointestinal hemorrhage, major bleeding, intracranial hemorrhage, hemorrhagic stroke, gastrointestinal bleeding, fatal bleeding, ICH, non-intracranial fatal bleed, gastrointestinal adverse reactions, abdominal pain upper, abdominal pain, abdominal discomfort, epigastric discomfort, GERD, esophagitis, erosive gastritis, gastric hemorrhage, hemorrhagic gastritis, hemorrhagic erosive gastritis, gastrointestinal ulcer, hypersensitivity reactions, urticaria, rash, pruritus, allergic edema, anaphylactic reaction, anaphylactic shock, myocardial infarction, angioedema, thrombocytopenia, esophageal ulcer"
184,PRADAXA,boxed warnings,"thrombotic events, spinal/epidural hematoma, paralysis"
185,PRADAXA,warnings and precautions,"bleeding, fatal bleeding, thrombotic events, blood loss, hypotension, pathological bleeding, spinal hematoma, permanent paralysis, neurological impairment, back pain, sensory deficits, motor deficits, numbness, tingling, weakness in lower limbs, bowel dysfunction, bladder dysfunction, thromboembolic events, valve thrombosis, stroke, transient ischemic attack, myocardial infarction, major bleeding, pericardial effusions"
186,VORAXAZE,adverse reactions,"serious allergic reactions, anaphylactic reactions, paraesthesias, flushing, nausea and/or vomiting, hypotension, headache, myelosuppression, mucositis, acute hepatitis, renal dysfunction, renal failure, paresthesia, blurred vision, diarrhea, hypersensitivity, hypertension, rash, throat irritation, throat tightness, tremor"
187,VORAXAZE,warnings and precautions,"Answer: 'serious allergic reactions, anaphylactic reactions'"
188,HORIZANT,adverse reactions,"'somnolence/sedation, dizziness, headache, nausea, dry mouth, flatulence, fatigue, irritability, feeling drunk, feeling abnormal, peripheral edema, weight increased, increased appetite, vertigo, depression, libido decreased, balance disorder, blurred vision, disorientation, lethargy, breast enlargement, gynecomastia, elevated creatine kinase'"
189,HORIZANT,warnings and precautions,"driving impairment, somnolence/sedation, dizziness, suicidal thoughts or behaviors, depression, mood or behavior changes, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), multiorgan hypersensitivity, fever, rash, lymphadenopathy, hepatitis, nephritis, hematological abnormalities, myocarditis, myositis, eosinophilia, withdrawal seizure, pancreatic acinar cell adenoma, pancreatic acinar cell carcinoma, fatigue/asthenia"
190,STENDRA,adverse reactions,"headache, flushing, nasal congestion, nasopharyngitis, back pain, upper respiratory infection, bronchitis, influenza, sinusitis, sinus congestion, hypertension, dyspepsia, nausea, constipation, rash, dizziness, arthralgia, diarrhea, edema peripheral, fatigue, angina, unstable angina, deep vein thrombosis, palpitations, gastritis, gastroesophageal reflux disease, hypoglycemia, blood glucose increased, alanine aminotransferase increased, oropharyngeal pain, stomach discomfort, vomiting, muscle spasms, musculoskeletal pain, myalgia, pain in extremity, depression, insomnia, somnolence, vertigo, cough, dyspnea exertional, epistaxis, wheezing, pruritus, balanitis, erection increased, hematuria, nephrolithiasis, pollakiuria, urinary tract infection, electrocardiogram abnormal, gastroenteritis viral, change in color vision, Non-arteritic anterior ischemic optic neuropathy (NAION)"
191,STENDRA,warnings and precautions,"hypotension, erection lasting greater than 4 hours, sudden loss of vision, sudden decrease or loss of hearing, symptomatic hypotension (e.g., dizziness, lightheadedness, fainting), increase in heart rate, decrease in standing blood pressure, dizziness, headache, bleeding disorders, active peptic ulceration"
192,ADCETRIS,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, progressive multifocal leukoencephalopathy, pulmonary toxicity, serious dermatologic reactions, neutropenia, peripheral sensory neuropathy, fatigue, nausea, anemia, upper respiratory tract infection, diarrhea, pyrexia, rash, thrombocytopenia, cough, vomiting, peripheral motor neuropathy, lymphadenopathy, headache, dizziness, chills, pain, edema peripheral, abdominal pain, constipation, pruritus, alopecia, night sweats, dry skin, dyspnea, oropharyngeal pain, arthralgia, myalgia, back pain, pain in extremity, muscle spasms, insomnia, anxiety, decreased appetite, weight decreased, febrile neutropenia, hyperglycemia, pancreatitis, noninfectious pulmonary toxicity, pneumonitis, interstitial lung disease, ARDS, toxic epidermal necrolysis"
193,ADCETRIS,boxed warnings,"Progressive multifocal leukoencephalopathy (PML), JC virus infection, death"
194,ADCETRIS,warnings and precautions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, hepatotoxicity, pulmonary toxicity, serious dermatologic reactions, embryo-fetal toxicity, severe neutropenia, Grade 3 or Grade 4 thrombocytopenia, anemia, febrile neutropenia, pneumonia, bacteremia, sepsis, septic shock, progressive multifocal leukoencephalopathy, pneumonitis, interstitial lung disease, acute respiratory distress syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, fetal harm, embryo-fetal toxicities, decreased embryo viability, fetal malformations"
195,ZERBAXA,adverse reactions,"'hypersensitivity reactions, Clostridium difficile-associated diarrhea, nausea, diarrhea, headache, pyrexia, constipation, insomnia, vomiting, hypokalemia, ALT increased, AST increased, anemia, thrombocytosis, abdominal pain, anxiety, dizziness, hypotension, atrial fibrillation, rash, renal impairment, renal failure, cardiac disorders, gastrointestinal disorders, general disorders and administration site conditions, infections and infestations, investigations, metabolism and nutrition disorders, nervous system disorders, respiratory, thoracic and mediastinal disorders, skin and subcutaneous tissue disorders, vascular disorders'"
196,ZERBAXA,warnings and precautions,"decreased efficacy, hypersensitivity reactions, anaphylactic reactions, Clostridium difficile-associated diarrhea (CDAD), fatal colitis"
197,ZYDELIG,adverse reactions,"hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, severe cutaneous reactions, anaphylaxis, neutropenia, diarrhea, pyrexia, fatigue, nausea, cough, pneumonia, abdominal pain, chills, rash, hypertriglyceridemia, hyperglycemia, ALT elevations, AST elevations, pneumonia, sepsis, febrile neutropenia, elevated transaminases, gastroesophageal reflux disease, stomatitis, headache, pain, nasal congestion, bronchitis, sinusitis, urinary tract infection, arthralgia, neutrophil count decreased, lymphocyte count decreased, lymphocyte count increased, GGT increased, triglycerides increased, hypoglycemia, hyponatremia, diarrhea, nausea, abdominal pain, vomiting, fatigue, asthenia, peripheral edema, upper respiratory tract infection, cough, dyspnea, rash, night sweats, headache, decreased appetite, insomnia, ALT increased, AST increased, neutrophils decreased, hemoglobin decreased, platelets decreased"
198,ZYDELIG,boxed warnings,"hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation"
199,ZYDELIG,warnings and precautions,"severe cutaneous reactions, anaphylaxis, neutropenia, embryo-fetal toxicity, hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, toxic epidermal necrolysis (TEN), dermatitis exfoliative, rash, rash erythematous, rash generalized, rash macular, rash maculo-papular, rash papular, rash pruritic, exfoliative rash, skin disorder"
200,SIMPONI,adverse reactions,"serious infections, malignancies, upper respiratory tract infection, viral infection, bronchitis, hypertension, rash, sepsis, pneumonia, cellulitis, abscess, opportunistic infections, tuberculosis, invasive fungal infections, liver enzyme elevations, autoimmune disorders, autoantibodies, infusion reactions, immunogenicity, infections and infestations, vascular disorders, skin and subcutaneous disorders, general disorders and administration site conditions, blood and lymphatic disorders, superficial fungal infection, sinusitis, lower respiratory tract infection, pyelonephritis, investigations, alanine aminotransferase increased, aspartate aminotransferase increased, neutrophil count decreased, nervous system disorders, dizziness, paresthesia, gastrointestinal disorders, constipation, neoplasm benign and malignant, melanoma, immune system disorders, serious systemic hypersensitivity reactions, anaphylactic reaction, sarcoidosis, respiratory, thoracic and mediastinal disorders, interstitial lung disease, skin and subcutaneous tissue disorders, skin exfoliation, bullous skin reactions"
201,SIMPONI,boxed warnings,"serious infections, hospitalization, death, tuberculosis (TB), bacterial sepsis, invasive fungal infections, histoplasmosis, opportunistic infections, sepsis, lymphoma, malignancies, active tuberculosis, reactivation of latent tuberculosis, disseminated disease, extrapulmonary disease, invasive fungal infections, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, bacterial infections, viral infections, Legionella, Listeria"
202,SIMPONI,warnings and precautions,"'serious infections, invasive fungal infections, hepatitis B reactivation, malignancies, heart failure, demyelinating disease, hypersensitivity reactions, tuberculosis, Hepatitis B Virus Reactivation, Malignancies in Pediatric Patients, Malignancies in Adult Patients, Congestive Heart Failure, Demyelinating Disorders, Hematologic Cytopenias, Vaccinations/Therapeutic Infectious Agents, Hypersensitivity Reactions'"
203,BLINCYTO,adverse reactions,"'cytokine release syndrome, neurological toxicities, infections, tumor lysis syndrome, neutropenia, febrile neutropenia, effects on ability to drive and use machines, elevated liver enzymes, leukoencephalopathy, preparation and administration errors, pyrexia, headache, peripheral edema, febrile neutropenia, nausea, hypokalemia, tremor, rash, constipation, pneumonia, sepsis, device-related infection, encephalopathy, infection, overdose, confusion, Staphylococcal bacteremia, anemia, thrombocytopenia, leukopenia, diarrhea, abdominal pain, vomiting, fatigue, chills, chest pain, cytokine release syndrome, other pathogen infections, bacterial infections, fungal infections, viral infections, pneumonia, sepsis, increased alanine aminotransferase, increased aspartate aminotransferase, increased weight, hypomagnesemia, hyperglycemia, decreased appetite, hypophosphatemia, back pain, pain in extremity, bone pain, arthralgia, dizziness, insomnia, cough, dyspnea, rash, hypotension, hypertension, leukocytosis, lymphopenia, tachycardia, edema, cytokine storm, decreased immunoglobulins, increased blood bilirubin, increased gamma-glutamyl-transferase, increased liver enzymes, tumor lysis syndrome, hypoalbuminemia, encephalopathy, paresthesia, aphasia, convulsion, memory impairment, cognitive disorder, speech disorder, confusion, disorientation, capillary leak syndrome, hypersensitivity, bronchospasm'"
204,BLINCYTO,boxed warnings,"Cytokine Release Syndrome (CRS), neurological toxicities"
205,BLINCYTO,warnings and precautions,"'infections, effects on ability to drive and use machines, preparation and administration errors, cytokine release syndrome (CRS), life-threatening or fatal CRS, pyrexia, headache, nausea, asthenia, hypotension, increased alanine aminotransferase, increased aspartate aminotransferase, increased total bilirubin, disseminated intravascular coagulation (DIC), capillary leak syndrome (CLS), hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS), neurological toxicities, encephalopathy, convulsions, speech disorders, disturbances in consciousness, confusion and disorientation, coordination and balance disorders, serious infections, sepsis, pneumonia, bacteremia, opportunistic infections, catheter-site infections, tumor lysis syndrome (TLS), neutropenia, febrile neutropenia, seizures, elevated liver enzymes, transient elevations in liver enzymes, Grade 3 or greater elevations in liver enzymes, leukoencephalopathy, preparation and administration errors'"
206,NATAZIA,adverse reactions,"serious cardiovascular events, stroke, vascular events, liver disease, irregular uterine bleeding, nausea, breast tenderness, headache, headaches, migraines, breast pain, menstrual disorders, metrorrhagia, menorrhagia, menstruation irregular, genital hemorrhage, vaginal hemorrhage, dysfunctional uterine bleeding, mood changes, depression, mood swings, mood altered, depressed mood, dysthymic disorder, crying, acne, increased weight, myocardial infarction, ruptured ovarian cyst, deep vein thrombosis, focal nodular hyperplasia of the liver, uterine leiomyoma, acute cholecystitis, chronic acalculous cholecystitis, venous thromboembolic events, arterial thromboembolic events, pulmonary emboli, cerebral thrombosis, hypertension, gallbladder disease, hepatitis, hypersensitivity, fluid retention, hypertriglyceridemia, dizziness, chloasma, angioedema, erythema nodosum, erythema multiforme, gastrointestinal symptoms, abdominal pain, vulvovaginal candidiasis"
207,NATAZIA,boxed warnings,serious cardiovascular events
208,NATAZIA,warnings and precautions,"thrombotic event, venous thromboembolism, arterial thromboses, strokes, myocardial infarctions, loss of vision, proptosis, diplopia, papilledema, retinal vascular lesions, retinal vein thrombosis, cervical cancer, intraepithelial neoplasia, jaundice, hepatic adenomas, intra-abdominal hemorrhage, hepatocellular carcinoma, cholestasis, high blood pressure, gallbladder disease, decreased glucose tolerance, adverse lipid changes, pancreatitis, headaches, migraine, breakthrough bleeding, spotting, amenorrhea, oligomenorrhea, intracyclic bleeding, depression, chloasma, hereditary angioedema"
209,DIFICID,adverse reactions,"nausea, vomiting, abdominal pain, gastrointestinal hemorrhage, anemia, neutropenia, abdominal distension, abdominal tenderness, dyspepsia, dysphagia, flatulence, intestinal obstruction, megacolon, increased blood alkaline phosphatase, decreased blood bicarbonate, increased hepatic enzymes, decreased platelet count, hyperglycemia, metabolic acidosis, drug eruption, pruritus, rash, hypersensitivity reactions, dyspnea, angioedema"
210,DIFICID,warnings and precautions,"acute hypersensitivity reactions, angioedema, dyspnea, pruritus, rash, hypersensitivity reactions, drug-resistant bacteria"
211,EDARBI,adverse reactions,"diarrhea, hypotension, orthostatic hypotension, nausea, asthenia, fatigue, muscle spasm, dizziness, dizziness postural, cough, serum creatinine increases, low hemoglobin, low hematocrit, low RBC counts, abnormal platelet counts, abnormal WBC counts, rash, pruritus, angioedema"
212,EDARBI,boxed warnings,fetal toxicity
213,EDARBI,warnings and precautions,"fetal toxicity, fetal lung hypoplasia, skeletal deformations, skull hypoplasia, anuria, hypotension, renal failure, death, symptomatic hypotension, oliguria, progressive azotemia, acute renal failure, increases in serum creatinine, increases in blood urea nitrogen"
214,IMBRUVICA,adverse reactions,"'hemorrhage, infections, cytopenias, atrial fibrillation, second primary malignancies, tumor lysis syndrome, thrombocytopenia, neutropenia, diarrhea, anemia, fatigue, musculoskeletal pain, bruising, nausea, upper respiratory tract infection, rash, peripheral edema, dyspnea, constipation, abdominal pain, vomiting, decreased appetite, pneumonia, stomatitis, dyspepsia, skin infections, sinusitis, pyrexia, asthenia, petechiae, muscle spasms, arthralgia, cough, epistaxis, dehydration, dizziness, headache, renal failure, creatinine increased, subdural hematoma, lymphocytosis, intracranial hemorrhage, lethargy, gait instability, hyperuricemia, laceration, anxiety, insomnia, hypertension, vision blurred, contusion, pruritus, arthropathy, skin cancer, hypersensitivity reactions, anaphylactic shock, urticaria, angioedema'"
215,IMBRUVICA,warnings and precautions,"hemorrhage, bleeding, subdural hematoma, gastrointestinal bleeding, hematuria, post procedural hemorrhage, bruising, petechiae, infections, progressive multifocal leukoencephalopathy (PML), cytopenias, neutropenia, thrombocytopenia, anemia, atrial fibrillation, atrial flutter, second primary malignancies, non-skin carcinomas, non-melanoma skin cancer, tumor lysis syndrome, embryo-fetal toxicity, malformations, reduced fetal weights"
216,DUREZOL,adverse reactions,"elevated intraocular pressure, optic nerve damage, visual acuity and field defects, posterior subcapsular cataract formation, secondary ocular infection, perforation of the globe, corneal edema, ciliary and conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, blepharitis, reduced visual acuity, punctate keratitis, eye inflammation, iritis, application site discomfort or irritation, corneal pigmentation and striae, episcleritis, eye pruritis, eyelid irritation and crusting, foreign body sensation, increased lacrimation, macular edema, sclera hyperemia, uveitis, blurred vision, eye irritation, headache, increased IOP, limbal and conjunctival hyperemia, anterior chamber flare, dry eye, iridocyclitis"
217,DUREZOL,warnings and precautions,"increase in intraocular pressure, glaucoma, damage to the optic nerve, defects in visual acuity, defects in fields of vision, posterior subcapsular cataract formation, delayed healing, increase in the incidence of bleb formation, corneal or scleral thinning, corneal or scleral perforations, suppression of host response, increase in the hazard of secondary ocular infections, mask infection, enhance existing infection, prolong the course of viral infections, exacerbate the severity of viral infections, fungal infections of the cornea, persistent corneal ulceration, fungus invasion"
218,ZYKADIA,adverse reactions,"Peripheral Neuropathy, Anaphylaxis, Infusion Reactions, Hematologic Toxicities, Serious Infections, Opportunistic Infections, Tumor Lysis Syndrome, Increased Toxicity in the Presence of Severe Renal Impairment, Increased Toxicity in the Presence of Moderate or Severe Hepatic Impairment, Hepatotoxicity, Severe or Persistent Gastrointestinal Toxicity, Interstitial Lung Disease/Pneumonitis, QT Interval Prolongation, Hyperglycemia, Bradycardia, Pancreatitis, Diarrhea, Nausea, Elevated Transaminases, Vomiting, Abdominal Pain, Fatigue, Decreased Appetite, Constipation, Convulsion, Pneumonia, ILD/Pneumonitis, Dyspnea, Dehydration, Hyperglycemia, Respiratory Failure, Pneumothorax, Gastric Hemorrhage, General Physical Health Deterioration, Pulmonary Tuberculosis, Cardiac Tamponade, Sepsis, Neuropathy, Vision Disorder, Prolonged QT Interval, Bradycardia, Hemoglobin Decreased, Alanine Transaminase Increased, Aspartate Transaminase Increased, Creatinine Increased, Glucose Increased, Phosphate Decreased, Lipase Increased, Bilirubin Increased"
219,ZYKADIA,warnings and precautions,"diarrhea, nausea, vomiting, abdominal pain, hepatotoxicity, interstitial lung disease (ILD), pneumonitis, QT interval prolongation, hyperglycemia, bradycardia, pancreatitis, embryofetal toxicity"
220,CHOLINE,adverse reactions,injection site reaction
221,CHOLINE,warnings and precautions,"'imaging errors, allergic reactions, radiation risk, false positive results, false negative results, tissue inflammation, prostatic hyperplasia, anaphylaxis, cancer risk'"
222,ERWINAZE,adverse reactions,"hypersensitivity reactions, pancreatitis, glucose intolerance, thrombosis, hemorrhage, systemic hypersensitivity, hyperglycemia, transaminases abnormal, fever, local reactions, vomiting, nausea, hyperbilirubinemia, abdominal pain/discomfort, diarrhea, allergy, coagulopathy, hyperbilirubinemia, hyperlipidemia, ketoacidosis, CNS events"
223,ERWINAZE,warnings and precautions,"hypersensitivity reactions, anaphylaxis, severe or hemorrhagic pancreatitis, glucose intolerance, hyperglycemia, thrombosis, hemorrhage, sagittal sinus thrombosis, pulmonary embolism, decreased fibrinogen, decreased protein C activity, decreased protein S activity, decreased anti-thrombin III"
224,SAPHRIS,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, dementia-related psychosis, neuroleptic malignant syndrome, tardive dyskinesia, metabolic changes, hypersensitivity reactions, oral ulcers, blisters, peeling/sloughing, inflammation, orthostatic hypotension, syncope, leukopenia, neutropenia, agranulocytosis, QT interval prolongation, hyperprolactinemia, seizures, cognitive and motor impairment, body temperature regulation, suicide, dysphagia, akathisia, oral hypoesthesia, somnolence, dizziness, extrapyramidal symptoms, increased weight, constipation, dry mouth, salivary hypersecretion, stomach discomfort, vomiting, fatigue, irritability, dyspepsia, toothache, arthralgia, pain in extremity, headache, anxiety, depression, insomnia, dysgeusia, nausea, increased appetite, abdominal pain, glossodynia, irritability, muscle strain, hyperinsulinemia, ALT increased, AST increased, dehydration, myalgia, tachycardia, oropharyngeal pain, nasal congestion, dyspnea, rash, dysmenorrhea, dystonia, parkinsonism, oculogyration, tremor, bradykinesia, muscle contractions involuntary, muscle twitching, musculoskeletal stiffness, protrusion tongue, resting tremor, oral paresthesia, transaminases elevations, creatine kinase elevations, anemia, thrombocytopenia, temporary bundle branch block, accommodation disorder, swollen tongue, idiosyncratic drug reaction, hyponatremia, dysarthria, diplopia, vision blurred, gastroesophageal reflux disease, fall, photosensitivity reaction, enuresis, application site reactions, choking, oropharyngeal muscular dysfunction, hypoesthesia"
225,SAPHRIS,boxed warnings,Answer: 'increased mortality in elderly patients with dementia-related psychosis'
226,SAPHRIS,warnings and precautions,"'cerebrovascular adverse events, stroke, transient ischemic attack, neuroleptic malignant syndrome, tardive dyskinesia, hyperglycemia, dyslipidemia, weight gain, hypersensitivity reactions, anaphylaxis, angioedema, orthostatic hypotension, syncope, leukopenia, neutropenia, agranulocytosis, QT prolongation, seizures, cognitive and motor impairment, suicide, dysphagia, aspiration pneumonia, somnolence, hyperprolactinemia, galactorrhea, amenorrhea, gynecomastia, impotence, decreased bone density, body temperature regulation disruption, pyrexia, feeling hot, esophageal dysmotility, aspiration pneumonia, myocardial infarction, unstable heart disease, cardiac dysrhythmia, tachycardia, diaphoresis, acute renal failure, muscle rigidity, altered mental status, autonomic instability, irregular pulse, blood pressure changes, elevated creatine phosphokinase, myoglobinuria, rhabdomyolysis, dizziness, tachycardia, bradycardia, hypotension, swollen tongue, dyspnea, wheezing, rash, fever, infection symptoms, Torsade de Pointes, delayed ventricular repolarization, bradycardia, hypokalemia, hypomagnesemia, congenital prolongation of the QT interval, hypothalamic GnRH suppression, reduced pituitary gonadotropin secretion, reproductive function impairment, prolactin-dependent breast cancers, operating hazardous machinery impairment, motor vehicle operation impairment, anticholinergic activity, dehydration, esophageal dysmotility, aspiration pneumonia risk'"
227,CARBAGLU,adverse reactions,"'anemia, ear infection, abdominal pain, diarrhea, vomiting, dysgeusia, asthenia, hyperhidrosis, pyrexia, infection, influenza, nasopharyngitis, pneumonia, tonsillitis, hemoglobin decreased, weight decreased, anorexia, headache, somnolence, rash'"
228,CARBAGLU,warnings and precautions,"hyperammonemia, injury to the brain, death, brain injury/damage"
229,PROMACTA,adverse reactions,"hepatic decompensation, hepatotoxicity, thrombotic/thromboembolic complications, cataracts, nausea, diarrhea, upper respiratory tract infection, vomiting, increased ALT, myalgia, urinary tract infection, nasopharyngitis, rhinitis, anemia, pyrexia, fatigue, headache, decreased appetite, influenza-like illness, asthenia, insomnia, cough, pruritus, chills, alopecia, peripheral edema, hemorrhage, oropharyngeal pain, increased AST, pharyngitis, back pain, influenza, paresthesia, rash, alopecia, musculoskeletal pain, blood alkaline phosphatase increased, dry mouth, hyperbilirubinemia, cataract, abdominal pain, toothache, vitamin D deficiency, thrombotic microangiopathy, acute renal failure"
230,PROMACTA,boxed warnings,hepatic decompensation
231,PROMACTA,warnings and precautions,"hepatic decompensation, ascites, encephalopathy, liver enzyme elevations, hyperbilirubinemia, clinical symptoms of liver injury, hepatic decompensation, thrombotic event, portal venous system events, venous events, arterial events, thromboembolism, Factor V Leiden, ATIII deficiency, antiphospholipid syndrome, chronic liver disease, thrombotic complications, portal vein thrombosis, abdominal pain, nausea, vomiting, diarrhea, cataracts"
232,BESIVANCE,adverse reactions,"conjunctival redness, blurred vision, eye pain, eye irritation, eye pruritus, headache"
233,BESIVANCE,warnings and precautions,"growth of resistant organisms, overgrowth of non-susceptible organisms, super-infection"
234,INLYTA,adverse reactions,"'hypertension, arterial thromboembolic events, venous thromboembolic events, hemorrhage, cardiac failure, gastrointestinal perforation, fistula formation, thyroid dysfunction, wound healing complications, RPLS, proteinuria, elevation of liver enzymes, hepatic impairment, fetal development, diarrhea, hypertension, fatigue, decreased appetite, nausea, dysphonia, palmar-plantar erythrodysesthesia syndrome, weight decreased, vomiting, asthenia, constipation, hypothyroidism, cough, mucosal inflammation, arthralgia, stomatitis, dyspnea, abdominal pain, headache, pain in extremity, rash, proteinuria, dysgeusia, dry skin, dyspepsia, pruritus, alopecia, erythema, dizziness, upper abdominal pain, myalgia, dehydration, epistaxis, anemia, hemorrhoids, hematuria, tinnitus, lipase increased, glossodynia, pulmonary embolism, rectal hemorrhage, hemoptysis, deep vein thrombosis, retinal-vein occlusion/thrombosis, polycythemia, transient ischemic attack, hemoglobin decreased, lymphocytes decreased, platelets decreased, white blood cells decreased, creatinine increased, bicarbonate decreased, hypocalcemia, ALP increased, hyperglycemia, lipase increased, amylase increased, ALT increased, AST increased, hypernatremia, hypoalbuminemia, hyperkalemia, hypoglycemia, hyponatremia, hypophosphatemia, hemoglobin increased, hypercalcemia'"
235,INLYTA,warnings and precautions,"'hypertension, hypertensive crisis, arterial thrombotic events, venous thrombotic events, hemorrhagic events, cardiac failure, gastrointestinal perforation, fistula, hypothyroidism, hyperthyroidism, reversible posterior leukoencephalopathy syndrome (RPLS), proteinuria, liver enzyme elevation, hepatic impairment, fetal harm'"
236,NORTHERA,adverse reactions,"supine hypertension, hyperpyrexia, confusion, ischemic heart disease, arrhythmias, congestive heart failure, headache, dizziness, nausea, hypertension, fatigue, falls, urinary tract infections, syncope"
237,NORTHERA,boxed warnings,supine hypertension
238,NORTHERA,warnings and precautions,"supine hypertension, hyperpyrexia, confusion, exacerbation of ischemic heart disease, arrhythmias, congestive heart failure, allergic reactions, bronchial asthma"
239,ADCETRIS,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, progressive multifocal leukoencephalopathy, pulmonary toxicity, serious dermatologic reactions, neutropenia, peripheral sensory neuropathy, fatigue, nausea, anemia, upper respiratory tract infection, diarrhea, pyrexia, rash, thrombocytopenia, cough, vomiting, peripheral motor neuropathy, lymphadenopathy, headache, dizziness, chills, pain, edema peripheral, abdominal pain, constipation, pruritus, alopecia, night sweats, dry skin, dyspnea, oropharyngeal pain, arthralgia, myalgia, back pain, pain in extremity, muscle spasms, insomnia, anxiety, decreased appetite, weight decreased, febrile neutropenia, hyperglycemia, pancreatitis, noninfectious pulmonary toxicity, pneumonitis, interstitial lung disease, ARDS, toxic epidermal necrolysis, embryo-fetal toxicity, Stevens-Johnson syndrome, tumor lysis syndrome, septic shock, supraventricular arrhythmia, urinary tract infection, pneumonia, acute respiratory distress syndrome, paraesthesia"
240,ADREVIEW,all-concat,"hypersensitivity reactions, dizziness, rash, pruritis, flushing, headache, injection site hemorrhage, hematoma, bruising, benzyl alcohol toxicity, Gasping Syndrome, hypotension, metabolic acidosis, kernicterus, increased radiation exposure, thyroid neoplasia, hypertension"
241,AFINITOR,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, non-infectious pneumonitis, infections, angioedema, oral ulceration, renal failure, impaired wound healing, stomatitis, rash, fatigue, diarrhea, edema, abdominal pain, nausea, fever, asthenia, cough, headache, decreased appetite, hypercholesterolemia, hyperglycemia, increased aspartate transaminase (AST), anemia, leukopenia, thrombocytopenia, lymphopenia, increased alanine transaminase (ALT), hypertriglyceridemia, dyspnea, pneumonitis, vomiting, constipation, dry mouth, pyrexia, weight decreased, arthralgia, back pain, pain in extremity, dysgeusia, insomnia, pruritus, alopecia, hot flush, hemoglobin decreased, WBC decreased, platelets decreased, glucose increased, cholesterol increased, triglycerides increased, albumin decreased, potassium decreased, creatinine increased, renal angiomyolipoma, SEGA, amenorrhea, menorrhagia, menstrual irregularities, vaginal hemorrhage, epistaxis, otitis media, depression, abnormal taste, increased blood luteinizing hormone (LH) levels, increased blood follicle stimulating hormone (FSH) levels, hypersensitivity, ovarian cyst, cellulitis, elevated creatinine, acute pancreatitis, cholecystitis, cholelithiasis, arterial thrombotic events, reflex sympathetic dystrophy, non-infectious pneumonitis, pneumonia, mycobacterial infections, invasive fungal infections, aspergillosis, candidiasis, pneumocystis jiroveci pneumonia (PJP), hepatitis B virus reactivation, sepsis, respiratory failure, hepatic failure, angioedema, mouth ulcers, stomatitis, oral mucositis, wound dehiscence, wound infection, incisional hernia, lymphocele, seroma, serum creatinine elevations, urinary protein, blood glucose elevations, lipid elevations, hemoglobin decrease, neutrophils decrease, platelets decrease, live vaccines, embryo-fetal toxicity, fetal harm, hyperglycemia, hyperlipidemia, hypertriglyceridemia, lymphopenia, increased creatinine, hypophosphatemia, hypercholesterolemia, elevated partial thromboplastin time, neutropenia, elevated aspartate transaminase (AST), elevated alanine transaminase (ALT), hypophosphatemia, hypercholesterolemia, elevated partial thromboplastin time, elevated aspartate transaminase (AST), hypertriglyceridemia, elevated alanine transaminase (ALT), hypophosphatemia, hyperglycemia, elevated creatinine, abdominal pain, dry mouth, hemorrhoids, dysphagia, pleural effusion, pharyngolaryngeal pain, rhinorrhea, hand-foot syndrome, nail disorder, erythema, onychoclasis, skin lesion, acneiform dermatitis, angioedema, exacerbation of pre-existing diabetes mellitus, new onset of diabetes mellitus, insomnia, dizziness, paresthesia, eyelid edema, conjunctivitis, hypertension, deep vein thrombosis, renal failure, tachycardia, congestive cardiac failure, jaw pain, hemorrhage"
242,AMPYRA,all-concat,"seizures, anaphylaxis, urinary tract infections, insomnia, dizziness, headache, nausea, asthenia, back pain, balance disorder, multiple sclerosis relapse, paresthesia, nasopharyngitis, constipation, dyspepsia, pharyngolaryngeal pain, confusional state"
243,AMYVID,all-concat,"headache, musculoskeletal pain, blood pressure increased, fatigue, nausea, injection site reaction, anxiety, back pain, claustrophobia, dizziness, feeling cold, insomnia, neck pain, infusion site rash, dysgeusia, pruritis, urticaria, flushing"
244,APTIOM,all-concat,"suicidal behavior and ideation, serious dermatologic reactions, drug reaction with eosinophilia and systemic symptoms (DRESS), anaphylactic reactions, angioedema, hyponatremia, neurological adverse reactions, drug induced liver injury, abnormal thyroid function tests, dizziness, somnolence, nausea, headache, diplopia, vomiting, fatigue, vertigo, ataxia, blurred vision, tremor, ear and labyrinth disorders, eye disorders, gastrointestinal disorders, general disorders and administration site conditions, infections and infestations, injury, poisoning and procedural complications, metabolism and nutrition disorders, nervous system disorders, psychiatric disorders, respiratory, thoracic and mediastinal disorders, skin and subcutaneous tissue disorders, vascular disorders, decreases in hemoglobin and hematocrit, increases in total cholesterol, triglycerides, LDL, increases in creatine phosphokinase, serious dermatologic reactions including Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), hepatitis, nephritis, hematological abnormalities, myocarditis, myositis, fever, rash, lymphadenopathy, laryngeal edema, seizures, severe nausea/vomiting, dehydration, severe gait instability, injury, hypochloremia, disturbance in gait and coordination, balance disorder, gait disturbance, nystagmus, abnormal coordination, asthenia, malaise, hypersomnia, sedation, lethargy, memory impairment, disturbance in attention, amnesia, confusional state, aphasia, speech disorder, slowness of thought, disorientation, psychomotor retardation, visual impairment, impaired vision, mild to moderate elevations in transaminases, elevations of total bilirubin, decreases in serum T3 and T4"
245,ARCAPTA,all-concat,"asthma-related death, cough, oropharyngeal pain, nasopharyngitis, headache, nausea, COPD exacerbation, pneumonia, angina pectoris, atrial fibrillation, muscle spasm, musculoskeletal pain, edema peripheral, diabetes mellitus, hyperglycemia, sinusitis, upper respiratory tract infection, hypersensitivity reactions, paradoxical bronchospasm, tachycardia, heart rate increase, palpitations, pruritus, rash, dizziness, immediate hypersensitivity reactions, life-threatening paradoxical bronchospasm, cardiovascular effects, ECG changes, hypokalemia, hyperglycemia"
246,BELEODAQ,all-concat,"hematologic toxicity, infection, hepatotoxicity, tumor lysis syndrome, gastrointestinal toxicity, nausea, fatigue, pyrexia, anemia, vomiting, constipation, diarrhea, dyspnea, rash, peripheral edema, cough, thrombocytopenia, pruritus, chills, increased blood lactate dehydrogenase, decreased appetite, headache, infusion site pain, hypokalemia, prolonged QT, abdominal pain, hypotension, phlebitis, dizziness, pneumonia, increased creatinine, multi-organ failure, hepatic failure, ventricular fibrillation, febrile neutropenia, leukopenia (neutropenia and lymphopenia), sepsis, embryo-fetal toxicity"
247,BENLYSTA,all-concat,"mortality, serious infections, malignancy, hypersensitivity reactions, anaphylaxis, infusion reactions, depression, immunization, progressive multifocal leukoencephalopathy (PML), nausea, diarrhea, pyrexia, nasopharyngitis, bronchitis, insomnia, pain in extremity, migraine, pharyngitis, cystitis, leukopenia, gastroenteritis viral, fatal anaphylaxis, infection, cardiovascular disease, suicide, upper respiratory tract infection, urinary tract infection, sinusitis, influenza, pneumonia, cellulitis, JC virus-associated PML, neurological deficits, non-melanoma skin cancers, rash, fatigue, myalgia, headache, facial edema, bradycardia, urticaria, hypotension, anxiety, psychiatric events, serious psychiatric events, serious depression, suicidal behavior, live vaccines, biologic therapies, intravenous cyclophosphamide"
248,BEPREVE,all-concat,"mild taste following instillation, eye irritation, headache, nasopharyngitis, hypersensitivity reactions, itching, body rash, swelling of lips, tongue and/or throat"
249,BESIVANCE,all-concat,"conjunctival redness, blurred vision, eye pain, eye irritation, eye pruritus, headache, overgrowth of non-susceptible organisms, super-infection"
250,BLINCYTO,all-concat,"cytokine release syndrome, neurological toxicities, infections, tumor lysis syndrome, neutropenia, febrile neutropenia, effects on ability to drive and use machines, elevated liver enzymes, leukoencephalopathy, preparation and administration errors, pyrexia, headache, peripheral edema, nausea, hypokalemia, tremor, rash, constipation, febrile neutropenia, pneumonia, sepsis, device-related infection, encephalopathy, infection, overdose, confusion, Staphylococcal bacteremia, anemia, thrombocytopenia, leukopenia, diarrhea, abdominal pain, vomiting, fatigue, chills, chest pain, cytokine release syndrome, other pathogen infections, bacterial infections, fungal infections, viral infections, increased alanine aminotransferase, increased aspartate aminotransferase, increased weight, hypomagnesemia, hyperglycemia, decreased appetite, hypophosphatemia, back pain, pain in extremity, bone pain, arthralgia, dizziness, insomnia, cough, dyspnea, hypotension, hypertension, leukocytosis, lymphopenia, tachycardia, edema, cytokine storm, decreased immunoglobulins, increased blood bilirubin, increased gamma-glutamyl-transferase, increased liver enzymes, tumor lysis syndrome, hypoalbuminemia, encephalopathy, paresthesia, aphasia, convulsion, memory impairment, cognitive disorder, speech disorder, confusion, disorientation, capillary leak syndrome, hypersensitivity, bronchospasm"
251,BOSULIF,all-concat,"'gastrointestinal toxicity, myelosuppression, hepatic toxicity, fluid retention, renal toxicity, diarrhea, nausea, thrombocytopenia, vomiting, abdominal pain, rash, anemia, pyrexia, fatigue, anaphylactic shock, increased alanine aminotransferase, headache, cough, increased aspartate aminotransferase, neutropenia, edema, arthralgia, decreased appetite, respiratory tract infection, nasopharyngitis, back pain, asthenia, pruritus, dizziness, dyspnea, QTcF interval prolongation, platelet count low, absolute neutrophil count low, hemoglobin low, SGPT/ALT elevation, SGOT/AST elevation, lipase increase, phosphorus low, total bilirubin increase, febrile neutropenia, pericardial effusion, pericarditis, tinnitus, gastritis, acute pancreatitis, gastrointestinal hemorrhage, chest pain, chest discomfort, pain, hepatotoxicity, toxic hepatitis, cytolytic hepatitis, abnormal hepatic function, liver disorder, liver injury, drug hypersensitivity, pneumonia, bronchopneumonia, lobar pneumonia, primary atypical pneumonia, influenza, bronchitis, electrocardiogram QT prolonged, increased blood creatine phosphokinase, increased blood creatinine, hyperkalemia, dehydration, myalgia, dysgeusia, acute renal failure, renal failure, pleural effusion, acute pulmonary edema, respiratory failure, pulmonary hypertension, urticaria, acne, erythema multiforme, exfoliative rash, drug eruption, embryofetal toxicity'"
252,BREO,all-concat,"asthma-related death, asthma-related hospitalization, nasopharyngitis, upper respiratory tract infection, headache, oral candidiasis, Candida albicans infection, pneumonia, immunosuppression, hypercorticism, adrenal suppression, bone mineral density reduction, paradoxical bronchospasm, cardiovascular effects, glaucoma, cataracts, convulsive disorders, thyrotoxicosis, diabetes mellitus, ketoacidosis, hypokalemia, hyperglycemia, growth reduction, anaphylaxis, angioedema, rash, urticaria, muscle spasms, tremor, nervousness, oropharyngeal pain, dysphonia, cough, bronchitis, sinusitis, influenza, back pain, arthralgia, pharyngitis, pyrexia, extrasystoles, upper abdominal pain, respiratory tract infection, allergic rhinitis, rhinitis, supraventricular extrasystoles, ventricular extrasystoles, acute sinusitis, tachycardia, palpitations"
253,CARBAGLU,all-concat,"'infections, vomiting, abdominal pain, pyrexia, tonsilitis, anemia, ear infection, diarrhea, nasopharyngitis, headache, dysgeusia, asthenia, hyperhidrosis, influenza, pneumonia, hemoglobin decreased, weight decreased, anorexia, somnolence, rash, hyperammonemia, brain injury, death, brain damage'"
254,CERDELGA,all-concat,"fatigue, headache, nausea, diarrhea, back pain, pain in extremities, upper abdominal pain, arthralgia, migraine, flatulence, oropharyngeal pain, dizziness, asthenia, cough, dyspepsia, gastroesophageal reflux disease, constipation, palpitations, rash, ECG changes, cardiac arrhythmias"
255,CHOLINE,all-concat,"injection site reaction, imaging errors, allergic reactions, anaphylaxis, radiation risk"
256,CIMZIA,all-concat,"upper respiratory tract infection, rash, urinary tract infection, serious infections, malignancies, heart failure, abdominal pain, diarrhea, intestinal obstruction, tuberculosis infections, pyrexia, urticaria, pneumonia, anemia, leukopenia, lymphadenopathy, pancytopenia, thrombophilia, angina pectoris, arrhythmias, atrial fibrillation, cardiac failure, hypertensive heart disease, myocardial infarction, myocardial ischemia, pericardial effusion, pericarditis, stroke, transient ischemic attack, optic neuritis, retinal hemorrhage, uveitis, bleeding, injection site reactions, elevated liver enzymes, hepatitis, alopecia totalis, anxiety, bipolar disorder, suicide attempt, nephrotic syndrome, renal failure, menstrual disorder, dermatitis, erythema nodosum, thrombophlebitis, vasculitis, systemic vasculitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, new or worsening psoriasis, sarcoidosis, disseminated or extrapulmonary disease, histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, Legionella, Listeria, lymphoma, hepatosplenic T-cell lymphoma, leukemia, worsening congestive heart failure, new onset congestive heart failure, angioedema, dermatitis allergic, dizziness (postural), dyspnea, hot flush, hypotension, malaise, serum sickness, (vasovagal) syncope, reactivation of latent tuberculosis, invasive fungal infections, bacterial infections, viral infections, opportunistic pathogens, hepatitis B virus reactivation, central nervous system demyelinating disease, multiple sclerosis, peripheral demyelinating disease, Guillain-Barre syndrome, seizure disorder, peripheral neuropathy, aplastic anemia, medically significant cytopenia, leukopenia, thrombocytopenia, lupus-like syndrome, autoantibodies, immunosuppression"
257,CLEVIPREX,all-concat,"hypotension, reflex tachycardia, headache, nausea, vomiting, acute renal failure, atrial fibrillation, myocardial infarction, cardiac arrest, syncope, dyspnea, increased blood triglycerides, ileus, hypersensitivity, decreased oxygen saturation, negative inotropic effects, rebound hypertension"
258,COARTEM,all-concat,"headache, anorexia, dizziness, asthenia, arthralgia, myalgia, pyrexia, cough, vomiting, hypersensitivity reactions, eosinophilia, tinnitus, conjunctivitis, constipation, dyspepsia, dysphagia, peptic ulcer, gait disturbance, abscess, acrodermatitis, bronchitis, ear infection, gastroenteritis, helminthic infection, hookworm infection, impetigo, influenza, lower respiratory tract infection, malaria, nasopharyngitis, oral herpes, pneumonia, respiratory tract infection, subcutaneous abscess, upper respiratory tract infection, urinary tract infection, alanine aminotransferase increased, aspartate aminotransferase increased, hematocrit decreased, lymphocyte morphology abnormal, platelet count decreased, platelet count increased, white blood cell count decreased, white blood cell count increased, hypokalemia, back pain, ataxia, clonus, fine motor delay, hyperreflexia, hypoesthesia, nystagmus, tremor, agitation, mood swings, hematuria, proteinuria, asthma, pharyngo-laryngeal pain, urticaria, anaphylaxis, angioedema, serious skin reactions (bullous eruption), QT prolongation, congenital prolongation of the QT interval, symptomatic cardiac arrhythmias, clinically relevant bradycardia, severe cardiac disease, sudden death, disturbances of electrolyte balance, hypokalemia, hypomagnesemia, recrudescence"
259,COMETRIQ,all-concat,"perforations, fistula, hemorrhage, thromboembolic events, wound complications, hypertension, osteonecrosis of the jaw, palmar-plantar erythrodysesthesia syndrome, proteinuria, reversible posterior leukoencephalopathy syndrome, embryofetal toxicity, gastrointestinal perforations, fistula formation, severe hemorrhage, hemoptysis, gastrointestinal hemorrhage, myocardial infarction, cerebral infarction, arterial thromboembolism, dehiscence, hypertensive crisis, nephrotic syndrome, seizures, headache, visual disturbances, confusion, altered mental function, diarrhea, stomatitis, decreased weight, decreased appetite, nausea, fatigue, oral pain, hair color changes, dysgeusia, abdominal pain, constipation, increased AST, increased ALT, lymphopenia, increased alkaline phosphatase, hypocalcemia, neutropenia, thrombocytopenia, hypophosphatemia, hyperbilirubinemia, asthenia, dehydration, arthralgia, muscle spasms, musculoskeletal chest pain, dysgeusia, headache, dizziness, paresthesia, peripheral sensory neuropathy, peripheral neuropathy, anxiety, dysphonia, rash, dry skin, alopecia, erythema, hyperkeratosis, hypotension, increased ALP, hypomagnesemia, hypokalemia, hyponatremia, pneumonia, septicemia, cardiac arrest, respiratory failure, unspecified death, pancreatitis, tracheal fistula formation, vomiting, increased levels of thyroid stimulating hormone (TSH), jaw pain, osteomyelitis, osteitis, bone erosion, tooth or periodontal infection, toothache, gingival ulceration or erosion, slow healing of the mouth or jaw after dental surgery, subcortical vasogenic edema"
260,DALVANCE,all-concat,"nausea, headache, diarrhea, vomiting, rash, pruritus, anemia, hemorrhagic anemia, leucopenia, neutropenia, thrombocytopenia, petechiae, eosinophilia, thrombocytosis, gastrointestinal hemorrhage, melena, hematochezia, abdominal pain, infusion-related reactions, hepatotoxicity, anaphylactoid reaction, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, hepatic transaminases increased, blood alkaline phosphatase increased, international normalized ratio increased, hypoglycemia, dizziness, bronchospasm, urticaria, flushing, phlebitis, wound hemorrhage, spontaneous hematoma, anaphylactic reactions, skin reactions, Red-Man Syndrome, Clostridium difficile-associated diarrhea (CDAD), ALT elevations"
261,DATSCAN,all-concat,"hypersensitivity reactions, injection site reactions, headache, nausea, vertigo, dry mouth, dizziness, rash, pruritis, injection site pain, skin erythema, anaphylactic reactions"
262,DIFICID,all-concat,"nausea, vomiting, abdominal pain, gastrointestinal hemorrhage, anemia, neutropenia, abdominal distension, abdominal tenderness, dyspepsia, dysphagia, flatulence, intestinal obstruction, megacolon, increased blood alkaline phosphatase, decreased blood bicarbonate, increased hepatic enzymes, decreased platelet count, hyperglycemia, metabolic acidosis, drug eruption, pruritus, rash, hypersensitivity reactions, dyspnea, angioedema"
263,DOTAREM,all-concat,"'NSF, hypersensitivity reactions, acute kidney injury, nausea, headache, injection site pain, injection site coldness, burning sensation, feeling cold, rash, somnolence, fatigue, dizziness, vomiting, pruritus, paresthesia, dysgeusia, pain in extremity, anxiety, hypertension, palpitations, oropharyngeal discomfort, serum creatinine increased, injection site reactions, site inflammation, extravasation, warmth, bradycardia, tachycardia, arrhythmia, hypersensitivity /anaphylactoid reactions, cardiac arrest, respiratory arrest, cyanosis, pharyngeal edema, laryngospasm, bronchospasm, angioedema, conjunctivitis, ocular hyperemia, eyelid edema, lacrimation increased, hyperhidrosis, urticaria, coma, convulsion, syncope, presyncope, parosmia, tremor, muscle contracture, muscle weakness, diarrhea, salivary hypersecretion, malaise, fever, NSF, superficial phlebitis, nephrogenic systemic fibrosis, anaphylactic reactions, circulatory collapse, extravasation, tissue irritation'"
264,DUAVEE,all-concat,"'cardiovascular disorders, malignant neoplasms, gallbladder disease, hypertriglyceridemia, venous thromboembolism, pulmonary embolism, stroke, retinal vascular thrombosis, endometrial cancer, breast cancer, ovarian cancer, dementia, gallbladder problems, loss of vision, high blood pressure, increased fats in your blood, liver problems, thyroid problems, fluid retention, low calcium, swelling of your mouth or tongue, worsening of other medical problems, blood clots, heart attack, cancer of the lining of the uterus, cancer of the ovary, muscle spasms, nausea, diarrhea, upset stomach, abdominal pain, throat pain, dizziness, neck pain, hot flush, abdominal pain upper, muscle spasms, nausea, diarrhea, dyspepsia, abdominal pain upper, oropharyngeal pain, dizziness, neck pain, venous thromboembolism, deep venous thrombosis, pulmonary embolism, retinal vein thrombosis, endometrial hyperplasia, stroke, deep vein thrombosis (DVT), probable dementia, visual abnormalities, retinal vascular thrombosis, elevated blood pressure, hypertriglyceridemia, pancreatitis, hepatic impairment, cholestatic jaundice, hypothyroidism, fluid retention, hypocalcemia, hereditary angioedema, exacerbation of asthma, diabetes mellitus, epilepsy, migraine, porphyria, systemic lupus erythematosus, hepatic hemangiomas, impaired glucose tolerance'"
265,DUREZOL,all-concat,"elevated intraocular pressure, optic nerve damage, visual acuity defects, field defects, posterior subcapsular cataract formation, secondary ocular infection, perforation of the globe, corneal edema, ciliary and conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, blepharitis, reduced visual acuity, punctate keratitis, eye inflammation, iritis, application site discomfort or irritation, corneal pigmentation and striae, episcleritis, eye pruritis, eyelid irritation and crusting, foreign body sensation, increased lacrimation, macular edema, sclera hyperemia, uveitis, blurred vision, eye irritation, headache, increased IOP, limbal and conjunctival hyperemia, anterior chamber flare, dry eye, iridocyclitis, glaucoma, defects in visual acuity and fields of vision, posterior subcapsular cataract formation, delayed healing, bleb formation, bacterial infections, viral infections, fungal infections"
266,DYSPORT,all-concat,"distant spread of toxin effect, lack of interchangeability between botulinum toxin products, spread of effects from toxin, dysphagia, breathing difficulties, facial anatomy in the treatment of glabellar lines, pre-existing neuromuscular disorders, human albumin, intradermal immune reaction, muscular weakness, dry mouth, injection site discomfort, fatigue, headache, neck pain, musculoskeletal pain, dysphonia, injection site pain, eye disorders, blurred vision, diplopia, reduced visual acuity and accommodation, disturbance in attention, eyelid disorder, feeling abnormal, nasopharyngitis, upper respiratory tract infection, eyelid edema, eyelid ptosis, sinusitis, nausea, urinary tract infection, dizziness, fall, depression, breathing difficulty, dyspnea, muscle atrophy, blood glucose increase, heart rate reduction, blood present in urine, bronchitis, influenza, pharyngolaryngeal pain, cough, contact dermatitis, injection site bruising, injection site reaction, injection site swelling, injection site erythema, injection site haematoma, eyelid ptosis, pain in extremity, back pain, convulsion, syncope, hypoaesthesia, partial seizures, asthenia, injury, contusion, diarrhea, constipation, blood triglycerides increased, hypertension, photophobia, influenza-like illness, amyotrophy, burning sensation, facial paresis, hypoesthesia, erythema, excessive granulation tissue, vertigo, generalized muscle weakness, ptosis, dysarthria, urinary incontinence, botulinum toxin effects, swallowing difficulties, respiratory failure, surgical alterations to the facial anatomy, excessive weakness, atrophy, marked facial asymmetry, inflammation, excessive dermatochalasis, deep dermal scarring, thick sebaceous skin, peripheral motor neuropathic diseases, amyotrophic lateral sclerosis, neuromuscular junction disorders, myasthenia gravis, Lambert-Eaton syndrome, dysphagia, respiratory compromise, transmission of viral diseases, Creutzfeldt-Jakob disease (CJD), immune reaction, hyperhidrosis"
267,EDARBI,all-concat,"'diarrhea, hypotension, orthostatic hypotension, nausea, asthenia, fatigue, muscle spasm, dizziness, dizziness postural, cough, serum creatinine increases, low hemoglobin, low hematocrit, low RBC counts, abnormal platelet counts, abnormal WBC counts, rash, pruritus, angioedema, fetal toxicity, oligohydramnios, fetal lung hypoplasia, skeletal deformations, skull hypoplasia, anuria, neonatal hypotension, renal failure, neonatal death, symptomatic hypotension, oliguria, progressive azotemia, acute renal failure'"
268,ELIQUIS,all-concat,"thrombotic events, bleeding, spinal/epidural anesthesia or puncture, increased risk of thrombotic events after premature discontinuation, hemorrhagic stroke, gastrointestinal bleed, fatal bleeding, intracranial bleeding, non-intracranial bleeding, hypersensitivity reactions, skin rash, anaphylactic reactions, allergic edema, syncope, nausea, anemia, contusion, hemorrhage, postprocedural hemorrhage, transaminases increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, thrombocytopenia, hypotension, epistaxis, gastrointestinal hemorrhage, hematochezia, liver function test abnormal, blood alkaline phosphatase increased, blood bilirubin increased, hematuria, wound secretion, incision-site hemorrhage, operative hemorrhage, gingival bleeding, hemoptysis, hypersensitivity, muscle hemorrhage, ocular hemorrhage, rectal hemorrhage, hemorrhagic anemia, hemorrhoidal hemorrhage, hematemesis, melena, anal hemorrhage, wound hemorrhage, postprocedural hemorrhage, traumatic hematoma, periorbital hematoma, muscle hemorrhage, vaginal hemorrhage, metrorrhagia, menometrorrhagia, genital hemorrhage, hemorrhage, ecchymosis, skin hemorrhage, petechiae, conjunctival hemorrhage, retinal hemorrhage, eye hemorrhage, blood urine present, occult blood positive, occult blood, red blood cells urine positive, injection-site hematoma, vessel puncture-site hematoma"
269,ENTEREG,all-concat,"dyspepsia, myocardial infarction, abdominal pain, nausea, vomiting, diarrhea"
270,EOVIST,all-concat,"nephrogenic systemic fibrosis (NSF), hypersensitivity reactions, nausea, headache, feeling hot, dizziness, back pain, vomiting, blood pressure increased, injection site reactions (pain, burning, coldness, extravasation, irritation), dysgeusia, paresthesia, flushing, parosmia, pruritus (generalized, eye), rash, respiratory disorders (dyspnea, respiratory distress), fatigue, chest pain, vertigo, dry mouth, chills, feeling abnormal, tremor, akathisia, bundle branch block, palpitation, oral discomfort, salivary hypersecretion, maculopapular rash, hyperhidrosis, discomfort, malaise, elevation of serum iron values, elevation of serum bilirubin, anaphylactic shock, hypotension, pharyngolaryngeal edema, urticaria, face edema, rhinitis, conjunctivitis, abdominal pain, hypoesthesia, sneezing, cough, pallor, tachycardia, restlessness, acute kidney injury, extravasation, injection site reactions, myocyte necrosis, inflammation, falsely high or low serum iron values"
271,ERWINAZE,all-concat,"hypersensitivity reactions, pancreatitis, glucose intolerance, thrombosis, hemorrhage, systemic hypersensitivity, hyperglycemia, transaminases abnormal, fever, local reactions, vomiting, nausea, hyperbilirubinemia, abdominal pain/discomfort, diarrhea, allergy, coagulopathy, hyperbilirubinemia, hyperlipidemia, ketoacidosis, CNS events, anaphylaxis, severe pancreatitis, hemorrhagic pancreatitis, sagittal sinus thrombosis, pulmonary embolism, fibrinogen decreased, protein C activity decreased, protein S activity decreased, anti-thrombin III decreased"
272,EYLEA,all-concat,"'endophthalmitis, retinal detachments, increased intraocular pressure, thromboembolic events, conjunctival hemorrhage, eye pain, cataract, vitreous floaters, intraocular pressure increased, vitreous detachment, ocular hyperemia, corneal epithelium defect, detachment of the retinal pigment epithelium, injection site pain, foreign body sensation in eyes, lacrimation increased, vision blurred, intraocular inflammation, retinal pigment epithelium tear, injection site hemorrhage, eyelid edema, corneal edema, hypersensitivity, retinal detachment, retinal tear, endophthalmitis'"
273,FANAPT,all-concat,"'peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, dizziness, dry mouth, fatigue, nasal congestion, orthostatic hypotension, somnolence, tachycardia, weight increased, arthralgia, musculoskeletal stiffness, vision blurred, nausea, diarrhea, abdominal discomfort, nasopharyngitis, upper respiratory tract infection, extrapyramidal disorder, tremor, lethargy, ejaculation failure, dyspnea, rash, hypotension, anemia, iron deficiency anemia, leukopenia, palpitations, arrhythmia, atrioventricular block first degree, cardiac failure, vertigo, tinnitus, hypothyroidism, conjunctivitis, dry eye, blepharitis, eyelid edema, eye swelling, lenticular opacities, cataract, hyperemia, gastritis, salivary hypersecretion, fecal incontinence, mouth ulceration, aphthous stomatitis, duodenal ulcer, hiatus hernia, hyperchlorhydria, lip ulceration, reflux esophagitis, stomatitis, edema, difficulty in walking, thirst, hyperthermia, cholelithiasis, weight decreased, hemoglobin decreased, neutrophil count increased, hematocrit decreased, increased appetite, dehydration, hypokalemia, fluid retention, myalgia, muscle spasms, torticollis, paresthesia, psychomotor hyperactivity, restlessness, amnesia, nystagmus, restless legs syndrome, aggression, delusion, hostility, libido decreased, paranoia, anorgasmia, confusional state, mania, catatonia, mood swings, panic attack, obsessive-compulsive disorder, bulimia nervosa, delirium, polydipsia psychogenic, impulse-control disorder, major depression, urinary incontinence, dysuria, pollakiuria, enuresis, nephrolithiasis, urinary retention, renal failure acute, erectile dysfunction, testicular pain, amenorrhea, breast pain, menstruation irregular, gynecomastia, menorrhagia, metrorrhagia, postmenopausal hemorrhage, prostatitis, epistaxis, asthma, rhinorrhea, sinus congestion, nasal dryness, dry throat, sleep apnea syndrome, dyspnea exertional, retrograde ejaculation, increased mortality, cerebrovascular adverse events, stroke, QT prolongation, arrhythmia, sudden death, Neuroleptic Malignant Syndrome, tardive dyskinesia, hyperglycemia, diabetes mellitus, dyslipidemia, seizures, leukopenia, neutropenia, agranulocytosis, suicide, priapism, cognitive and motor impairment, hyperprolactinemia, body temperature regulation, dysphagia'"
274,FARXIGA,all-concat,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, increases in low-density lipoprotein cholesterol (LDL-C), bladder cancer, volume depletion, renal failure, blood creatinine increase, bone fractures, hypersensitivity reactions, angioedema, urticaria, anaphylactic reactions, severe cutaneous adverse reactions, increase in hematocrit, increase in serum inorganic phosphorus, nasopharyngitis, urinary tract infections, back pain, increased urination, male genital mycotic infections, nausea, influenza, dyslipidemia, constipation, discomfort with urination, pain in extremity"
275,FERRIPROX,all-concat,"chromaturia, nausea, vomiting, abdominal pain, alanine aminotransferase increased, arthralgia, neutropenia, agranulocytosis, elevated ALT, decreased plasma zinc concentrations, neutropenia, agranulocytosis, abdominal pain/discomfort, diarrhea, dyspepsia, neutrophil count decreased, weight increased, aspartate aminotransferase increased, increased appetite, decreased appetite, back pain, pain in extremity, arthropathy, headache, thrombocytosis, pancytopenia, atrial fibrillation, cardiac failure, hypospadias, diplopia, papilledema, retinal toxicity, enterocolitis, rectal hemorrhage, gastric ulcer, pancreatitis, parotid gland enlargement, chills, pyrexia, edema peripheral, multi-organ failure, jaundice, hepatomegaly, anaphylactic shock, hypersensitivity, cryptococcal cutaneous infection, enteroviral encephalitis, pharyngitis, pneumonia, sepsis, furuncle, infectious hepatitis, rash pustular, subcutaneous abscess, blood bilirubin increased, blood creatinine phosphokinase increased, metabolic acidosis, dehydration, myositis, chondropathy, trismus, cerebellar syndrome, cerebral hemorrhage, convulsion, gait disturbance, intracranial pressure increased, psychomotor skills impaired, pyramidal tract syndrome, somnolence, bruxism, depression, obsessive-compulsive disorder, glycosuria, hemoglobinuria, acute respiratory distress syndrome, epistaxis, hemoptysis, pulmonary embolism, hyperhidrosis, periorbital edema, photosensitivity reaction, pruritis, urticaria, rash, Henoch-Schonlein purpura, hypotension, hypertension"
276,FIRAZYR,all-concat,"injection site reactions, pyrexia, transaminase increase, dizziness, rash, nausea, headache, anti-icatibant antibodies, hypersensitivity, anaphylactic reactions"
277,FULYZAQ,all-concat,"upper respiratory tract infection, bronchitis, cough, flatulence, increased bilirubin, nausea, back pain, arthralgia, urinary tract infection, nasopharyngitis, musculoskeletal pain, hemorrhoids, giardiasis, anxiety, increased alanine aminotransferase, abdominal distension, abdominal pain, acne, increased aspartate aminotransferase, increased conjugated bilirubin, increased unconjugated blood bilirubin, constipation, depression, dermatitis, dizziness, dry mouth, dyspepsia, gastroenteritis, herpes zoster, nephrolithiasis, pain in extremity, pollakiuria, procedural pain, seasonal allergy, sinusitis, decreased white blood cell count"
278,GADAVIST,all-concat,"'peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, increased toxicity, hepatotoxicity, nephrogenic systemic fibrosis (NSF), hypersensitivity reactions, headache, nausea, dizziness, dysgeusia, feeling hot, injection site reactions, vomiting, rash, pruritus, erythema, hypersensitivity/anaphylactoid, dyspnea, paresthesia, loss of consciousness, convulsion, parosmia, tachycardia, palpitation, dry mouth, malaise, feeling cold, cardiac arrest, anaphylactic shock, circulatory collapse, respiratory arrest, pulmonary edema, bronchospasm, cyanosis, oropharyngeal swelling, laryngeal edema, blood pressure increased, chest pain, angioedema, conjunctivitis, hyperhidrosis, cough, sneezing, burning sensation, pallor, acute kidney injury, extravasation, moderate irritation'"
279,GILENYA,all-concat,"'bradyarrhythmia, atrioventricular blocks, infections, progressive multifocal leukoencephalopathy, macular edema, posterior reversible encephalopathy syndrome, respiratory effects, liver injury, headache, liver transaminase elevation, diarrhea, cough, influenza, sinusitis, back pain, abdominal pain, pain in extremity, bronchitis, herpes zoster, tinea versicolor, bradycardia, migraine, nausea, asthenia, alopecia, actinic keratosis, blood triglycerides increased, dyspnea, vision blurred, hypertension, lymphopenia, leukopenia, skin papilloma, basal cell carcinoma, dizziness, pneumonia, eczema, pruritus, ischemic strokes, hemorrhagic strokes, peripheral arterial occlusive disease, lymphomas, symptomatic bradycardia, hypotension, fatigue, palpitations, chest pain, transient AV conduction delays, second-degree AV blocks, Mobitz Types I, 2:1 AV blocks, third-degree AV block, AV block with junctional escape, transient asystole, unexplained death, syncope, dose-dependent reduction in peripheral lymphocyte count, serious infections, bronchitis, herpes zoster, influenza, sinusitis, pneumonia, herpetic infections, disseminated primary herpes zoster, herpes simplex encephalitis, disseminated varicella zoster, herpes simplex infections, encephalitis, multiorgan failure, cryptococcal infections, cryptococcal meningitis, varicella zoster virus antibody testing, vaccination, opportunistic viral infection, JC virus, progressive weakness, clumsiness of limbs, disturbance of vision, changes in thinking, memory, orientation, confusion, personality changes, blurred vision, decreased visual acuity, dose-dependent reductions in forced expiratory volume, diffusion lung capacity for carbon monoxide, unexplained dyspnea, elevations of liver enzymes, nausea, vomiting, abdominal pain, anorexia, jaundice, dark urine, fetal harm, increase in systolic pressure, increase in diastolic pressure, hypertension, immune system effects'"
280,GILOTRIF,all-concat,"diarrhea, bullous and exfoliative skin disorders, interstitial lung disease, hepatic toxicity, keratitis, pancreatitis, dehydration, renal failure, pulmonary toxicity/ILD-like adverse reactions, sepsis, pneumonia, vomiting, dyspnea, fatigue, hypokalemia, rash/dermatitis acneiform, stomatitis, paronychia, dry skin, decreased appetite, nausea, pruritus, epistaxis, rhinorrhea, weight decreased, pyrexia, conjunctivitis, alanine aminotransferase increased, aspartate aminotransferase increased, cystitis, ventricular dysfunction, diastolic dysfunction, left ventricular dysfunction, ventricular dilation, embryofetal toxicity"
281,GRANIX,all-concat,"splenic rupture, acute respiratory distress syndrome, serious allergic reactions, capillary leak syndrome, tumor growth stimulatory effects on malignant cells, bone pain, leukocytosis, myalgia, headache, vomiting, Sweet's syndrome, cutaneous vasculitis, thrombocytopenia, anaphylaxis, angioneurotic edema, dermatitis allergic, drug hypersensitivity, hypersensitivity, rash, pruritic rash, urticaria, sickle cell crisis"
282,HALAVEN,all-concat,"'neutropenia, anemia, asthenia/fatigue, alopecia, peripheral neuropathy, nausea, constipation, febrile neutropenia, mucosal inflammation, pyrexia, diarrhea, vomiting, arthralgia/myalgia, back pain, bone pain, pain in extremity, weight decreased, anorexia, cough, dyspnea, urinary tract infection, peripheral motor neuropathy, liver function test abnormalities, increased lacrimation, dyspepsia, abdominal pain, stomatitis, dry mouth, peripheral edema, upper respiratory tract infection, hypokalemia, muscle spasms, muscular weakness, dysgeusia, dizziness, insomnia, depression, rash, lymphopenia, pancreatitis, hepatotoxicity, drug hypersensitivity, pneumonia, sepsis/neutropenic sepsis, hypomagnesemia, dehydration, interstitial lung disease, pruritus, embryo-fetal toxicity, QT prolongation'"
283,HORIZANT,all-concat,"'somnolence/sedation, dizziness, headache, nausea, dry mouth, flatulence, fatigue, irritability, feeling drunk, feeling abnormal, peripheral edema, weight increased, increased appetite, vertigo, depression, libido decreased, balance disorder, blurred vision, disorientation, lethargy, breast enlargement, gynecomastia, elevated creatine kinase, driving impairment, suicidal thoughts or behaviors, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity, withdrawal seizure, pancreatic acinar cell adenoma, carcinoma, tumors, worsened tumors'"
284,ILARIS,all-concat,"'upper respiratory tract infections, serious infections, nasopharyngitis, diarrhea, influenza, headache, nausea, infections, abdominal pain, injection site reactions, pneumonia, varicella, gastroenteritis, measles, sepsis, otitis media, sinusitis, adenovirus, lymph node abscess, pharyngitis, abdominal pain (upper), infections and infestations, gastrointestinal disorders, skin and subcutaneous tissue disorders, hypersensitivity, immunogenicity, hematology, decreased white blood cells, neutrophils, platelets, hepatic transaminases, elevations of transaminases, bilirubin, asymptomatic and mild elevations of serum bilirubin, serious infections, opportunistic infections, tuberculosis, reactivation of latent tuberculosis, immunosuppression, malignancies, hypersensitivity reactions, anaphylactic reactions, immunizations, live vaccines, macrophage activation syndrome (MAS)'"
285,IMBRUVICA,all-concat,"hemorrhage, infections, cytopenias, atrial fibrillation, second primary malignancies, tumor lysis syndrome, embryo-fetal toxicity, thrombocytopenia, neutropenia, diarrhea, anemia, fatigue, musculoskeletal pain, bruising, nausea, upper respiratory tract infection, rash, peripheral edema, dyspnea, constipation, abdominal pain, vomiting, decreased appetite, pneumonia, renal failure, creatinine increased, subdural hematoma, lymphocytosis, intracranial hemorrhage, lethargy, gait instability, headache, uric acid increased, hyperuricemia, pyrexia, asthenia, muscle spasms, arthralgia, cough, epistaxis, dehydration, dizziness, stomatitis, dyspepsia, sinusitis, urinary tract infection, skin infections, petechiae, chills, anxiety, insomnia, hypertension, laceration, vision blurred, contusion, pruritus, arthropathy, oropharyngeal pain, skin cancer, hypersensitivity reactions, anaphylactic shock, urticaria, angioedema, progressive multifocal leukoencephalopathy (PML), palpitations, lightheadedness, non-skin carcinomas, non-melanoma skin cancer, malformations in animals, reduced fetal weights"
286,INLYTA,all-concat,"'hypertension, arterial thromboembolic events, venous thromboembolic events, hemorrhage, cardiac failure, gastrointestinal perforation, fistula formation, thyroid dysfunction, wound healing complications, RPLS, proteinuria, elevation of liver enzymes, hepatic impairment, fetal development, diarrhea, fatigue, decreased appetite, nausea, dysphonia, palmar-plantar erythrodysesthesia syndrome, weight decreased, vomiting, asthenia, constipation, hypothyroidism, cough, mucosal inflammation, arthralgia, stomatitis, dyspnea, abdominal pain, headache, pain in extremity, rash, proteinuria, dysgeusia, dry skin, dyspepsia, pruritus, alopecia, erythema, dizziness, upper abdominal pain, myalgia, dehydration, epistaxis, anemia, hemorrhoids, hematuria, tinnitus, lipase increased, glossodynia, pulmonary embolism, rectal hemorrhage, hemoptysis, deep vein thrombosis, retinal-vein occlusion/thrombosis, polycythemia, transient ischemic attack, hemoglobin decreased, lymphocytes decreased, platelets decreased, white blood cells decreased, creatinine increased, bicarbonate decreased, hypocalcemia, ALP increased, hyperglycemia, amylase increased, ALT increased, AST increased, hypernatremia, hypoalbuminemia, hyperkalemia, hypoglycemia, hyponatremia, hypophosphatemia, hypertensive crisis, cerebrovascular accident, myocardial infarction, retinal artery occlusion, cerebral hemorrhage, lower gastrointestinal hemorrhage, melena, gastric hemorrhage, cardiac failure, gastrointestinal perforation, fistulas, hyperthyroidism, reversible posterior leukoencephalopathy syndrome (RPLS), alanine aminotransferase (ALT) elevations, hepatic impairment (Child-Pugh class B and C), teratogenic effects, embryotoxic effects, fetotoxic effects'"
287,INTELENCE,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, increased toxicity, hepatotoxicity, severe skin reactions, hypersensitivity reactions, rash, diarrhea, myocardial infarction, angina pectoris, atrial fibrillation, vertigo, blurred vision, gastroesophageal reflux disease, flatulence, gastritis, abdominal distension, pancreatitis, constipation, dry mouth, hematemesis, retching, stomatitis, sluggishness, hemolytic anemia, hepatic failure, hepatomegaly, cytolytic hepatitis, hepatic steatosis, hepatitis, drug hypersensitivity, immune reconstitution syndrome, diabetes mellitus, anorexia, dyslipidemia, paraesthesia, somnolence, convulsion, hypoesthesia, amnesia, syncope, disturbance in attention, hypersomnia, tremor, anxiety, sleep disorders, abnormal dreams, confusional state, disorientation, nervousness, nightmares, acute renal failure, gynecomastia, exertional dyspnea, bronchospasm, night sweats, lipohypertrophy, prurigo, hyperhidrosis, dry skin, swelling face, acquired lipodystrophy, angioneurotic edema, erythema multiforme, haemorrhagic stroke, pancreatic amylase increase, lipase increase, creatinine increase, decreased hemoglobin, white blood cell count decrease, neutrophils decrease, platelet count decrease, total cholesterol increase, low density lipoprotein increase, triglycerides increase, elevated glucose levels, alanine amino transferase increase, aspartate amino transferase increase, severe hypersensitivity reactions, DRESS, hepatic failure, rhabdomyolysis, toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema multiforme, Drug Rash with Eosinophilia and Systemic Symptoms (DRESS), redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, cushingoid appearance, immune reconstitution syndrome, inflammatory response to indolent or residual opportunistic infections, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome"
288,INVOKANA,all-concat,"hypotension, impairment in renal function, hyperkalemia, hypoglycemia, genital mycotic infections, hypersensitivity reactions, bone fracture, increased LDL-C, peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, urinary tract infections, increased urination, male genital mycotic infections, vulvovaginal pruritus, thirst, constipation, nausea, abdominal pain, fatigue, loss of strength or energy, asthenia, pancreatitis, erythema, rash, pruritus, urticaria, angioedema, photosensitivity reactions, polymorphic light eruption, sunburn, volume depletion-related adverse reactions, hypotension, postural dizziness, orthostatic hypotension, syncope, dehydration, falls, increased blood creatinine, decreased glomerular filtration rate, renal impairment, acute renal failure, phimosis, severe hypoglycemia, increases in serum potassium, increases in serum magnesium, increases in serum phosphate, increases in hemoglobin, decreases in bone mineral density"
289,JARDIANCE,all-concat,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, urinary tract infections, increased low-density lipoprotein cholesterol (LDL-C), increased urination, dyslipidemia, arthralgia, nausea, thirst, volume depletion, blood pressure decreased, blood pressure systolic decreased, dehydration, hypovolemia, orthostatic hypotension, syncope, polyuria, pollakiuria, nocturia, serum creatinine increased, eGFR decreased, hematocrit increased, phimosis"
290,JEVTANA,all-concat,"Bone Marrow Suppression, Hypersensitivity Reactions, Gastrointestinal Adverse Reactions, Renal Failure, Embryo-Fetal Toxicity, neutropenia, anemia, leukopenia, thrombocytopenia, diarrhea, fatigue, nausea, vomiting, constipation, asthenia, abdominal pain, hematuria, back pain, anorexia, peripheral neuropathy, pyrexia, dyspnea, dysgeusia, cough, arthralgia, alopecia, infections, renal failure, ventricular fibrillation, cerebral hemorrhage, dyspnea, febrile neutropenia, arrhythmia, peripheral edema, mucosal inflammation, pain, urinary tract infection, weight decreased, dehydration, muscle spasms, dizziness, headache, dysuria, hypotension, gastritis, intestinal obstruction, neutropenic deaths, generalized rash/erythema, hypotension, bronchospasm, neutropenic infections, neutropenic enterocolitis, gastrointestinal hemorrhage, perforation, ileus, enterocolitis, obstructive uropathy, sepsis, septic shock"
291,JUBLIA,all-concat,"Ingrown toenails, application site dermatitis, application site vesicles, application site pain"
292,KALBITOR,all-concat,"hypersensitivity reactions, anaphylaxis, headache, nausea, diarrhea, pyrexia, injection site reactions, nasopharyngitis, fatigue, upper respiratory tract infection, vomiting, pruritus, upper abdominal pain, chest discomfort, flushing, pharyngeal edema, rhinorrhea, sneezing, nasal congestion, throat irritation, wheezing, hypotension, rash"
293,KALYDECO,all-concat,"transaminase elevations, headache, oropharyngeal pain, upper respiratory tract infection, nasal congestion, abdominal pain, nasopharyngitis, diarrhea, rash, nausea, dizziness, infections, infestations, rhinitis, aspartate aminotransferase increased, bacteria in sputum, blood glucose increased, hepatic enzyme increased, musculoskeletal and connective tissue disorders, arthralgia, musculoskeletal chest pain, myalgia, nervous system disorders, sinus headache, respiratory, thoracic and mediastinal disorders, pharyngeal erythema, pleuritic pain, sinus congestion, wheezing, skin and subcutaneous tissue disorders, acne, hypoglycemia, cataracts"
294,KYPROLIS,all-concat,"'peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, cardiac toxicities, acute renal failure, pulmonary toxicity, pulmonary hypertension, dyspnea, hypertension, venous thrombosis, thrombocytopenia, hepatic toxicity, hepatic failure, thrombotic thrombocytopenic purpura/hemolytic uremic syndrome, posterior reversible encephalopathy syndrome, anemia, fatigue, nausea, pyrexia, decreased platelets, diarrhea, decreased lymphocyte, headache, decreased hemoglobin, cough, edema peripheral, decreased lymphocytes, decreased absolute neutrophil count, decreased phosphorus, neutropenia, decreased total white blood cell count, muscle spasm, upper respiratory tract infection, hypokalemia, pneumonia, respiratory tract infection, pulmonary embolism, constipation, asthenia, nasopharyngitis, bronchitis, hypokalemia, hypocalcemia, hyperglycemia, muscle spasms, insomnia, rash, embolic and thrombotic events, venous, febrile neutropenia, lymphopenia, cardiac arrest, cardiac failure, cardiac failure congestive, myocardial infarction, myocardial ischemia, cataract, vision blurred, abdominal pain, abdominal pain upper, dyspepsia, toothache, chills, infusion site reaction, multi-organ failure, pain, influenza, sepsis, urinary tract infection, viral infection, dehydration, hyperkalemia, hyperuricemia, hypoalbuminemia, hyponatremia, muscular weakness, myalgia, hypoesthesia, paresthesia, deafness, anxiety, delirium, renal failure, renal failure acute, renal impairment, dysphonia, epistaxis, oropharyngeal pain, pulmonary edema, erythema, hyperhidrosis, pruritus, deep vein thrombosis, hypotension, dehydration, thrombotic thrombocytopenic purpura/hemolytic uremic syndrome, cardiac failure, myocardial infarction, acute renal failure, hypercalcemia, congestive heart failure, multiple myeloma, acute respiratory distress syndrome, acute respiratory failure, acute diffuse infiltrative pulmonary disease, pneumonitis, interstitial lung disease, pulmonary arterial hypertension, hypertensive crisis, hypertensive emergency, infusion reactions, febrile neutropenia, hepatic failure, bronchitis, nasopharyngitis, respiratory tract infection, hyperglycemia, hyperuricemia, hypoalbuminemia, hypocalcemia, hypomagnesemia, hypophosphatemia, musculoskeletal chest pain, erythema, rash, embolic and thrombotic events, venous, decreased appetite, hypercalcemia, back pain, arthralgia, pain in extremity, musculoskeletal pain, headache, dizziness, insomnia, dyspnea, epistaxis, renal failure, embryo-fetal toxicity'"
295,LUMIZYME,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, hypersensitivity reactions, rash, pyrexia, flushing/feeling hot, urticaria, headache, hyperhidrosis, nausea, cough, decreased oxygen saturation, tachycardia, tachypnea, chest discomfort, dizziness, muscle twitching, agitation, cyanosis, erythema, hypertension/increased blood pressure, pallor, rigors, tremor, vomiting, fatigue, myalgia, acute cardiorespiratory failure, livedo reticularis, irritability, retching, increased lacrimation, ventricular extrasystoles, nodal rhythm, rales, respiratory tract irritation, cold sweat, angioedema, throat tightness, chest pain/discomfort, supraventricular tachycardia, local swelling, diarrhea, pruritus, delayed-onset reactions, hyperhidrosis, fatigue, myalgia, nausea, edema, peripheral, rash papular, throat tightness, anaphylactic shock, respiratory failure, respiratory arrest, cardiac arrest, hypoxia, dyspnea, wheezing, convulsions, peripheral coldness, restlessness, nervousness, back pain, stridor, pharyngeal edema, abdominal pain, apnea, muscle spasm, conjunctivitis, hyperparathyroidism, proteinuria, nephrotic syndrome, membranous glomerulonephritis, necrotizing skin lesions, flu-like illness, chills, arthralgia, pain, immune-mediated reactions, cardiac arrhythmia, sudden cardiac death, cardiac hypertrophy, fluid overload, bradycardia, bronchospasm, hypotension, face edema, convulsions, peripheral coldness, restlessness, nervousness, back pain, paresthesia, inflammatory arthropathy, elevated erythrocyte sedimentation rate, immune complex deposition, antibody development, loss of motor function, ventilator dependence, death, inhibitory antibody activity, IgE antibodies."
296,MULTAQ,all-concat,"'new or worsening heart failure, liver injury, pulmonary toxicity, hypokalemia, hypomagnesemia, QT prolongation, diarrhea, nausea, abdominal pain, vomiting, asthenia, bradycardia, rashes, pruritus, eczema, dermatitis, dermatitis allergic, photosensitivity reaction, dysgeusia, increases in creatinine, QTc prolonged, atrial flutter with 1:1 atrioventricular conduction, interstitial lung disease, pneumonitis, pulmonary fibrosis, anaphylactic reactions, angioedema, vasculitis, leukocytoclastic vasculitis, death, stroke, heart failure, hepatocellular liver injury, acute liver failure, hepatotoxicity, renal impairment, renal failure, pre-renal azotemia, acute renal failure, fetal harm'"
297,NATAZIA,all-concat,"serious cardiovascular events, stroke, vascular events, liver disease, irregular uterine bleeding, nausea, breast tenderness, headache, headaches, irregular uterine bleeding, headache, breast tenderness, pain, menstrual disorders, nausea, vomiting, acne, mood changes, increased weight, menstrual disorder, metrorrhagia, menorrhagia, menstruation irregular, genital hemorrhage, vaginal hemorrhage, dysfunctional uterine bleeding, mood changes, depression, mood swings, mood altered, depressed mood, dysthymic disorder, crying, headache, breast pain, discomfort, tenderness, menstrual disorders, metrorrhagia, menstruation irregular, menorrhagia, vaginal hemorrhage, dysfunctional uterine bleeding, genital hemorrhage, abnormal withdrawal bleeding, uterine hemorrhage, nausea, vomiting, mood changes, depression, mood swings, depressed mood, mood altered, affect lability, dysthymic disorder, myocardial infarction, ruptured ovarian cyst, deep vein thrombosis, focal nodular hyperplasia of the liver, uterine leiomyoma, acute cholecystitis, chronic acalculous cholecystitis, venous thromboembolic events, pulmonary emboli, deep vein thrombosis, cerebral thrombosis, myocardial infarction, stroke, hypertension, gallbladder disease, hepatitis, hypersensitivity, fluid retention, hypertriglyceridemia, dizziness, chloasma, angioedema, erythema nodosum, erythema multiforme, gastrointestinal symptoms, abdominal pain, vulvovaginal candidiasis, thrombotic event, venous thromboembolism, arterial thromboses, strokes, myocardial infarctions, retinal vein thrombosis, carcinoma of the breasts, cervical cancer, intraepithelial neoplasia, liver disease, jaundice, hepatic adenomas, hepatocellular carcinoma, high blood pressure, gallbladder disease, carbohydrate and lipid metabolic effects, glucose tolerance, dyslipidemia, hypertriglyceridemia, pancreatitis, headache, bleeding irregularities, breakthrough bleeding, spotting, amenorrhea, oligomenorrhea, intracyclic bleeding, depression, hereditary angioedema, symptoms of angioedema, chloasma"
298,NESINA,all-concat,"nasopharyngitis, headache, upper respiratory tract infection, pancreatitis, hypersensitivity reactions, serum sickness, hypoglycemia, anaphylaxis, angioedema, rash, urticaria, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic enzyme elevations, fulminant hepatic failure, severe and disabling arthralgia, acute pancreatitis"
299,NEURACEQ,all-concat,"'injection site reaction, erythema, irritation, pain, image interpretation errors, radiation risk'"
300,NORTHERA,all-concat,"supine hypertension, hyperpyrexia, confusion, ischemic heart disease, arrhythmias, congestive heart failure, headache, dizziness, nausea, hypertension, falls, urinary tract infections, syncope, allergic reactions"
301,NULOJIX,all-concat,"PTLD, CNS PTLD, malignancies, serious infections, JC virus-associated PML, polyoma virus nephropathy, anemia, diarrhea, urinary tract infection, peripheral edema, constipation, hypertension, pyrexia, graft dysfunction, cough, nausea, vomiting, headache, hypokalemia, hyperkalemia, leukopenia, cytomegalovirus infection, complications of transplanted kidney, CNS infections, cryptococcal meningitis, Chagas encephalitis, cerebral aspergillosis, West Nile encephalitis, infusion-related reactions, hypotension, hypertension, proteinuria, immunogenicity, new-onset diabetes after transplantation (NODAT), dyslipidemia, infections and infestations, upper respiratory infection, nasopharyngitis, influenza, bronchitis, gastrointestinal disorders, abdominal pain, metabolism and nutrition disorders, hypophosphatemia, dyslipidemia, hyperglycemia, hypocalcemia, hypercholesterolemia, hypomagnesemia, hyperuricemia, procedural complications, general disorders, blood and lymphatic system disorders, renal and urinary disorders, hematuria, dysuria, renal tubular necrosis, vascular disorders, respiratory, thoracic, and mediastinal disorders, dyspnea, investigations, musculoskeletal and connective tissue disorders, arthralgia, back pain, nervous system disorders, dizziness, tremor, skin and subcutaneous tissue disorders, acne, psychiatric disorders, insomnia, anxiety, Guillain-Barre syndrome, stomatitis, aphthous stomatitis, chronic allograft nephropathy, wound dehiscence, arteriovenous fistula thrombosis, neutropenia, renal impairment, acute renal failure, renal artery stenosis, urinary incontinence, hydronephrosis, hematoma, lymphocele, musculoskeletal pain, alopecia, hyperhidrosis, cardiac disorders, atrial fibrillation"
302,ONFI,all-concat,"'somnolence or sedation, potentiation of sedation, withdrawal symptoms, serious dermatological reactions, physical and psychological dependence, suicidal behavior and ideation, constipation, pyrexia, lethargy, drooling, vomiting, dysphagia, irritability, fatigue, upper respiratory tract infection, pneumonia, urinary tract infection, bronchitis, decreased appetite, increased appetite, somnolence, sedation, ataxia, aggression, insomnia, cough, anemia, eosinophilia, leukopenia, thrombocytopenia, diplopia, vision blurred, abdominal distention, hypothermia, hepatic enzyme increased, muscle spasms, agitation, anxiety, apathy, confusional state, depression, delirium, delusion, hallucination, urinary retention, aspiration, respiratory depression, rash, urticaria, angioedema, facial and lip edema, Stevens-Johnson syndrome, toxic epidermal necrolysis, convulsions, psychosis, hallucinations, behavioral disorder, tremor, dysphoria'"
303,OTEZLA,all-concat,"'psoriatic arthritis, diarrhea, nausea, headache, psoriasis, upper respiratory tract infection, tension headache, serious adverse reaction of nausea and vomiting, serious adverse reaction of diarrhea, serious adverse reaction of headache, upper respiratory tract infection, vomiting, nasopharyngitis, abdominal pain upper, hypersensitivity, weight decrease, frequent bowel movement, gastroesophageal reflux disease, dyspepsia, decreased appetite, migraine, cough, rash, abdominal pain, fatigue, dyspepsia, decrease appetite, insomnia, back pain, migraine, frequent bowel movements, depression, bronchitis, tooth abscess, folliculitis, sinus headache, severe worsening of psoriasis (rebound), depression, suicidal thoughts, mood changes, weight decrease, drug interactions, loss of efficacy'"
304,PICATO,all-concat,"ophthalmic adverse reaction, hypersensitivity reactions, local skin reactions, application site pain, application site pruritus, application site irritation, application site infection, periorbital edema, nasopharyngitis, headache, erythema, flaking/scaling, crusting, swelling, vesiculation/pustulation, erosion/ulceration, eyelid edema, eye pain, conjunctivitis, hypersensitivity, allergic contact dermatitis, herpes zoster, chemical conjunctivitis, corneal burn, eyelid ptosis, severe eye pain, anaphylaxis"
305,POTIGA,all-concat,"'retinal abnormalities, potential vision loss, urinary retention, skin discoloration, neuropsychiatric symptoms, dizziness, somnolence, QT interval effect, suicidal behavior and ideation, withdrawal seizures, diplopia, blurred vision, nausea, constipation, dyspepsia, fatigue, asthenia, influenza, weight increased, memory impairment, tremor, vertigo, abnormal coordination, disturbance in attention, gait disturbance, aphasia, dysarthria, balance disorder, paresthesia, amnesia, dysphasia, confusional state, anxiety, disorientation, psychotic disorder, dysuria, urinary hesitation, hematuria, chromaturia, increased appetite, hallucinations, myoclonus, peripheral edema, hypokinesia, dry mouth, dysphagia, hyperhydrosis, malaise, increased liver enzymes, rash, nystagmus, dyspnea, leukopenia, muscle spasms, alopecia, nephrolithiasis, syncope, neutropenia, thrombocytopenia, euphoric mood, renal colic, coma, encephalopathy'"
306,PRADAXA,all-concat,"bleeding, gastritis-like symptoms, gastrointestinal hemorrhage, diarrhea, major bleeding, intracranial hemorrhage, hemorrhagic stroke, gastrointestinal bleeds, fatal bleeding, non-intracranial fatal bleed, gastrointestinal adverse reactions, dyspepsia, abdominal pain upper, abdominal pain, abdominal discomfort, epigastric discomfort, GERD, esophagitis, erosive gastritis, gastric hemorrhage, hemorrhagic gastritis, hemorrhagic erosive gastritis, gastrointestinal ulcer, hypersensitivity reactions, urticaria, rash, pruritus, allergic edema, anaphylactic reaction, anaphylactic shock, myocardial infarction, thrombocytopenia, esophageal ulcer, thrombotic events, spinal/epidural hematoma, paralysis, thromboembolic events, valve thrombosis, stroke, transient ischemic attack, myocardial infarction, major bleeding, post-operative pericardial effusions"
307,PRISTIQ,all-concat,"hypersensitivity, suicidal thoughts and behaviors, serotonin syndrome, elevated blood pressure, abnormal bleeding, angle closure glaucoma, activation of mania/hypomania, discontinuation syndrome, seizure, hyponatremia, interstitial lung disease, eosinophilic pneumonia, nausea, dizziness, insomnia, hyperhidrosis, constipation, somnolence, decreased appetite, anxiety, male sexual function disorders, blood pressure increased, dry mouth, vomiting, fatigue, chills, feeling jittery, tremor, disturbance in attention, nervousness, abnormal dreams, urinary hesitation, yawning, vision blurred, mydriasis, vertigo, tinnitus, dysgeusia, hot flush, anorgasmia, libido decreased, orgasm abnormal, ejaculation delayed, erectile dysfunction, ejaculation disorder, ejaculation failure, sexual dysfunction, tachycardia, asthenia, weight increased, liver function test abnormal, blood prolactin increased, musculoskeletal stiffness, syncope, convulsion, dystonia, depersonalization, bruxism, urinary retention, rash, alopecia, photosensitivity reaction, angioedema, Stevens-Johnson syndrome, suicidal thoughts and behaviors, clinical worsening/suicide risk, serotonin syndrome, elevated blood pressure, abnormal bleeding, angle closure glaucoma, activation of mania/hypomania, discontinuation syndrome, seizure, hyponatremia, interstitial lung disease, eosinophilic pneumonia"
308,PROLIA,all-concat,"hypocalcemia, serious infections, dermatologic adverse reactions, osteonecrosis of the jaw, atypical subtrochanteric and diaphyseal femoral fractures, pancreatitis, new malignancies, hypersensitivity reactions, anaphylaxis, rash, urticaria, facial swelling, erythema, severe symptomatic hypocalcemia, musculoskeletal pain, severe bone pain, joint pain, muscle pain, marked elevation in serum PTH, anemia, angina pectoris, atrial fibrillation, vertigo, abdominal pain upper, flatulence, gastroesophageal reflux disease, edema peripheral, asthenia, cystitis, upper respiratory tract infection, pneumonia, pharyngitis, herpes zoster, hypercholesterolemia, back pain, pain in extremity, musculoskeletal pain, bone pain, myalgia, spinal osteoarthritis, sciatica, insomnia, rash, pruritus, cataracts, severe infections, skin infections, erysipelas, cellulitis, opportunistic infections, epidermal and dermal adverse events, dermatitis, eczema, rashes, suppression of bone turnover, bone remodeling, osteonecrosis, atypical fractures, delayed fracture healing"
309,PROMACTA,all-concat,"hepatic decompensation, hepatotoxicity, thrombotic/thromboembolic complications, cataracts, nausea, diarrhea, upper respiratory tract infection, vomiting, increased ALT, myalgia, urinary tract infection, nasopharyngitis, rhinitis, anemia, pyrexia, fatigue, headache, decreased appetite, influenza-like illness, asthenia, insomnia, cough, pruritus, chills, alopecia, peripheral edema, hemorrhage, oropharyngeal pain, increased AST, pharyngitis, back pain, influenza, paresthesia, rash, alopecia, musculoskeletal pain, blood alkaline phosphatase increased, dry mouth, hyperbilirubinemia, cataract, headache, abdominal pain, toothache, vitamin D deficiency, thrombotic microangiopathy with acute renal failure, ascites, encephalopathy, serum liver test abnormalities, portal vein thromboses, pain in extremity, dyspnea, dizziness, febrile neutropenia, ecchymosis, muscle spasms, transaminases increased, arthralgia, rhinorrhea"
310,QUTENZA,all-concat,"application-associated pain, increase in blood pressure, application site erythema, application site pain, application site pruritus, application site papules, application site edema, application site swelling, application site dryness, nasopharyngitis, bronchitis, sinusitis, nausea, vomiting, pruritus, hypertension, application site urticaria, application site paresthesia, application site dermatitis, application site hyperesthesia, application site excoriation, application site warmth, application site anesthesia, application site bruising, application site inflammation, application site exfoliation, peripheral edema, headache, burning sensation, peripheral sensory neuropathy, dizziness, dysgeusia, hyperesthesia, hypoesthesia, cough, throat irritation, abnormal skin odor"
311,SAPHRIS,all-concat,"'peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, dementia-related psychosis, neuroleptic malignant syndrome, tardive dyskinesia, metabolic changes, hypersensitivity reactions, oral ulcers, blisters, peeling/sloughing, inflammation, orthostatic hypotension, syncope, hemodynamic effects, leukopenia, neutropenia, agranulocytosis, QT interval prolongation, hyperprolactinemia, seizures, cognitive and motor impairment, body temperature regulation, suicide, dysphagia, cerebrovascular adverse events, stroke, transient ischemic attack, hyperpyrexia, muscle rigidity, altered mental status, autonomic instability, irregular pulse, blood pressure, tachycardia, diaphoresis, cardiac dysrhythmia, myoglobinuria, rhabdomyolysis, acute renal failure, hyperglycemia, dyslipidemia, weight gain, hyperosmolar coma, death, pneumonia, systemic infection, extrapyramidal signs, symptoms, central anticholinergic toxicity, heat stroke, drug fever, primary central nervous system pathology, akathisia, oral hypoesthesia, somnolence, dizziness, extrapyramidal symptoms, increased weight, dysgeusia, oral paresthesia, nausea, increased appetite, fatigue, constipation, dry mouth, salivary hypersecretion, stomach discomfort, vomiting, irritability, insomnia, hypertension, anxiety, depression, dysmenorrhea, oropharyngeal pain, nasal congestion, dyspnea, rash, muscle strain, hyperinsulinemia, ALT increased, AST increased, dehydration, myalgia, headache, parkinsonism, suicidal ideation, anger, dyspnea, photosensitivity reaction, enuresis, choking, oropharyngeal muscular dysfunction, hypoesthesia, cerebrovascular adverse events, ketoacidosis, polydipsia, polyuria, polyphagia, weakness, fasting glucose changes, total cholesterol changes, LDL changes, HDL changes, fasting triglycerides changes, orthostatic vital signs, hypotension, bradycardia, respiratory depression, central nervous system depression, leukopenia, neutropenia, agranulocytosis, transaminases elevations, prolactin elevations, galactorrhea, amenorrhea, gynecomastia, impotence, decreased bone density, hypogonadism, seizures, cognitive impairment, motor impairment, body temperature increases, pyrexia, feeling hot, aspiration pneumonia, myocardial infarction, unstable heart disease, cardiac patients'"
312,SIMPONI,all-concat,"serious infections, malignancies, upper respiratory tract infection, viral infection, bronchitis, hypertension, rash, sepsis, pneumonia, cellulitis, abscess, opportunistic infections, tuberculosis, invasive fungal infections, liver enzyme elevations, autoimmune disorders, autoantibodies, infusion reactions, immunogenicity, leukopenia, superficial fungal infection, sinusitis, lower respiratory tract infection, pyelonephritis, alanine aminotransferase increased, aspartate aminotransferase increased, neutrophil count decreased, dizziness, paresthesia, constipation, melanoma, systemic hypersensitivity reactions, anaphylactic reaction, sarcoidosis, interstitial lung disease, skin exfoliation, bullous skin reactions, hepatitis B reactivation, congestive heart failure, demyelinating disorders, hematologic cytopenias, pancytopenia, aplastic anemia, thrombocytopenia"
313,SIRTURO,all-concat,"increased mortality, QT prolongation, hepatotoxicity, nausea, arthralgia, headache, hemoptysis, chest pain, anorexia, transaminases increased, rash, blood amylase increased, aminotransferase elevations, ventricular arrhythmia, Torsade de Pointes, congenital long QT syndrome, hypothyroidism, bradyarrhythmias, uncompensated heart failure, clinically significant ventricular arrhythmia, syncope"
314,STENDRA,all-concat,"headache, flushing, nasal congestion, nasopharyngitis, back pain, upper respiratory infection, bronchitis, influenza, sinusitis, sinus congestion, hypertension, dyspepsia, nausea, constipation, rash, dizziness, arthralgia, diarrhea, edema peripheral, fatigue, angina, unstable angina, deep vein thrombosis, palpitations, gastritis, gastroesophageal reflux disease, hypoglycemia, blood glucose increased, alanine aminotransferase increased, oropharyngeal pain, stomach discomfort, vomiting, muscle spasms, musculoskeletal pain, myalgia, pain in extremity, depression, insomnia, somnolence, vertigo, cough, dyspnea exertional, epistaxis, wheezing, pruritus, balanitis, erection increased, hematuria, nephrolithiasis, pollakiuria, urinary tract infection, electrocardiogram abnormal, gastroenteritis viral, color vision change, non-arteritic anterior ischemic optic neuropathy (NAION), sudden loss of vision, prolonged erection, priapism, sudden decrease or loss of hearing, tinnitus, symptomatic hypotension, bleeding disorders, peptic ulceration, sexually transmitted diseases"
315,STRIBILD,all-concat,"'peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, lactic acidosis, severe hepatomegaly with steatosis, severe acute exacerbations of hepatitis B, new onset or worsening renal impairment, bone effects of tenofovir DF, immune reconstitution syndrome, nausea, diarrhea, ocular icterus, flatulence, fatigue, jaundice, somnolence, headache, dizziness, insomnia, abnormal dreams, rash, suicidal ideation, suicide attempt, allergic reaction, angioedema, hypokalemia, hypophosphatemia, dyspnea, pancreatitis, increased amylase, abdominal pain, hepatic steatosis, hepatitis, increased liver enzymes, rhabdomyolysis, osteomalacia, muscular weakness, myopathy, acute renal failure, renal failure, acute tubular necrosis, Fanconi syndrome, proximal renal tubulopathy, interstitial nephritis, nephrogenic diabetes insipidus, renal insufficiency, proteinuria, polyuria, asthenia, redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement, peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", immune reconstitution syndrome, inflammatory response to indolent or residual opportunistic infections, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome'"
316,TAFINLAR,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, new primary malignancies, tumor promotion in BRAF wild-type melanoma, hemorrhage, venous thromboembolism, cardiomyopathy, ocular toxicities, serious febrile reactions, serious skin toxicity, hyperglycemia, glucose-6-phosphate dehydrogenase deficiency, hyperkeratosis, headache, pyrexia, arthralgia, papilloma, alopecia, palmar-plantar erythrodysesthesia syndrome, chills, fatigue, rash, nausea, vomiting, diarrhea, abdominal pain, peripheral edema, cough, night sweats, decreased appetite, constipation, myalgia, back pain, myalgia, cuSCC, cough, constipation, nasopharyngitis, pancreatitis, hypersensitivity manifesting as bullous rash, interstitial nephritis, vision blurred, transient blindness, stomatitis, asthenia, cellulitis, folliculitis, paronychia, rash pustular, skin papilloma, palmar-plantar erythrodysesthesia syndrome, hyperhidrosis, hypertension, leukopenia, lymphopenia, neutropenia, anemia, thrombocytopenia, increased AST, increased alkaline phosphatase, increased ALT, hyperbilirubinemia, hyperglycemia, increased GGT, hyponatremia, hypoalbuminemia, hypophosphatemia, hypokalemia, increased creatinine, hypomagnesemia, hyperkalemia, hypercalcemia, hypocalcemia, QT prolongation, retinal vein occlusion, interstitial lung disease, cutaneous squamous cell carcinoma, keratoacanthoma, melanoma, basal cell carcinoma, non-cutaneous malignancies, deep vein thrombosis, pulmonary embolism, decreased LVEF, retinal pigment epithelial detachment, uveitis, iritis, fever, rigors, chills, dehydration, renal failure, syncope, serious skin toxicity, secondary infections of the skin, hemolytic anemia, embryofetal toxicity"
317,TANZEUM,all-concat,"'thyroid C-cell tumors, acute pancreatitis, hypoglycemia, hypersensitivity reactions, renal impairment, upper respiratory tract infection, diarrhea, nausea, injection site reaction, cough, back pain, arthralgia, sinusitis, influenza, vomiting, gastroesophageal reflux disease, dyspepsia, constipation, injection site hematoma, injection site erythema, injection site rash, injection site hypersensitivity, injection site hemorrhage, injection site pruritus, pneumonia, atrial fibrillation, atrial flutter, appendicitis, liver enzyme abnormalities, gamma glutamyltransferase (GGT) increase, heart rate increase'"
318,TECFIDERA,all-concat,"'anaphylaxis, angioedema, progressive multifocal leukoencephalopathy, lymphopenia, flushing, abdominal pain, diarrhea, nausea, vomiting, pruritus, rash, albumin urine present, erythema, dyspepsia, aspartate aminotransferase increased, eosinophilia, PML, weakness on one side of the body, clumsiness of limbs, disturbance of vision, changes in thinking, memory, and orientation, confusion, personality changes'"
319,TEFLARO,all-concat,"hypersensitivity reactions, Clostridium difficile-associated diarrhea, direct Coombs' test seroconversion, diarrhea, nausea, rash, constipation, vomiting, increased transaminases, hypokalemia, phlebitis, anemia, eosinophilia, neutropenia, thrombocytopenia, bradycardia, palpitations, abdominal pain, pyrexia, hepatitis, anaphylaxis, Clostridium difficile colitis, hyperglycemia, hyperkalemia, dizziness, convulsion, renal failure, urticaria, agranulocytosis"
320,TIVICAY,all-concat,"hypersensitivity reactions, effects on serum liver biochemistries, fat redistribution, immune reconstitution syndrome, insomnia, fatigue, headache, abdominal pain, abdominal discomfort, flatulence, upper abdominal pain, vomiting, hepatitis, myositis, suicidal ideation, attempt, behavior, or completion, renal impairment, pruritus, rash, depression, abnormal dreams, dizziness, nausea, diarrhea, vertigo, ALT abnormalities, AST abnormalities, creatine kinase abnormalities, hyperglycemia, lipase abnormalities, total neutrophils abnormalities, cholesterol changes, HDL cholesterol changes, LDL cholesterol changes, triglycerides changes, elevated total bilirubin, elevated lipase, worsening or development of transaminase elevations, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", inflammatory response to infections, autoimmune disorders (such as Graves' disease, polymyositis, and Guillain-Barre syndrome)"
321,TOVIAZ,all-concat,"dry mouth, constipation, dyspepsia, nausea, abdominal pain upper, urinary tract infection, upper respiratory tract infection, dry eyes, dysuria, urinary retention, cough, dry throat, edema peripheral, back pain, insomnia, ALT increased, GGT increased, rash, angina, chest pain, gastroenteritis, QT prolongation on ECG, blurred vision, palpitations, hypersensitivity reactions, angioedema with airway obstruction, face edema, dizziness, headache, somnolence, urticaria, pruritus, urinary retention, diverticulitis, irritable bowel syndrome, electrocardiogram QT corrected interval prolongation"
322,TREANDA,all-concat,"myelosuppression, infections, anaphylaxis, infusion reactions, tumor lysis syndrome, skin reactions, other malignancies, extravasation injury, pyrexia, nausea, vomiting, asthenia, fatigue, malaise, weakness, dry mouth, somnolence, cough, constipation, headache, mucosal inflammation, stomatitis, worsening hypertension, hypersensitivity, gastrointestinal disorders, immune system disorders, hematologic abnormalities, increased bilirubin, increased AST, increased ALT, creatinine levels changes, tachycardia, abdominal pain, dyspepsia, gastroesophageal reflux disease, abdominal pain upper, abdominal distension, chills, edema peripheral, chest pain, infusion site pain, pain, catheter site pain, herpes zoster, upper respiratory tract infection, urinary tract infection, sinusitis, febrile neutropenia, oral candidiasis, nasopharyngitis, weight decreased, anorexia, dehydration, decreased appetite, hypokalemia, back pain, arthralgia, pain in extremity, bone pain, headache, dizziness, dysgeusia, insomnia, anxiety, depression, dyspnea, pharyngolaryngeal pain, wheezing, nasal congestion, rash, pruritus, dry skin, night sweats, hyperhidrosis, hypotension, lymphocytes decreased, leukocytes decreased, hemoglobin decreased, neutrophils decreased, platelets decreased, acute renal failure, cardiac failure, pulmonary fibrosis, myelodysplastic syndrome, hemolysis, taste disorder, atypical pneumonia, sepsis, erythema, dermatitis, skin necrosis, anaphylaxis, injection or infusion site reactions, phlebitis, irritation, pain, swelling, pneumocystis jiroveci pneumonia, pneumonitis, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), neutropenic sepsis, diffuse alveolar hemorrhage, opportunistic infection (CMV), myeloproliferative disorders, acute myeloid leukemia, bronchial carcinoma, embryo-fetal toxicity."
323,TRULICITY,all-concat,"thyroid C-cell tumors, pancreatitis, hypoglycemia, hypersensitivity reactions, renal impairment, severe gastrointestinal disease, nausea, diarrhea, vomiting, abdominal pain, decreased appetite, dyspepsia, fatigue, gastrointestinal adverse reactions, constipation, flatulence, abdominal distension, gastroesophageal reflux disease, eructation, documented symptomatic hypoglycemia, severe hypoglycemia, heart rate increase, tachycardia, sinus tachycardia, immunogenicity, systemic hypersensitivity, injection-site reactions, PR interval prolongation, first degree AV block, amylase increase, lipase increase"
324,TUDORZA,all-concat,"paradoxical bronchospasm, worsening of narrow-angle glaucoma, worsening of urinary retention, immediate hypersensitivity reactions, headache, nasopharyngitis, cough, diarrhea, sinusitis, rhinitis, toothache, fall, vomiting, diabetes mellitus, dry mouth, 1st degree AV block, osteoarthritis, cardiac failure, cardio-respiratory arrest, anaphylaxis, angioedema, urticaria, rash, bronchospasm, itching"
325,ULESFIA,all-concat,"ocular irritation, application site irritation, application site anesthesia, hypoesthesia, pain, pruritus, erythema, pyoderma, ocular irritation, application site dryness, application site excoriation, paraesthesia, application site dermatitis, excoriation, thermal burn, dandruff, rash, skin exfoliation, gasping syndrome, eye irritation, contact dermatitis"
326,ULORIC,all-concat,"'peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, increased toxicity, hepatotoxicity, liver function abnormalities, nausea, arthralgia, rash, dizziness, anemia, idiopathic thrombocytopenic purpura, leukocytosis/leukopenia, neutropenia, pancytopenia, splenomegaly, thrombocytopenia, angina pectoris, atrial fibrillation/flutter, cardiac murmur, ECG abnormal, palpitations, sinus bradycardia, tachycardia, deafness, tinnitus, vertigo, vision blurred, abdominal distention, abdominal pain, constipation, dry mouth, dyspepsia, flatulence, frequent stools, gastritis, gastroesophageal reflux disease, gastrointestinal discomfort, gingival pain, haematemesis, hyperchlorhydria, hematochezia, mouth ulceration, pancreatitis, peptic ulcer, vomiting, asthenia, chest pain/discomfort, edema, fatigue, feeling abnormal, gait disturbance, influenza-like symptoms, mass, pain, thirst, cholelithiasis/cholecystitis, hepatic steatosis, hepatitis, hepatomegaly, hypersensitivity, herpes zoster, contusion, anorexia, appetite decreased/increased, dehydration, diabetes mellitus, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypokalemia, weight decreased/increased, arthritis, joint stiffness, joint swelling, muscle spasms/twitching/tightness/weakness, musculoskeletal pain/stiffness, myalgia, altered taste, balance disorder, cerebrovascular accident, Guillain-Barre syndrome, headache, hemiparesis, hypoesthesia, hyposmia, lacunar infarction, lethargy, mental impairment, migraine, paresthesia, somnolence, transient ischemic attack, tremor, agitation, anxiety, depression, insomnia, irritability, libido decreased, nervousness, panic attack, personality change, hematuria, nephrolithiasis, pollakiuria, proteinuria, renal failure, renal insufficiency, urgency, incontinence, breast pain, erectile dysfunction, gynecomastia, bronchitis, cough, dyspnea, epistaxis, nasal dryness, paranasal sinus hypersecretion, pharyngeal edema, respiratory tract congestion, sneezing, throat irritation, upper respiratory tract infection, alopecia, angio-edema, dermatitis, dermographism, ecchymosis, eczema, hair color changes, hair growth abnormal, hyperhidrosis, peeling skin, petechiae, photosensitivity, pruritus, purpura, skin discoloration/altered pigmentation, skin lesion, skin odor abnormal, urticaria, flushing, hot flush, hypertension, hypotension, activated partial thromboplastin time prolonged, creatine increased, bicarbonate decreased, sodium increased, EEG abnormal, glucose increased, cholesterol increased, triglycerides increased, amylase increased, potassium increased, TSH increased, platelet count decreased, hematocrit decreased, hemoglobin decreased, MCV increased, RBC decreased, creatinine increased, blood urea increased, BUN/creatinine ratio increased, creatine phosphokinase (CPK) increased, alkaline phosphatase increased, LDH increased, PSA increased, urine output increased/decreased, lymphocyte count decreased, neutrophil count decreased, WBC increased/decreased, coagulation test abnormal, low density lipoprotein (LDL) increased, prothrombin time prolonged, urinary casts, urine positive for white blood cells and protein, hepatic failure, jaundice, liver function test results abnormal, liver disorder, anaphylactic reaction, rhabdomyolysis, psychotic behavior including aggressive thoughts, tubulointerstitial nephritis, generalized rash, Stevens Johnson Syndrome, hypersensitivity skin reactions, gout flare, cardiovascular thromboembolic events, myocardial infarction, stroke, hepatic failure, transaminase elevations'"
327,VICTRELIS,all-concat,"'anemia, neutropenia, pancytopenia, hypersensitivity, fatigue, nausea, headache, dysgeusia, agranulocytosis, thrombocytopenia, mouth ulceration, stomatitis, pneumonia, sepsis, angioedema, urticaria, drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, exfoliative rash, exfoliative dermatitis, Stevens-Johnson syndrome, toxic skin eruption, toxicoderma, embryofetal toxicity, decreased hemoglobin, decreased neutrophils, decreased platelets, dyspnea, exertional dyspnea, dizziness, syncope, thromboembolic events, pulmonary embolism, acute myocardial infarction, cerebrovascular accident, deep vein thrombosis, serious infections, life-threatening neutropenia, serious acute hypersensitivity reactions'"
328,VIMIZIM,all-concat,"'anaphylaxis, hypersensitivity reactions, pyrexia, vomiting, headache, nausea, abdominal pain, chills, fatigue, anti-drug antibodies, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, retching, peripheral edema, acute respiratory complications, spinal or cervical cord compression'"
329,VIZAMYL,all-concat,"flushing, headache, increased blood pressure, nausea, dizziness, serious hypersensitivity reaction, dyspnea, chest pressure, hypersensitivity reactions, radiation risk"
330,VORAXAZE,all-concat,"serious allergic reactions, anaphylactic reactions, paraesthesias, flushing, nausea and/or vomiting, hypotension, headache, myelosuppression, mucositis, acute hepatitis, renal dysfunction, renal failure, paresthesia, blurred vision, diarrhea, hypersensitivity, hypertension, rash, throat irritation, throat tightness, tremor"
331,XALKORI,all-concat,"'hepatotoxicity, interstitial lung disease/pneumonitis, QT interval prolongation, bradycardia, severe visual loss, vision disorders, diarrhea, nausea, vomiting, constipation, edema, elevated transaminases, upper respiratory infection, decreased appetite, dysgeusia, dyspnea, pulmonary embolism, septic shock, acute respiratory failure, diabetic ketoacidosis, nausea, elevated transaminases, hepatotoxicity, ILD, vision disorder, vomiting, diarrhea, constipation, dyspepsia, dysphagia, abdominal pain, edema, pyrexia, upper respiratory infection, weight increased, pain in extremity, muscle spasm, dizziness, dysgeusia, headache, neuropathy, rash, renal cyst, ILD, syncope, neutropenia, lymphopenia, ALT elevation, AST elevation, hypophosphatemia, pneumonia, pulmonary embolism, dyspnea, ILD, respiratory failure, sepsis, alanine aminotransferase (ALT) elevation, QTc prolongation, neutropenia, ILD, ALT and AST elevation, dyspnea, pulmonary embolism, dizziness, dysgeusia, syncope, vision disorder, vomiting, nausea, diarrhea, constipation, dyspepsia, upper respiratory infection, pulmonary embolism, edema, fatigue, neuropathy, rash, ILD, renal cyst, hepatic failure, neutropenia, lymphopenia, ALT elevation, AST elevation, hypokalemia, hypophosphatemia, visual impairment, photopsia, blurred vision, vitreous floaters, sensory neuropathy, renal cysts, hepatotoxicity, fatal hepatotoxicity, ILD/pneumonitis, QTc prolongation, symptomatic bradycardia, severe visual loss, embryofetal toxicity, optic atrophy, optic nerve disorder'"
332,XEOMIN,all-concat,"hypersensitivity, dysphagia, breathing difficulties, spread of effects from toxin, cervical dystonia, neck pain, muscle weakness, injection site pain, musculoskeletal pain, blepharospasm, eyelid ptosis, dry eye, dry mouth, diarrhea, headache, visual impairment, dyspnea, nasopharyngitis, respiratory tract infection, glabellar lines, facial paresis, injection site hematoma, eyelid edema, eye swelling, nausea, flu-like symptoms, injection site reaction, allergic dermatitis, localized allergic reactions, swelling, edema, erythema, pruritus, rash, herpes zoster, muscular weakness, muscle spasm, dysarthria, myalgia, asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphonia, urinary incontinence, corneal exposure, corneal ulceration, ectropion, ecchymosis"
333,XIAFLEX,all-concat,"tendon ruptures, injury to the injected extremity, corporal rupture (penile fracture), severe penile hematoma, penile ecchymoses, sudden penile detumescence, penile ""popping"" sound or sensation, edema peripheral, contusion, injection site hemorrhage, injection site reaction, pain in the injected extremity, tenderness, injection site swelling, pruritus, lymphadenopathy, skin laceration, lymph node pain, erythema, axillary pain, vasovagal syncope, flexor tendon rupture, pulley rupture, ligament injury, complex regional pain syndrome (CRPS), sensory abnormality of the hand, skin laceration (tear), blood blister, injection site hematoma, ecchymosis, penile swelling, penile pain, penile blister, pruritus genital, painful erection, erectile dysfunction, skin discoloration, procedural pain, injection site vesicles, localized edema, dyspareunia, injection site pruritus, nodule, suprapubic pain, hypersensitivity reactions, anaphylaxis, ecchymosis/contusion, injection site hemorrhage, penile hematoma, penile ecchymosis, allergic reactions (pruritus), severe allergic reactions, IgE-anti-drug antibodies"
334,XTANDI,all-concat,"seizure, asthenia/fatigue, back pain, decreased appetite, constipation, arthralgia, diarrhea, hot flush, upper respiratory tract infection, peripheral edema, dyspnea, musculoskeletal pain, weight decreased, headache, hypertension, dizziness/vertigo, peripheral edema, muscular weakness, musculoskeletal stiffness, diarrhea, hot flush, hypertension, headache, dizziness, spinal cord compression and cauda equina syndrome, paresthesia, mental impairment disorders, hypoesthesia, upper respiratory tract infection, lower respiratory tract and lung infection, insomnia, anxiety, hematuria, pollakiuria, fall, non-pathologic fractures, pruritus, dry skin, epistaxis, constipation, diarrhea, dizziness, dysgeusia, mental impairment disorders, restless legs syndrome, dyspnea, upper respiratory tract infection, lower respiratory tract and lung infection, insomnia, hematuria, fall, non-pathological fracture, decreased appetite, weight decreased, gynecomastia, neutropenia, thrombocytopenia, elevations in ALT, elevations in bilirubin, infections, sepsis, falls and fall-related injuries, hypertensive crisis"
335,YERVOY,all-concat,"immune-mediated enterocolitis, immune-mediated hepatitis, immune-mediated dermatitis, immune-mediated neuropathies, immune-mediated endocrinopathies, ocular manifestations, fatigue, diarrhea, pruritus, rash, colitis, gastrointestinal disorders, skin and subcutaneous tissue disorders, general disorders and administration site conditions, enterocolitis, hepatotoxicity, dermatitis, neuropathy, endocrinopathy, hypopituitarism, adrenal insufficiency, pneumonitis, meningitis, nephritis, eosinophilia, pericarditis, urticaria, large intestinal ulcer, esophagitis, acute respiratory distress syndrome, renal failure, infusion reaction, DRESS syndrome, Guillain-Barre syndrome, peripheral motor neuropathy, myasthenia gravis, hypothyroidism, hyperthyroidism, Cushing's syndrome, hypophysitis, nephritis, pneumonitis, meningitis, pericarditis, uveitis, iritis, hemolytic anemia, myocarditis, angiopathy, temporal arteritis, vasculitis, polymyalgia rheumatica, conjunctivitis, blepharitis, episcleritis, scleritis, leukocytoclastic vasculitis, erythema multiforme, psoriasis, pancreatitis, arthritis, autoimmune thyroiditis, sarcoidosis, neurosensory hypoacusis, autoimmune central neuropathy (encephalitis), myositis, polymyositis, ocular myositis"
336,ZERBAXA,all-concat,"hypersensitivity reactions, Clostridium difficile-associated diarrhea, nausea, diarrhea, headache, pyrexia, constipation, insomnia, vomiting, hypokalemia, ALT increased, AST increased, anemia, thrombocytosis, abdominal pain, anxiety, dizziness, hypotension, atrial fibrillation, rash, renal impairment, renal failure, cardiac disorders, tachycardia, angina pectoris, gastrointestinal disorders, ileus, gastritis, abdominal distension, dyspepsia, flatulence, ileus paralytic, general disorders and administration site conditions, infusion site reactions, infections and infestations, candidiasis, oropharyngeal, fungal urinary tract infection, investigations, increased serum gamma-glutamyl transpeptidase (GGT), increased serum alkaline phosphatase, positive Coombs test, metabolism and nutrition disorders, hyperglycemia, hypomagnesemia, hypophosphatemia, nervous system disorders, ischemic stroke, respiratory, thoracic and mediastinal disorders, dyspnea, skin and subcutaneous tissue disorders, urticaria, vascular disorders, venous thrombosis"
337,ZYDELIG,all-concat,"hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, severe cutaneous reactions, anaphylaxis, neutropenia, fatal hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, hepatotoxicity, diarrhea, colitis, pneumonitis, intestinal perforation, severe cutaneous reactions, anaphylaxis, neutropenia, embryo-fetal toxicity, ALT elevations, AST elevations, neutrophil count decreased, lymphocyte count decreased, lymphocyte count increased, GGT increased, hypertriglyceridemia, hyperglycemia, hypoglycemia, hyponatremia, ALT increased, AST increased, neutrophils decreased, hemoglobin decreased, platelets decreased, toxic epidermal necrolysis (TEN), dermatitis exfoliative, rash, rash erythematous, rash generalized, rash macular, rash maculo-papular, rash papular, rash pruritic, exfoliative rash, skin disorder"
338,ZYKADIA,all-concat,"Severe or Persistent Gastrointestinal Toxicity, Hepatotoxicity, Interstitial Lung Disease/Pneumonitis, QT Interval Prolongation, Hyperglycemia, Bradycardia, Pancreatitis, Embryofetal Toxicity, Diarrhea, Nausea, Vomiting, Abdominal pain, Constipation, Esophageal disorder, Fatigue, Decreased appetite, Rash, Interstitial lung disease/pneumonitis, Neuropathy, Vision disorder, Prolonged QT interval, Hemoglobin decreased, Alanine transaminase (ALT) increased, Aspartate transaminase (AST) increased, Creatinine increased, Glucose increased, Phosphate decreased, Lipase increased, Bilirubin (total) increased, Convulsion, Pneumonia, Dyspnea, Dehydration, Hyperglycemia, Respiratory failure, Pneumothorax, Gastric hemorrhage, General physical health deterioration, Pulmonary tuberculosis, Cardiac tamponade, Sepsis"
339,ZYTIGA,all-concat,"hypertension, hypokalemia, fluid retention, adrenocortical insufficiency, hepatotoxicity, fatigue, joint swelling, discomfort, edema, hot flush, diarrhea, vomiting, cough, dyspnea, urinary tract infection, contusion, anemia, elevated alkaline phosphatase, hypertriglyceridemia, lymphopenia, hypercholesterolemia, hyperglycemia, elevated AST, hypophosphatemia, elevated ALT, muscle discomfort, dyspepsia, upper respiratory tract infection, urinary frequency, nocturia, fractures, arrhythmia, chest pain, chest discomfort, cardiac failure, non-infectious pneumonitis, myopathy, rhabdomyolysis, pyrexia, groin pain, constipation, insomnia, falls, nasopharyngitis, hematuria, rash, hypernatremia, myocardial ischemia, myocardial infarction, cardiorespiratory arrest"
